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901-125 Long-Term Electrical Conduction Across Human Adult 
Mesenchymal Stem Cells Connecting Two Fields 
of Cultured Cardiomyocytes and the Effect of Cx43 
Knockdown by RNA Interference
Daniël A. Pijnappels, John van Tuyn, Twan A. de Vries, Arnoud van der Laarse, Ernst 
E. van der Wall, Martin J. Schalij, Douwe E. Atsma, Leiden University Medical Center, 
Leiden, The Netherlands
Background: Previously we showed the ability of bone-marrow derived human adult 
mesenchymal stem cells (hMSCs) to restore a conduction block for 48 h. To assess 
whether this beneﬁcial effect is sustained we studied the long-term conduction properties 
of hMSCs. Furthermore we studied the role of Connexin43 (Cx43), a major component 
of gap junctions, in current conduction across hMSCs using RNA interference (RNAi) 
technique.
Methods: Neonatal rat cardiomyocytes (CMCs) are cultured in Multi Electrode Arrays 
(Multichannel Systems, Germany). After 2 days, a spontaneously and synchronously 
beating monolayer is present. By abrasion of a central channel in this monolayer, two 
asynchronously beating CMC ﬁelds are created. hMSCs are transfected by adeno-viral 
constructs knocking down Cx43 (hMSCs-Cx43↓) or Fireﬂy luciferase (pLuc) ( (hMSCs-
pLuc↓) as control. Then, 5x104 hMSCs-Cx43↓ or hMSCs-pLuc↓ are applied in the 
channel. Conduction velocity (CV) across the channel with hMSCs is measured for up to 
14 days and compared with CV across CMCs.
Results: In the control group, hMSCs-pLuc↓ (n=4) restored conduction between two 
CMC ﬁelds in all monolayers after 24 h. This was sustained for at least 14 days. CV across 
hMSCs-pLuc↓ was stable from 1.4 ±0.3 cm/s (day1) to 1.5±0.6 cm/s (day 7). However, 
from day 7 onwards CV increased persistently to 3.5±0.5 cm/s (day 14). On the other 
hand, hMSCs-Cx43↓ (n=5) did not restore conduction between two CMC ﬁelds. Western 
blot analysis showed a >70% decrease in Cx43 expression in hMSCs-Cx43� compared 
to hMSCs-pLuc↓. Across CMCs (n=9) CV was constant at 14-15 cm/s throughout 14 
days. Cx43 immunostaining was observed between 1. adjacent CMCs and 2. adjacent 
CMCs and hMSCs-pLuc↓. However, no Cx43 immunostaining could be observed in 
hMSCs-Cx43↓.
Conclusions: Bone-marrow derived human adult mesenchymal stem cells (hMSCs) are 
able to restore conduction for at least 14 days. Conduction velocity (CV) across hMSCs 
increases over time, however it remains lower than CV across cardiomyocytes (CMCs). 
hMSCs with a reduction of at least 70% in Connexin43 (Cx43) expression are not able 
to restore electrical conduction. Cx43 is essential for electrical coupling between CMCs 
and hMSCs.
901-126 Signiﬁcant Low-Voltage ECG and Impaired Systolic 
Cardiac Function in Neonatal Mice Expressing 
Connexin 31 Instead of 43
Alexander Ghanem, Qingyi Zheng-Fischhofer, Jorg O. Schwab, Jung-Sun Kim, Mark 
Kibschull, Gaby Schwarz, James Nagy, Elke Winterhager, Berndt Luderitz, Klaus 
Willecke, Klaus Tiemann, University of Bonn, Bonn, Germany, Institute of Genetics, 
University of Bonn, Bonn, Germany
Background: Deﬁciency for Connexin43 (Cx43) is the cause for early postnatal death 
in mice due to obstruction of the right ventricular outﬂow tract. Aim of the study was to 
determine the impact of substitution of Cx43 with Cx31 in Cx43-knock-in-Cx31 mouse 
model (Cx43KI31).
Methods: 6-lead ECG was performed in 81 neonatal mice (23 wild type (WT), 43 
heterozygous (HT), 15 homozygous (HO)) on ﬁrst postnatal day (P0). ECG channels were 
ampliﬁed, ﬁltered between 10 and 100 Hz and sampled with a rate of 2 kHz. All standard 
ECG parameters were evaluated off-line in signal-averaged ECG (ADInstruments, Milford, 
MA, USA). High-resolutional 2-D echocardiography (HDI 5000, Philips Ultrasound, 
Bothell, WA, USA) was performed in 18 mice (4 WT, 9 HT, 5 HO) on P4.
Results: The offspring of heterozygous and homozygous Cx43KI31 mice resulted in 
Mendelian frequencies, but all homozygous Cx43KI31 mice died before P12. Neonatal 
homozygous Cx43KI31 hearts showed irregular hypertrophic trabeculae with abnormal 
pouches in the subpulmonary outlet of the right ventricle similar to general Cx43 deﬁcient 
mice. Electrocardiography of P0 mice revealed signiﬁcantly lower heart rates in the HO 
group (295 bpm ± 25) as compared to WT and HT (362 bpm ± 65, 325 bpm ± 35, p < 
0.05). Moreover, voltage of the QRS complex - expressed as mean sum of Einthoven’s 
leads I and II - was signiﬁcantly lower in homozygous Cx43KI31 animals (188 µV ± 77) 
as compared to WT and HT (1300 µV ± 418, 1096 µV ± 390, p<0.001). Echocardiography 
revealed signiﬁcantly lower ejection fraction in HO mice (65% ± 10) as compared to WT 
and HT mice (87% ± 7, 78% ±10, p<0.01) indicating reduced systolic function in mice 
lacking Cx43.
Conclusion: Lack of Cx43 in homozygous Cx43KI31 mice might increase proportion 
of slow signal progression in the transverse direction, resulting in destruction of cardiac 
uniform anisotropy. Dispersion of the electrical vector might explain signiﬁcant low voltage 
and impaired systolic left-ventricular function.
901-127 Conditional Expression of a Gain of Function Alpha-5 
Integrin in Adult Mouse Heart Increases Ventricular 
Automaticity
Nathan M. Segerson, Ping Hu, Dongfang Zhang, Sheldon E. Litwin, University of Utah, 
Salt Lake City, UT
Background: Previous studies have shown contractile dysfunction, reduced ECG voltage, 
reduced connexin43 expression, and increased mortality in transgenic mice expressing a 
gain-of-function alpha-5 integrin. To determine the electrophysiological consequences of 
this mutation, we performed serial epicardial in vivo EP studies, before and after activation 
of the doxycycline (Dox) regulated transgene.
Methods: EP studies were performed usin a multi-electrode catheter placed on the 
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901-123 Connexin30.2 Containing Gap Junction Channels 
Decelerate AV-nodal Conduction
Jan W. Schrickel, Maria Kreuzberg, Alexander Ghanem, Jung-Sun Kim, Joachim Degen, 
Klaus Tiemann, Berndt Lüderitz, Thorsten Lewalter, Klaus Willecke, University of Bonn, 
Bonn, Germany, Inst. for Genetics, University of Bonn, Bonn, Germany
Background: In the mammalian heart, gap junction channels between electrically coupled 
cardiomyocytes are necessary for impulse propagation and coordinated contraction of 
atria and ventricles. Recently, mouse connexin30.2 (Cx30.2) was shown to be expressed 
in the cardiac conduction system, predominantly in the sinoatrial and atrioventricular 
nodes. The corresponding gap junctional channels exhibit the lowest unitary conductance 
of all connexin channels. The aim of the present study was to evaluate in vivo effects of 
connexin30.2 depletion on murine cardiac electrophysiological properties. 
Methods: 25 mice [16 male, 14 Cx30.2 deﬁcient mice (expressing a LacZ reporter 
gene instead of connexin30.2 coding region: Cx30.2LacZ/LacZ) and 11 wild-type littermates 
(Cx30.2+/+)] were electrophysiologically examined. Transvenous catheterization with 
intracardiac recording and stimulation was performed in all animals. Surface ECG and 
standard electrophysiological parameters were analyzed. 
Results: Cx30.2LacZ/LacZ exhibit, at equal P-wave durations, a PQ interval that is about 
25% shorter as compared to Cx30.2+/+ (35 ± 3.9 ms versus 47 ± 4.9 ms, P<0.0001). Atrial 
(A), His (H) and ventricular (V) signals show that this acceleration of AV-nodal conduction 
is attributed to signiﬁcantly accelerated supra-Hisian conduction (AH: 27.9 ± 5.1 ms in 
Cx30.2LacZ/LacZ compared to 37.1 ± 4.1 ms in Cx30.2+/+; P<0.0001), whereas infra-Hisian 
conduction is unchanged. In analogy, atrial ﬁxed rate stimulation revealed a signiﬁcantly 
reduced Wenckebach periodicity of 78 ± 7.5 ms in Cx30.2LacZ/LacZ versus 87 ± 7.9 ms 
in wild type mice (P=0.018). Conclusions: Our results show that the newly discovered 
Cx30.2 accounts for a relevant slow-down of impulse propagation in the murine AV-node, 
which is signiﬁcantly accelerated when Cx30.2 is missing. Thus, Cx30.2 and its human 
orthologue, Cx31.9 are likely to contribute to the protective function of the AV-node 
against rapid conduction of supraventricular tachyarrhythmias. Moreover, they might be 
pathophysiologically involved in functional and morphological disorders of the AV-node, 
such as dual-pathway formation in AV-nodal reentry tachycardias.
901-124 Forced Expression of Human Myocardin Increases 
Electrical Conduction Velocity Across Human Adult 
Mesenchymal Stem Cells to Levels Comparable to 
Cardiomyocytes.
Daniël A. Pijnappels, John van Tuyn, Arnoud van der Laarse, Twan A. de Vries, Ernst 
E. van der Wall, Martin J. Schalij, Douwe E. Atsma, Department of Cardiology, Leiden 
University Medical Center, Leiden, The Netherlands
Background: Previously we showed that human adult mesenchymal stem cells (hMSCs) 
can repair experimental conduction block. Secondly, after forced expression of human 
cardiogenic transcription factor myocardin (Myo) hMSCs express cardiac muscle 
genes. We studied the conduction properties of Myo-hMSCs in a model of experimental 
conduction block.
Methods: Neonatal rat cardiomyocytes (CMCs) are cultured in Multi Electrode Arrays 
(Multichannel Systems, Germany). By abrasion of a central channel in a spontaneously 
beating monolayer, two asynchronously beating CMC ﬁelds are created. Then, either 
5x104 GFP labelled Myo-hMSCs are applied crossing the channel, or LacZ-hMSCs, 
which serve as control. After 24 h, current conduction between the two CMC ﬁelds is 
present for both cell types. Conduction velocity (CV) across the channel with Myo-hMSCs 
is measured for 8 days, and compared with CV across LacZ-hMSCs and CMCs.
Results: At day 1, CV across CMCs (n=9) is 16.9±0.8 cm/s compared to 1.1±0.1 cm/s 
and 2.9±0.1 cm/s across LacZ-hMSCs (n=5) and Myo-hMSCs (n=4), respectively (ﬁg). 
CV across Myo-hMSCs increases steadily to 14.1±1.9 cm/s after 8 days, while CV across 
CMCs and LacZ-hMSCs does not change signiﬁcantly. Immunostaining shows a time-
dependent increase in fast-sodium ion channel (SCN5A) expression in Myo-hMSCs.
Conclusions: hMSCs expressing myocardin exhibit an increase in CV that is comparable 
to CMCs. Increased expression of SCN5A in hMSCs expressing myocardin may contribute 
to the increased CV.
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anterior epicardium via left-sided thoracotomy. Studies were performed at baseline and 
after 5-10 days of Dox (n=5).
Results: Baseline rhythm, RR, PR, and QRS intervals, AV conduction, and atrial / 
ventricular refractory periods did not change signiﬁcantly. The mean QTc increased (113 
vs. 140ms, p<0.05). At baseline, recovery after all pacing drives during EP study occurred 
mainly via sinus node (88%) or fusion beats (8%). After transgene activation, recovery 
was mainly via nonsustained ventricular rhythms (21%) or sustained ventricular rhythms 
(65%). This trend was seen equally with atrial or ventricular pacing (p=0.67). See ﬁgure 
for example tracings. 
Conclusions: Despite stable sinus and AV nodal function, there is a dramatic shift 
toward earlier ventricular activation and sustained ventricular rhythms in recovery 
from pacing drives in mice expressing a gain-of-function integrin alpha-5 transgene. 
This ﬁnding suggests a possible important role of integrin dysregulation in ventricular 
arrhythmogenesis.
901-128 Cardiac Kir2.x Channels in Homomeric and Heteromeric 
Composition Are Markedly Activated by Adrenergic β3-
Receptors: Role of Protein Kinases A and C
Daniel Scherer, Edgar Zitron, Claudia Kiesecker, Sonja Lück, Ramona Bloehs, Eberhard 
P. Scholz, Markus Alter, Sven Kathöfer, Dierk Thomas, Volker A.W. Kreye, Johann Kiehn, 
Christoph A. Karle, Department of Cardiology, Heidelberg, Germany
Background: In human cardiomyocytes the cardiac inwardly rectifying potassium current 
IK1 is essential to maintain the resting membrane potential. An increase of cardiac IK1 
current is associated with novel Short QT Syndrome Type 3. Adrenergic β3-receptors are 
increasingly recognised to contribute to cardiac physiology and pathophysiology. There 
is mounting evidence that heteromeric assembly of Kir2.1, Kir2.2 and Kir2.3 potassium 
channels underlies a main part of the IK1 current. Therefore, we investigated the regulation 
of these channel subunits by β3 adrenergic receptors.
Methods: Human adrenergic β3-receptors and Kir2.1, Kir2.2 and Kir2.3 potassium 
channels were coexpressed in Xenopus oocytes. Experiments were performed using two-
microelectrode voltage-clamp.
Results: Activation of β3-receptors with isoproterenol (10 µM) resulted in markedly 
increased currents in Kir2.1 (+50%) and in Kir2.2 (+104%) potassium channels. In 
Kir2.3 channels, activation was only weak (+15%). Coapplication of speciﬁc inhibitors of 
proteinkinase A (KT-5720) and calmodulinkinase (KN-93) had no effects on the observed 
regulation in Kir2.1. However, coapplication of proteinkinase C inhibitors staurosporine 
and chelerythrine suppressed the observed effect. In Kir2.2, coapplication of KT-5720 
(+39%) reduced the effect of �3-receptor activation. No differences in current increase 
after application of isoproterenol (10 µM) were observed between mutant Kir2.2 potassium 
channels lacking all functional PKC phosphorylation sites and Kir2.2 wild-type channels. 
In heteromeric Kir2.x channels, all types of heteromers were activated: In Kir2.1/Kir2.3 
channels (+31%) activation was only weak. However, in Kir2.1/Kir2.2 (+72%) and in 
Kir2.2/Kir2.3 channels (+141%) activation was very pronounced.
Conclusions:
Homomeric and heteromeric Kir2.x channels are activated by β3 adrenergic receptors 
via different protein kinase dependent pathways: Kir2.1 subunits are modulated by PKC 
whereas Kir2.2 is modulated by PKA. Kir2.2 channel subunits seem to play a major role 
in this regulation. These results elucidate further details of the molecular mechanisms of 
adrenergic regulation of cardiac IK1 current.
901-129 ZnT-1, A Missing Link in the Regulation of Cardiac L-
Type Calcium Channels
Ofer Beharier, Yoram Etzion, Amos Katz, Hani Friedman, Nir Tenbosh, Saar Zacharish, 
Enbal Bental, Uri Goshen, Arie Moran, Ben-Gurion University, Beer-Sheva, Israel, 
Soroka University Medical Center, Beer-Sheva, Israel
BACKGROUND: L-type calcium channels (LTCC) play a key role in cardiac function. ZnT-
1 is a ubiquitous protein shown to inhibit cationic inﬂux. We studied ZnT-1 effects on the 
LTCC activity in Xenopus oocytes and cardiomyocytes in culture attempting to elucidate 
its, yet unknown activity, in the heart. METHODS AND RESULTS: In Xenopus oocytes, 
two electrode voltage clamp measurements showed that ZnT-1 co expressed with the 
LTCC led to reduction of the LTCC current with no apparent shift in the current -voltage 
relationship (n=5). In isolated rat cardiomyocytes, ZnT-1 expression was increased by 
transfection to 464±55 % of control (n=5, p<0.05), while siRNA designed to inhibit ZnT-
1 expression, decreased the expression of ZnT-1 in cardiomyocytes to 60.6±3.6 % of 
control (n=4, p<0.05). In the cardiomyocytes the nifedipine sensitive Ba2+ inﬂux, assessed 
by fura-2 and application of high K+ (ﬁgure), was reduced in ZnT-1 transfected cells to 
51.0±2.5 % of controls (p<0.01), while siRNA increased the inﬂux to 167.0±4.25 % 
(p<0.01). The ﬁgure shows that rapid pacing of cardiomyocytes, at double threshold 
intensity, increased ZnT-1 expression to 175±18 % of controls (C) (p<0.01, n=4) and 
reduced Ba2+ inﬂux to 48.0±1.8 % (p<0.01). This was without changes in expression of the 
LTCC α1c subunit. CONCLUSIONS: Our ﬁndings are consistent with ZnT-1 being a major 
physiological inhibitor of the cardiac LTCC. Consequently, ZnT-1 seems to be a missing 
link in tachycardia-induced cardiac electrical remodeling.
901-130 Hydrogen Peroxide-Induced Arrhythmogenic Activity 
and Contractile Dysfunction of Ventricular Myocytes is 
Reduced by a Blocker of Late Sodium Current
Yejia Song, John C. Shryock, Luiz Belardinelli, University of Florida, Gainesville, FL, CV 
Therapeutics, Inc., Palo Alto, CA
Background: Reactive oxygen species, including hydrogen peroxide (H2O2), cause 
intracellular calcium overload and ischemia-reperfusion damage. This study examined 
the hypothesis that H2O2-induced arrhythmic activity and contractile dysfunction are the 
result of an effect of H2O2 to increase the magnitude of the late sodium current (late 
INa). Methods: Guinea pig isolated ventricular myocytes were exposed to H2O2 (200 
µmol/L) for up to 15 min. Transmembrane voltages and currents, and twitch shortening 
were measured using the whole-cell patch-clamp technique and a video edge detector, 
respectively. Results: H2O2 markedly and time-dependently prolonged the action 
potential duration (APD) and induced early afterdepolarizations (EADs). H2O2 caused 
a persistent late INa that was almost completely inhibited by tetrodotoxin (10 µmol/L; n 
= 5). H2O2 slowed the relaxation rate of a contraction from 12.2±1.0 to 7.3±1.3 µm/sec 
and induced EADs. Ranolazine (10 µmol/L), a novel inhibitor of late INa, attenuated H2O2-
induced late INa by 51±9 % (n = 10, p < 0.01). Ranolazine (10 µmol/L) attenuated H2O2-
induced APD prolongation by 58±8% (n = 8, p < 0.001) and inhibited the EADs (n = 
3). Ranolazine delayed the development of APD prolongation caused by exposure to 
H2O2. The increases in APD after a 9-min exposure of myocytes to H2O2 in the presence 
and absence of ranolazine (10 µmol/L) were 6±4% and 42±6%, respectively (n = 6, p 
< 0.001). Ranolazine (10 µmol/L) increased the twitch relaxation rate from 7.3±1.3 to 
15.0±1.9 µm/sec in the presence of H2O2 (n = 5, p < 0.001) and abolished H2O2-induced 
aftercontractions. Conclusion: The results conﬁrm the hypothesis that an increase of late 
INa during exposure of ventricular myocytes to H2O2 contributes to electrical and contractile 
dysfunction, and suggest that inhibition of late INa may offer protection against free radical-
induced sodium-calcium overload and myocyte damage.
901-131 Cardiac Pacemaker Precursor Cells Can Be Obtained 
From Human Endometrial Mesenchymal Stem Cells for 
Biological Pacemaker Cell Transplantation.
Shunichiro Miyoshi, Nobuhiro Nishiyama, Naoko Hida, Yukinori Ikegami, Yoko Hagiwara, 
Kazuma Okamoto, Taro Uyama, Kenji Miyado, Michiie Sakamoto, Satoshi Ogawa, 
Akihiro Umezawa, Keio University school of Medicine, Tokyo, Japan, National Research 
Institute for Child Health and Development, Tokyo, Japan
Background: Mesenchymal stem cell (MSC)-derived cardiomyocyte with pacemaker 
potential provides us a promising cellular source for making biological pacemaker. 
The pacemaker activity of the MSC-derived cardiomyocyte might disappear after the 
maturation of the cell, thus longevity of the pacemaker activity is important. We have 
reported that the human endometrial MSC (E-MSC) have a higher cardiomyogenic 
potential than marrow derived MSC.
Methods and results: E-MSCs were obtained by the limiting dilution method. Two cell-
lines were selected for the experiment. On day 5 of cardiomyogenic induction, almost 
all of the E-MSC (E-MSC100; 64.1%, E-MSC214; 82.7%) contracted rhythmically and 
synchronously. The cardiomyocyte-speciﬁc action potential (AP) was recorded. The 
observed ratio of pacemaker like potential was signiﬁcantly higher in E-MSC214 (29/41) 
than it in E-MSC100 (1/28, p<0.01). The incidence of pacemaker activity did not decrease 
as a function of time after the induction (1w; 63, 2w; 65, 3w; 100%). The duration of 
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AP was signiﬁcantly shorter in E-MSC214 than E-MSC100 (185 ±16 vs 326 ±12 msec, 
p<0.01). Surface antigen of CD-133 was weakly detected in E-MSC214 while not in E-
MSC100.
Conclusion: The phenotype of cardiac pacemaker cell was stably observed in the 
monoclonal cell line of E-MSC214, but not E-MSC100. Our data suggest the presence of 
precursor cells in CD-133 positive E-MSC that were destined to be a pacemaker cell and 
may be good biomaterial for making cardiac biological pacemaker. 
901-132 In-Vivo Sympathetic Nerve Stimulation Induces Ectopic 
Beats and Focal Atrial Tachycardia from Thoracic Veins 
in Dogs: Insights From Sympathetic Nerve Recording 
and High Density Mapping
Alex Y. Tan, Shengmei Zhou, Byung-Chun Jung, Masahiro Ogawa, Michael C. Fishbein, 
Peng-Sheng Chen, Cedars-Sinai Medical Center, Los Angeles, CA, David Geffen 
School of Medicine, UCLA, Los Angeles, CA
BACKGROUND: The effects of sympathetic tone on thoracic vein arrhythmogenicity 
remain unclear.
METHODS: We performed in-vivo recording of stellate ganglia nerve activity (SGNA), 
epicardial thoracic vein mapping with 1792-bipolar electrodes and stellate ganglia (SG) 
stimulation (20Hz, 10-50mA) before and after sinus node (SN) crushing in 8 normal dogs 
followed by Periodic Acid Schiff (PAS) and immunostaining of tissues.
RESULTS: No spontaneous arrhythmia was present at baseline. SG stimulation 
triggered SGNA, with signiﬁcant elevations of transcardiac norepinephrine (NE) levels 
from -20 ± 78 to 1752 ± 339 pg/ml, P<0.001), blood pressure from 77 ± 25 to 142 ± 
33 mmHg (P<0.01) and heart rate from 115 ± 14 to 195 ± 35 bpm (P<0.01). Before SN 
crushing, SG stimulation induced atrial tachycardia in 2/8 dogs, arising from the anterior 
RA and left superior pulmonary vein (LSPV) respectively. After SN crushing but without 
SG stimulation, a slow junctional rhythm (51 ± 6 bpm) was observed. Subsequent SG 
stimulation resulted in induction of ectopic beats in 7/8 dogs (n=20 episodes) arising 
from the LA (n=2), RA (n=5), PVs (n=11) and vein of Marshall (VOM, n=2). The removal 
of the SN coupled with SG stimulation increased the propensity for left sided ectopic 
rhythms (P<0.001), and increased the incidence of thoracic vein (PV or VOM) ectopy 
formation (1/8 dogs vs 7/8 dogs, p<0.05) compared to SG stimulation with functional SN. 
PV tachycardia occurred during SG stimulation in 3/8 dogs (CL 273 ± 35 ms, duration 16 
± 4 sec). No difference in thoracic vein ectopy inducibility was observed between left and 
right SG stimulation (6 vs 7 episodes). PAS staining at the site of ectopy showed abundant 
pale-looking glycogen rich cells morphologically consistent with specialized conducting 
(Purkinje) cells. Immunostaining showed abundant sympathetic (tyrosine hydroxylase 
positive) nerves at those sites.
CONCLUSIONS: Sympathetic nerve stimulation results in local release of NE from 
cardiac nerves. In the absence of a SN, thoracic veins became dominant sites for ectopy 
during SG stimulation. Hyperadrenergic automaticity from PAS-positive specialized 
conduction cells in the PVs are likely sources of ectopic activity.
901-133 Intracellular Calcium Transient Dynamics and the 
Mechanism of Shock-Induced Ventricular Fibrillation 
and Deﬁbrillation in Rabbit Hearts
Gyo-Seung Hwang, Hideki Hayashi, Liang Tang, Masahiro Ogawa, Heidy Hernandez, 
Alex Y Tan, Hrayr S Karagueuzian, James N. Weiss, Shien-Fong Lin, Peng-Sheng Chen, 
Cedars-Sinai Medical Center, LA, CA, David Geffen School of Medicine, LA, CA
Background: The relation between intracellular calcium (Cai) dynamics and the 
mechanisms of shock-induced ventricular ﬁbrillation (VF) (vulnerability) and deﬁbrillation 
(DF) is unclear.
Methods: In 17 Langendorff-perfused rabbit ventricles, we simultaneously mapped 
membrane potential (Vm) and Cai during upper limit of vulnerability (ULV) testing by shock 
on T, and during DF threshold (DFT) testing with up-down protocol using biphasic shocks. 
We analyzed 89 episodes of VF induction by shocks on T and 173 episodes of attempted 
deﬁbrillation. We selected for analyses 80 episodes with postshock activation that started 
from the center of the mapped region.
Results: The ULV and the DFT were 217±81 V and 266±79 V, respectively (p=NS). 
Shock-induced activation resulted in a heterogeneous postshock distribution of Cai with 
the emergence of an area characterized with low Cai surrounded by areas of elevated 
Cai (“Cai sinkhole”). These Cai sinkholes emerged on the Cai map 43±16 ms after the 
shock. The ﬁrst postshock Vm activation always originated from the sinkhole hole 73±20 
ms after shock, and spread in a centrifugal pattern. Sinkholes were present in type-B but 
not type-A successful deﬁbrillation. For shock on T, a Cai sinkhole was present 46±40 ms 
after the shock. The sinkhole was followed 30±19 ms later by propagated wavefronts that 
arose from the sinkhole during late phase 3 of action potential, leading to a spiral wave 
that initiates VF. Assuming that the membrane potential varied from -75 mV to +15 mV in 
S1-paced beats, the take off potential of the ﬁrst postshock activation was -46.2±0.7 mV. 
No sinkhole was present at shock strengths above the ULV. Thapsigargin (200 nM) and 
ryanodine (5 µM) increased APD90 from 176±40 ms to 273±46 ms (P= 0.009), sinus cycle 
length from 492±281 ms to 997±244 ms (p=0.02), decreased ULV from 393±137 V to 
171±99 V (p=0.007) and DFT from 429±141 V to 271±202 V (p=0.005).
Conclusions: We conclude that Cai dynamics is important in the mechanisms of 
vulnerability and deﬁbrillation. The formation of Cai sinkhole in the immediate postshock 
period appears necessary for the initiation of postshock activation perhaps mediated by 
a Cai dependent mechanism.
901-134 Genetic Analysis of Hyperpolarization-activated and 
Cyclic Nucleotide-gated Cation Channels 4 (HCN4) in 
Patients With Bradyarrhythmia
Takahiro Doi, Hidetada Yoshida, Seiko Ohno, Takeru Makiyama, Keiko Tsuji, Yukiko 
Nishio, Kei Nishiyama, Satoshi Shizuta, Masaharu Akao, Takeshi Kimura, Toru Kita, 
Minoru Horie, University Graduate School of Medicine, Kyoto, Japan, Shiga University of 
Medical Science, Otsu, Japan
Background: Sinus rate in heart is primarily determined by pacemaker current, If. 
Hyperpolarization-activated cyclic nucleotide gated cation channels (encoded by HCN4) 
play a key role in generating If. It remains however unknown whether HCN4 mutations 
correlate to bradyarrhythimas, such as sinus nodal dysfunction or AV conduction defect.
Methods and Results: Extensive mutational analyses were conducted for HCN4, 
in patients with bradyarrhythmia (n=32) and their family members (n=8). Written 
informed consent was obtained from all participants according to the guidelines of 
the Institutional Ethics Committee. At ﬁrst, we collected genomic DNAs isolated from 
leukocytes, and screened by exonic PCR ampliﬁcation and denaturing high-performance 
liquid chromatography (DHPLC). Abnormal conformers were analyzed by bidirectional 
sequencing. In a 72-year-old man with sinus bradycardia and AV conduction defect, 
we identiﬁed a single base pair substitution (C to G) of HCN4 at the position of 2900. 
This variation resulted in a missense mutation (S967C), and was not detected in > 80 
healthy individuals. In this patient, we also identiﬁed an SCN5A mutation (4729 ins AA), 
suggesting that he has compound heterozygous mutations of cardiac ion channels. The 
location of S967C was in a C-terminus of HCN4 channel, nearby the cyclic nucleotide 
binding domain which contributes to the regulation of channel gating. Thus, the S967C 
mutation should affect the function of HCN4 channel, and thereby alter the If current 
properties. Among other patients, we also identiﬁed 2 silent mutations; F613F (n=3; 7.5%) 
and P1200P (n=6; 15%) in 9 probands independent of each.
Conclusions: We identiﬁed a novel missense mutation of HCN4 in a patient with 
bradycardia and atrioventricular conduction defect among 40 cases of bradyarrhytmia. 
Mutations of HCN4 appear to be rare in bradyarrhythmias.
901-135 Cardiac P2X4 Receptors: A Physiologic Role in 
Mediating ATP-evoked Current and Regulation in 
Human Atrial Fibrillation
Jian-Bing Shen, David Silverman, Peter Schulman, Michael Azrin, David Hager, 
Jonathan Hammond, Achilles Pappano, Bruce Liang, University of Connecticut Health 
Center, Farmington, CT
Background: Extracellular ATP can regulate cardiac function by augmenting contractility. 
It is not clear how ATP exerts such an effect. The objective here was to determine a 
possible role of the P2X4 receptor (P2X4R) in mediating the extracellular action of ATP in 
cardiac myocytes. Membrane current under voltage clamp was performed in ventricular 
myocytes of wild type (WT) and transgenic (TG) mice with cardiac-speciﬁc overexpression 
of human P2X4R. Methods and Results: Potassium currents and the Na/K pump current 
were suppressed by Cs+ and ouabain, respectively. The P2X receptor agonist 2-meSATP 
induced an inward current at -100 mV that was greater in magnitude (2-fold) in cells from 
TG mice. Replacing external Na+ led to a 2-meSATP-stimulated current outward at all 
potentials positive to -124 mV indicating Na+ and Cs+ as the main charge carriers. In the 
presence of 10 µM Zn2+, or the P2X4R-selective allosteric enhancer ivermectin (3 µM), the 
agonist-stimulated current increased signiﬁcantly in cardiac myocytes from both TG and 
WT hearts. That the 2-meSATP-induced current reversed at 0 mV and that the P2X4R-
selective allosteric enhancer ivermectin could potentiate the agonist-evoked current in 
not only the TG but also the WT myocytes suggest a physiologic role of this receptor in 
the action of extracellular ATP. The regulation of P2X4R was examined in human atria 
obtained from patients with normal sinus rhythm (NSR) or chronic atrial ﬁbrillation (AF). 
After matching for gender, age and cardiac function, the atria of chronic AF patients 
showed a signiﬁcant up-regulation of the P2X4R (AF: 1999 ± 1299 I.U. vs. NSR: 978 ± 602 
I.U., P=0.027, n= 9 pairs, Wilcoxon Signed Rank Sum test) as determined by quantitative 
immunoblotting (Am J Physiol 287: H1096, 2004). Conclusion: P2X4R is an important 
part of the native P2X receptor that mediates the extracellular ATP-induced current in 
mammalian cardiac myocytes. This receptor channel is up-regulated in atria of patients 
with chronic AF.
901-136 New in-vivo Canine Model of Drug-induced Long-QT1 
Syndrome: Beta-adrenergic Challenges Trigger Torsade 
De Pointes
Gallacher David, Van de Water Andre, Hermans An, Lu Hua Rong, Volders Paul, 
Center of Excellence for Cardiovascular Research, Johnson & Johnson Pharmaceutical 
Research &, Beerse, Belgium, Cardiovascular Research Institute, University of 
Maastricht, Maastricht, The Netherlands
Background: the congenital long-QT1 syndrome (LQT1) is caused by genetic defects in 
IKs. Stress and exercise are notorious sympathetic triggers of life-threatening torsade de 
pointes (TdP). ß-Adrenergic receptor (ß-AR) stimulation plays a key proarrhythmic role. 
The electrophysiological mechanisms leading to TdP in LQT1 are still poorly resolved. An 
in-vivo experimental model is lacking.
Methods: adult beagle dogs of either sex (12.0±1.6 kg) were anesthetized with 
lofentanyl/etomidate. ß-AR activity is preserved under these conditions, evident from 
intact chronotropic, inotropic and baroreﬂex responses. The IKs blocker HMR1556 (HMR) 
was administered i.v. to mimic LQT1. Temporal and spatial repolarization parameters 
were measured from ECG lead II and monophasic action potentials (MAP) from left and 
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right ventricular endocardium. The selectivity of HMR for IKs over IKr was studied on stably-
transfected HEK293 or CHO cells expressing either KCNQ1 and KCNE1 or KCNH2.
Results: HMR (1 mg/kg) prolonged the QTc interval from 246±6.7 to 305±12.7 ms 
(+24%), prolonged Tpeak-Tend from 25±2.7 to 70±9.2 ms (+180%), increased beat-to-beat 
QT instability from 2.7±1.0 to 6.0±1.5 ms (+122%) and exaggerated interventricular 
dispersion duration from 29±3.7 to 73±15.5 ms (+152%). All changes: p<0.05 vs 
baseline and vs solvent. ß-AR challenges with isoproterenol (2.5 µg/kg i.v. bolus; n=6) 
on top of HMR exaggerated repolarization abnormalities further, elicited ectopic R on 
T waves and then acceleration-induced TdP in 6/6 dogs vs 0/6 dogs, with either HMR 
or isoproterenol alone. The ß-AR blocker esmolol (5 mg/kg i.v.; n=4) largely prevented 
HMR- and isoproterenol-induced changes. Free plasma level of HMR after 1 mg/kg i.v. 
was 392 ng/mL (0.94 µmol/L) indicating selective IKs inhibition (IC50 = 0.07 µmol/L for IKs vs 
>10 µmol/L for IKr), concurrent with data in canine ventricular myocytes.
Conclusions: we have developed a new canine model of drug-induced LQT1 with 
pronounced repolarization instability. Sudden ß-adrenergic challenges trigger TdP in 
100% of cases. This model could be used to further elucidate the electrophysiological 
mechanisms of LQT1-related TdP in vivo and ﬁnd an adequate therapy.
901-137 Circadian, Daily, and Seasonal Distributions of 
Ventricular Tachyarrhythmias in Patients With 
Implantable Cardioverter-Deﬁbrillator
Arash Aryana, Syed M. Mohiuddin, Chandra S. Pingili, Miranda M. Materi, David A. 
Cloutier, Dennis J. Esterbrooks, Aryan N. Mooss, Creighton University Medical Center, 
Omaha, NE
Background: The aim of this study was to investigate the circadian, daily, and seasonal 
distributions of ventricular tachycardias (VT) and ventricular tachycardias/ﬁbrillation 
requiring antitachycardia pacing/shock therapy (VT/VF), in patients with implantable 
cardioverter-deﬁbrillators (ICD) with ischemic (IHD) and non-ischemic heart disease 
(NIHD).
Methods: We performed retrospective chart reviews of ICD patients at Creighton 
University Medical Center between January 2000 and December 2004.
Results: We analyzed data from 154 consecutive patients (mean age of 67 years, 78% 
male, 71% with IHD, and a mean left ventricular ejection fraction of 34%) during a mean 
follow-up of 34 months. A total of 1,055 episodes of VT and 612 episodes of VT/VF 
occurred. We observed similar distributions in incidence of VT and VT/VF in patients with 
IHD and NIHD. The largest percentage of episodes occurred in January (18% of VT, 17% 
of VT/VF), February (16% of VT, 18% of VT/VF), and December (13% of VT, 15% of 
VT/VF). The percentage of episodes was highest in winter (47% of VT, 51% of VT/VF), 
lowest in summer (14% of VT, 13% of VT/VF), and intermediate in spring (24% of VT, 19% 
of VT/VF) and fall (15% of VT, 17% of VT/VF). A linear regression between number of 
episodes and average daily temperature was statistically signiﬁcant for patients with IHD 
(R2=0.65, p=0.0016) and NIHD (R2=0.71, p=0.0006), and for episodes of VT (R2=0.66, 
p=0.0013) and VT/VF (R2=0.82, p<0.0001), suggesting a greater likelihood of both events 
on colder days irrespective of cardiac disease etiology. A daily variation (p<0.0001) with 
the greatest number of episodes occurring on Fridays (16.5%) and the least occurring on 
Sundays (8.2%) was also present. In addition, a bimodal circadian distribution of episodes 
(p<0.0001) with the largest peak between 8 AM and 1 PM and a smaller peak between 
5 PM and 10 PM was noted.
Conclusions: Occurrence of ventricular tachyarrhythmias appears to follow a circadian, 
daily, and seasonal distribution that is similar in patients with IHD and NIHD. The 
incidence inversely correlates with average daily temperatures implicating a possible role 
for environmental triggers. These ﬁndings may have therapeutic implications.
901-138 Reentry during Ventricular Fibrillation Is Less Common 
Intramurally than Epicardially in Swine
Jian Huang, Kang-An Cheng, Jack M. Rogers, Raymond E. Ideker, University of 
Alabama at Birmingham, Birmingham, AL
Background: Reentry is relatively uncommon on the epicardium during ventricular 
ﬁbrillation (VF) in the pig. A simulation study by others demonstrated that the ﬁlament 
about which reentry rotates occurs much more commonly along than across the long 
axis of myocardial ﬁbers. Since the long axis of ﬁbers is almost parallel to the epicardium 
and endocardium, this simulation suggests that most reentry is intramural during VF. We 
tested this hypothesis.
Methods: Using two 528 channel mapping systems in tandem, we mapped VF from 
three unipolar electrode arrays in 6 open-chest pigs. Two of these arrays consisted of two 
rows of crisscross plunge needles (horizontal and vertical) punched through the midlines 
of the third array, an epicardial mapping plaque (21x24, 2 mm apart). This plaque was 
sutured on the anterior-lateral left ventricular epicardium. The horizontal row consisted 
of 21 needles and the vertical row 24 needles. Each plunge needle held 12 electrodes 
placed 2 mm apart. Thus these three arrays formed three orthogonal mapping planes. 
The vertical row of plunge needles was directed from base to apex of the heart. Four 
electrically-induced VF episodes were mapped simultaneously with these three arrays for 
20 sec. We quantiﬁed the percentage of time reentry was present within each array.
Results: Reentry was present signiﬁcantly more often in the epicardial array (mean +sd 
of 0.8%+0.2% of VF wavefronts) than in the horizontal array (0.2%+0.4%) or the vertical 
array (0.6%+0.2%).
Conclusions: Contrary to the hypothesis, reentry was identiﬁed on the epicardial 
surface more often than on the horizontal or vertical intramural surfaces, indicating that 
the ﬁlament of reentry was more commonly oriented perpendicular to the epicardium 
than parallel to it. Reentry was sparse in all three planes, suggesting that the number of 
simultaneous reentrant circuits present during VF is small.
901-139 Does the Point of Closest Approach Between the 
Esophagus and the Posterior Left Atrium Move with the 
Cardiac Cycle?
Angela Malloy, David Krum, Daniel Bloomgarden, Masood Akhtar, Jasbir Sra, Aurora 
Sinai/St. Luke’s Medical Centers, Milwaukee, WI
Background: Recent approaches to left atrial (LA) ablation for patients with atrial 
ﬁbrillation (AF) have included linear ablations in the posterior LA. This approach has 
raised questions about potentially serious complications - the creation of a ﬁstula in the 
esophagus leading to exsanguination or esophageal perforation leading to mediastinosis. 
We used computed tomography (CT) to determine the areas of the LA and esophagus 
most vulnerable to perforation and to assess the relative movement of these structures 
throughout the cardiac cycle.
Methods: 10 consecutive patients (52.8 ± 9.0 y/o, 4 females, 6 males) undergoing LA 
ablation underwent CT scanning with ECG gated acquisition. Axial image sets were 
generated from data acquired throughout the cardiac cycle in 10 phases, and left atrial 
and esophageal segmentation was performed on a workstation (Advantage Windows, GE 
Health Care, Waukesha, WI). Three dimensional volumes, as well as axial and oblique 
views of the LA and esophagus were analyzed in ten steps (5%, 15%, 25% . . . 95%. 
of the R-R interval) to determine if relative movement between the left atrium and the 
esophagus occurred throughout the cardiac cycle. The point of closest approach between 
the posterior LA and the esophagus was tracked to determine if the most vulnerable area 
moved during systole.
Results: The mean distance from the LA endocardium to the esophageal lumen at the 
point of closest approach varied from 5.1 to 5.7 mm throughout the cardiac cycle. The 
location of this point moved laterally 1.2 mm throughout the cardiac cycle, superior-
inferiorly (S-I) 5.2 mm, and anterior-posteriorly (A-P) 2.0 mm. For comparison, the center 
of mass of the LA moved laterally 1.9 mm throughout the cardiac cycle, S-I 3.9 mm, and 
A-P 2.8 mm.
Conclusions: Creation of RF lesions in the posterior LA that extend through to the lumen 
of the esophagus is a possibility. Linear lesions connecting the left PVs to the right PVs 
actually bisect the area of greatest vulnerability. There is some movement of the most 
vulnerable area with the cardiac cycle, so keeping approximately 6 mm from this location, 
perhaps by locating this line more superiorly across the dome of the left atrium, may 
minimize the risk of complications.
901-140 Atrial Arrhythmias Post Atricure Radiofrequency 
Ablation for Atrial Fibrillation: Findings During Catheter 
Ablation
Oussama M. Wazni, Subramanya Prasad, Dimpi Patel, Mohamed Kanj, Mauricio 
Arruda, Marketa Kozeluhova, Dhanunjaya Lakkireddy, Sergio Thal, Walid Saliba, Robert 
Schweikert, David Martin, David Burkhardt, Patrick Tchou, Andrea Natale, Cleveland 
Clinic Foundation, Cleveland, OH
Background: The Atricure bipolar radiofrequency (RF) system is being used for 
intraoperative ablation of atrial ﬁbrillation (AF).
We describe our ﬁndings in patients undergoing ablation of recurrent atrial arrhythmias 
after Atricure RF ablation for atrial ﬁbrillation.
Methods and results: The management and clinical course of consecutive patients with 
post Atricure arrhythmias refractory to antiarrhythmic drugs between Jan 2003- Dec 2004 
are presented. Fifteen patients presented after 12± 8 months after RF ablation with the 
Atricure for treatment of AF. Three patients underwent the procedure for lone AF with no 
other surgical indication. Twelve patients underwent another surgical procedure: mitral 
valve surgery (6 patients) and CABG (6 patients). Seven patients (47%) had recurrent AF 
secondary to recovered pulmonary vein ostial conduction. Two patients were documented 
to have focal atrial tachycardia which was mapped to the coronary sinus in one patient, 
and to the to the left atrial (LA) septum in another. Two patients had typical cavotricuspid 
isthmus dependent RA atrial ﬂutter (AFL), one patient had RA incisional AFL and 3 had 
LA incisional AFL which was mapped around the right pulmonary veins in one patient 
and around the mitral valve annulus in 2 patients.All patients were treated successfully 
with radiofrequency ablation . At one-year followup all patients were arrhythmia free on 
no antiarrhythmic medications.
Conclusion: After Atricure radiofrquency ablation approximately 40% of patients 
experiencing atrial arrhythmias have AF secondary to PV-LA conduction recovery. 
Moreover, incisional AFL seems to be a common ﬁnding in this group of patients. Catheter 
based mapping and ablation of these arrhythmias seems to be feasible and effective.
901-141 Safety and Efﬁcacy of Remote Ablation by Magnetic 
Catheter in Patients With WPW Syndrome
Carlo Pappone, Gabriele Vicedomini, Nicoleta Sora, Simone Sala, Enrico Frigoli, Maria 
Avitabile, Alﬁo Stuto, Giuseppe Augello, Stefania Sacchi, Alessandra Marzi, Vincenzo 
Santinelli, San Raffaele University Hospital, Milano, Italy
Background: Accessory pathway (AP) itself rather than its insertion is the best target for 
successful ablation but AP electrograms are rarely recorded. We report our experience 
on safety, feasability and efﬁcacy of remote magnetic catheter (MC) guidance in patients 
with WPW syndrome undergoing transcatheter APs ablation.
Methods and Results: 118 consecutive symptomatic patients (76 males; median age, 23 
years) with manifest APs and reproducibly induced atrioventricular reentrant tachycardia 
(AVRT) underwent ablation of 128 APs using MC by remote navigation system NIOBE 
(Stereotaxis, Inc). Transeptal approach was used in 60 patients for mapping and ablation 
of left APs. After catheter positioning, ablation was performed from the control room with 
MC in a temperature-controlled mode (55°C, max 50 W, 60 sec). Ablation end point was 
d wave disappearance, absence of anterograde and retrograde conduction over AP, and 
failure to induce AVRT. MC ablation was successful in all patients in a single session 
without switch to standard catheters (SC). The overall median mapping and ablation time 
was 10 min (range 2 - 30 min), much longer in the ﬁrst 10 patients (24 min; P<0.001). MC 
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recorded electrical activation of Kent bundle in 115/118 patients, that disappeared within 
a few seconds after RF application onset simultaneously with passage of a preexcited 
to a normal QRS complex. Two RF applications of 60 seconds each were delivered in 
all patients. The sites of Kent APs were left-sided in 65, right-sided in 17, para-septal in 
27 and septal in 19 patients. Multiple APs were found in 5 patients. No adverse effects 
occurred during the procedure. At a mean follow-up of 6.2 months neither ventricular 
preexcitation on the ECG nor arrhythmia recurrence occurred.
Conclusions: Electrical recording of Kent bundle and successful ablation of the 
accessory pathway can be commonly obtained by magnetic catheters even in challenging 
sites without complications.
901-142 Remote Radiofrequency Ablation of Left Sided 
Accessory Pathways Using the Retrograde Transaortic 
Approach: A Comparison of Catheters With Different 
Magnetic Mass
Andrew S. Thornton, Maximo Rivero-Ayerza, Paul Knops, Dominic A. Theuns, Luc J. 
Jordaens, Erasmus Medical Centre, Rotterdam, The Netherlands
Background: A novel magnetic navigation system (Stereotaxis, St. Louis, MO, USA) 
has been designed with the purpose of allowing remote guidance of radiofrequency (RF) 
ablation catheters and guide-wires. The different magnetic masses (Mm) of these catheters 
probably determine their ability to be remotely steered and consequently their performance 
during RF ablation. Our objectives were to evaluate the feasibility of performing RF ablations 
of left sided accessory pathways (AP) using the retrograde trans-aortic approach and to 
compare the performance of 2 catheters with different magnetic mass.
Methods: 18 consecutive pts with left sided AP were included. In all cases RF ablation 
was performed using a retrograde trans-aortic approach. In 6 pts a Helios II (Stereotaxis) 
RF catheter with lower Mm was used (Low Mm). In 12 pts a Celsius RMT (Biosense 
Webster) with higher Mm was used (High Mm).
Results: 
Low Mm High Mm P value
N 6 12
Success (y/n) 3/3 10/2
Proc. Time (min) 232±51 175±48 0.0001
Physician ﬂuoro time (min) 5.7±2.7 3±1.95 0.001
Pt. Fluoro time 35±23 27±21 0.015
RF time (min) 8.2±5.7 4±3.15 0.005
# RF applications 14.5±12 9.6±9 0.012
No complications were observed in any group. The failed ablations were all successfully 
treated with a conventional RF catheter, in the Low Mn group all retrogradely, and in the 
High Mm group 1 retrogradely, while 1 required a transseptal approach.
Conclusions: Remote ablation of left sided APs is safe and feasible using the retrograde 
trans-aortic approach. It also reduces physician’s exposure to ﬂuoroscopy. Using a 
catheter with higher magnetic mass signiﬁcantly improves success rate, and reduces 
procedure and ﬂuoroscopy times in this patient group.
901-143 Clopidogrel is Associated With a Reduced 
Thrombogenic Response in Radiofrequency Ablation 
Procedures Compared to Aspirin
Kostas Polymeropoulos, Vassilis Vassilikos, Stelios Paraskevaidis, Pantelis Makris, 
Theodoros Karamitsos, Sotirios Mochlas, John Stiliadis, George Parcharidis, George 
Louridas, AHEPA University Hospital, Thessaloniki, Greece
Background: We aimed to investigate the hemostatic system activation after aspirin or 
clopidogrel pretreatment, during RFA procedures.
Methods: We studied 45 patients (19 men) who underwent RFA for supraventricular 
tachyarrhythmias in the right heart (atrioventricular nodal re-entry tachycardia n=32, 
atrioventricular re-entry tachycardia due to right-sided accessory pathways n=11, and 
typical atrial ﬂutter n=2). Twenty-two patients received aspirin (325 mg the day before 
RFA, followed by 325 mg for one month) and twenty-three received clopidogrel (300 mg 
the day before RFA, followed by 75 mg for one month). Adenosine diphosphate (ADP, 
10 µmol/L) and collagen (2 µg/ml) induced platelet aggregation (PA) was assessed, and 
D-dimer (D-d) and thrombin-antithrombin complex (TAT) levels were determined. Blood 
samples were collected at baseline, before sheath insertion (T1), after completion of the 
procedure (T2), 24 hours later (T3) and after 1 month (T4).
Results: A signiﬁcant inhibition of PA and signiﬁcantly lower D-d values were observed in 
the clopidogrel arm, while TAT levels were similar in both groups. (Table)
Conclusions:
 n patients undergoing RFA procedures, clopidogrel signiﬁcantly inhibited platelet 
aggregation and attenuated ﬁbrinolysis, compared to aspirin. Thrombin generation 
was not affected. Clopidogrel treatment requires further evaluation for establishing its 
beneﬁcial effect in preventing thromboembolism during RFA. 
Values of PA (%), D-d (µg/L), and TAT (µg/L)
Aspirin Clopidogrel p value
T1 ADP 69±9 39±13 p<0.001
T2 ADP 72±7 46±9 p<0.001
T3 ADP 75±8 48±10 p<0.001
T4 ADP 70±9 47±8 p<0.001
T1 collagen 73±10 66±12 p=0.04
T2 collagen 74±6 44±11 p<0.001
T3 collagen 76±8 47±10 p<0.001
T4 collagen 73±8 49±9 p<0.001
T1 D-d 26±20 19±9 NS
T2 D-d 111±15 72±16 p<0.001
T3 D-d 160±91 92±31 p<0.001
T4 D-d 23±12 21±9 NS
T1 TAT 2.1±0.6 1.8±0.4 NS
T2 TAT 18.1±8.5 17.2±8.3 NS
T3 TAT 9.7±4.7 7.8±4.2 NS
T4 TAT 1.8±0.8 1.6±0.4 NS
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924-123 QRS Duration and Microvolt T Wave Alternans Testing in 
Patients With Ischemic Cardiomyopathy
Theodore Chow, Syed Saghir, Cheryl Bartone, Terri Booth, Paul Chan, Ohio Heart & 
Vascular Center, Cincinnati, OH, University of Michigan, Ann Arbor, MI
Background: Prior studies assessing the relative prognostic utility of microvolt T-wave 
alternans (MTWA) and QRS>120ms have been limited by small sample sizes and study 
design limitations. These studies also suggested that MTWA was not predictive in patients 
with QRS>120msec.
Objective: To determine the relative predictive value of MTWA and QRS>120ms for 
mortality in patients with ischemic cardiomyopathy, and assess whether QRS duration 
interacts with the prognostic accuracy of MTWA.
Methods: We developed a prospective database of 768 patients with ischemic 
cardiomyopathy (LVEF<35%) and no prior history of sustained ventricular arrhythmia, 
of which 392 (52%) received ICDs. Mean follow up was 18+10 months. We assessed 
the degree to which a non-negative (positive and indeterminate) MTWA test and a 
QRS>120ms predicted mortality risk using stratiﬁed (by ICD status) Cox proportional 
hazards analyses that controlled for demographic, clinical, and medication treatment 
variables.
Results: In our cohort, 67% of patients had a non-negative MTWA test and 32% had 
a QRS>120ms on ECG. Unadjusted Kaplan-Meier survival estimates showed that both 
a non-negative MTWA [stratiﬁed log-rank test=13.5; p=0.0002] and a QRS>120ms 
[stratiﬁed log-rank test= 9.7; p=0.0018] were associated with lower survival probability. 
After multivariable adjustment, MTWA remained an independent predictor of mortality 
[stratiﬁed hazard ratio=2.24 (1.33, 3.76); p=0.0023], whereas QRS>120ms was no longer 
predictive [stratiﬁed hazard ratio=1.51 (0.90, 2.51); p=0.12]. No signiﬁcant interaction 
existed between ICD and MTWA status (p=0.47) or between MTWA and QRS>120ms 
(p=0.25).
Conclusion: MTWA, but not QRS>120ms, is predictive of mortality in patients with 
ischemic cardiomyopathy. QRS duration does not affect the prognostic ability of MTWA.
924-124 Do All Phenotypic Forms of Outﬂow Tract Arrhythmias 
Have a Similar Mechanism?
Robert J. Kim, Sei Iwai, Steven M. Markowitz, Suneet Mittal, Kenneth M. Stein, Bindi 
K. Shah, Jim W. Cheung, Vivian Tan, David P. Dobesh, Sandhya Dhruvakumar, Dmitry 
Nemirovsky, Bruce B. Lerman, Cornell University Medical Center, New York, NY
Background: Pts with exercise-induced sustained ventricular outﬂow tract (OT) 
tachycardia have an electropharmacologic proﬁle that is consistent with cAMP-mediated 
triggered activity. These pts generally have inducible VT which terminates with adenosine 
and verapamil. The purpose of this study was to examine pts with OT arrhythmias 
who present with either non-sustained ventricular tachycardia (NSVT) or repetitive 
monomorphic PVCs, and to determine whether they share a similar electropharmacologic 
proﬁle to those with sustained VT. Methods: All pts underwent electrophysiologic testing. 
Results: Of 126 consecutive pts presenting with OT arrhythmias, 44 presented with 
sustained VT, 37 with NSVT, and 45 with PVCs. There was no difference among the 
three groups of pts with respect to age, gender, presence of structural heart disease 
or CAD. Sustained VT was inducible in 46% with NSVT vs. 9% with PVCs. Induction 
of sustained VT was catecholamine-dependent in a similar proportion of pts from both 
groups (Table). Adenosine terminated induced VT in a similar proportion of pts in both 
groups. Conclusions: Despite differences in clinical presentation, a signiﬁcant subset of 
pts with non-sustained OT arrhythmias show mechanistic evidence for cAMP-mediated 
triggered activity. Whether pts who are non-inducible have a different underlying cellular 
mechanism or a different threshold for inducibility remains unclear.
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Parameter NSVT (n=37) PVCs (n=45) p value
Sustained VT at EPS 46% (17) 9% (4) p<0.001
Required catecholamine infusion for induction 82% (14) 75% (3) p=NS
Adenosine terminated induced VT 87% (13/15) 75% (3/4) p=NS
924-125 Three Dimensional Activation Patterns During 
Ventricular Fibrillation in Swine Heart
Jian Huang, Kang-An Cheng, Jack M. Rogers, Raymond E. Ideker, University of 
Alabama at Birmingham, Birmingham, AL
Background: Most studies of ventricular ﬁbrillation (VF) are based on epicardial or 
endocardial recordings. We applied plunge needles with a sufﬁcient density of electrodes 
to observe the transmural activity of VF.
Methods:We mapped VF from three planes of unipolar electrode arrays in 6 pigs with 
electrodes spaced 2 mm apart. The vertical array was a row of 24 plunge needles and the 
horizontal was 21 plunge needles. Each plunge needle held 12 electrodes. The epicardial 
array was placed to surround the two lines of plunge needles to form a 22x25 array. 
Four VF episodes were mapped for 20 sec each. We quantiﬁed within each array (1) the 
number of wavefronts per cm2 (WFs); (2) percent of WFs that arose within the mapped 
region by breakthrough/focal activity (F); (3) multiplicity, the number of distinct activation 
pathways (M); (4) mean area activated by WFs (A); (5) percentage of all VF wavefronts 
that completed at least one cycle of reentry (Re).
Results: The number of WFs, M, A, and Re were signiﬁcantly greater epicardially than 
intramurally. The F and M were signiﬁcantly greater in the vertical plane than horizontal 
plane. However, the A and the Re were signiﬁcantly greater in the horizontal than the 
vertical plane.
Conclusions: VF activation sequences differ in different planes. The increased F, 
increased M, decreased Re and decreased A in the vertical plane compared to horizontal 
plane with a similar number of WFs in both planes indicate that more VF wavefronts 
propagate around versus along the long axis of the LV.
*=p<0.01 compared with both transmural arrays **=p<0.01 between 
horizontal and vertical data
Epicardial Horizontal Vertical
WFs/cm2 3.2±0.67* 2.02±0.13 2.07±0.16
F% 36±12* 45±18** 66±15
M 9.8±2.2* 3.7±1.3** 4.5±1.4
A mm2 202±33* 182±46** 161±32
 
924-126 Patients With Coronary Artery Disease that Suffer 
Sudden Cardiac Death Have Exaggerated Prolongation 
of Ventricular Repolarization: A Three-Year Community-
Wide Study
Tejwant Singh, Erin Wallace, Carmen Socoteanu, Kyndaron Reinier, Celia Dervan, Eric 
C. Stecker, Catherine Vickers, Wendy Post, Peter Spooner, Karen Gunson, Jonathan 
Jui, Sumeet Chugh, Oregon Health and Science University, Portland, OR, The Johns 
Hopkins Reynolds Cardiovascular Center, Baltimore, MD
Background: The potential role of the corrected QT interval (QTc) as a predictor of sudden 
cardiac death (SCD) among patients with signiﬁcant coronary artery disease (CAD) has 
been assessed in cohort studies, but not in the general population.
Methods: In the ongoing Oregon Sudden Unexpected Death Study (Ore-SUDS) all adult 
residents of Multnomah County, OR (population 700,000) who suffered SCD were identiﬁed 
prospectively (2002-2005). Of these, we identiﬁed the subgroup of SCDs that underwent 
12-lead ECG prior to death and also had known associated CAD. Comparisons were 
conducted with a geographically matched control group of subjects with known CAD, but 
no history of SCD, ventricular arrhythmia or syncope. QTc and JTc were measured from 
the 12-lead ECG (Bazett’s correction). Patients with atrial ﬁbrillation/ﬂutter or ventricular 
pacing on ECG were excluded for JTc and QTc comparisons and those with wide QRS 
(≥120 ms) were excluded for QTc comparisons.
Results: A total of 286 SCD cases had ECGs performed prior to death and 136 (48% 
of total, 31% female) had CAD based on medical records or autopsy ﬁndings. Among 
controls, 313 (94% of total, 34% female) had an ECG available. For SCD cases, ECGs 
analyzed were performed a mean of one year prior to SCD. Male SCD cases had 
signiﬁcantly longer QTc (mean 470±56 vs. 430±39 ms, p<0.0001) and JTc (mean 368±46 
vs. 341±39 ms, p<0.0001) vs. male controls. Differences were similar but smaller in 
females: (mean QTc 464±46 vs. 446±31 ms, p=0.04) and JTc (mean 376±52 vs. 359±35 
ms, p=0.07). In an analysis of covariance model controlling for age, sex, and heart rate, 
cases had signiﬁcantly longer adjusted mean QTc (466 vs. 437 ms, p<0.0001) and JTc 
(372 vs. 350 ms, p<0.0001).
Conclusion: CAD patients that had SCD were distinguishable by signiﬁcantly longer QTc 
and JTc on the 12-lead ECG, after controlling for age, sex and heart rate. These data have 
implications for SCD risk stratiﬁcation in subjects with coronary artery disease.
924-127 Predictors of Successful Catheter Ablation of 
Ventricular Tachycardia in Ischemic and Nonischemic 
Cardiomyopathy
Girish Nair, Mithilesh Kumar Das, Krannert Institute of Cardiology, Indianapolis, IN
Background: Radiofrequency ablation (RFA) is the only curative therapy for refractory 
ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. 
However, the success rate of RFA in ischemic than non-ischemic cardiomyopathy differs. 
In this study, we examined the differences in electrophysiologic properties and predictive 
factors for acute success between ischemic (I) and non-ischemic (NI) ventricular 
tachycardia (VT).
Methods: We studied the demographics and electrophysiological ﬁndings of patients 
undergoing RF ablation for inducible sustained VT in patients with ischemic and 
nonischemic cardiomyopathy. Ablation success was deﬁned as non-inducibility of the 
targeted VT at study conclusion.
Results: 118 VT (I VT: 77, and NI VT: 41) were observed in 42 patients (I: 26; NI: 16). 
Patients with NI VT were younger (NI, 57.7 ± 16.4; I, 64.4 ± 10.5 years, p <0.01), more 
often women (NI: 33%; I: 4%, p<0.001), and less likely to have hypertension (NI: 26; I: 
44 percent, p<0.001). They had smaller ventricles (LVDd NI, 5.22 ± 0.98; LVDd I, 5.90 
± 0.63cm, p=0.001) but the ejection fraction was not different (NI, 31.4 ± 14.9; I, 26.7 ± 
8.3, p=0.08). At EP study, patients with NI VTs had a shorter H-V (NI: 57.5 ± 9.0; =I: 67.7 
± 14.3ms. p<0.001). The VT cycle length (NI VT: 384 ± 16 ms and I VT: 411 ± 12 ms. p 
= 0.19) and number of RFA (NI VT: 10.4 ± 2.1, I VT: 9.1± 1.6, P=NS) were not different 
in these two groups The incidence of posterobasal VT was signiﬁcantly higher in NI VT 
(n=31/41, 76%) than in I VT (29/77, 38%). However, better pacemap (I VT: 11.1± 0.3 
leads, NI VT: 7.5 ± 1.0 leads, p <0.01) and entrainment (I VT: 46; NI VT: 10; p <0.01) was 
achieved in I VT than NI VT. The mid-diastolic potential to QRS signal (NI VT: 83.7 ± 99.4; 
=I VT: 118.9 ± 61.1ms, p=0.047) during VT and RFA success was higher in I VT (69/77) 
compared to NI VT (26/41, p<0.001).
Conclusion: I VT is associated with signiﬁcantly better pacemap, higher rate for 
entrainment and longer diastolic potential to QRS (during VT) as compared to NI VT , 
which may explain a higher success rate in I VT.
924-128 Sustained Polymorphic Arrhythmias Induced by 
Programmed Ventricular Stimulation Have Prognostic 
Value in Patients Receiving Deﬁbrillators for Primary 
Prevention of Sudden Cardiac Death
Scott L. Greenberg, Jose M. Sanchez, Jonas A. Cooper, Michael E. Cain, Jane Chen, 
Marye J. Gleva, Bruce D. Lindsay, Timothy W. Smith, Mitchell N. Faddis, Washington 
University, St. Louis, MO
Background: Patients with ischemic cardiomyopathy (ICM) who have monomorphic 
ventricular tachycardia (VT) induced by programmed ventricular stimulation (PVS) are at 
increased risk of sudden cardiac death (SCD). Whether patients with induced, sustained 
polymorphic arrhythmias have similar rates of spontaneous arrhythmia occurrences is 
unknown. Our objective was to determine whether the induction of sustained, polymorphic 
ventricular arrhythmias predicts clinical arrhythmias in patients receiving an implantable 
cardioverter deﬁbrillator (ICD) for primary prevention of SCD.
Methods: We retrospectively evaluated 105 consecutive patients who received an ICD 
for primary prevention of SCD in the setting of ICM and non-sustained VT. At baseline, 
75 patients had induction of monomorphic VT (Group I) and 30 patients had a ventricular 
arrhythmia other than monomorphic VT (including ventricular ﬂutter, ventricular ﬁbrillation, 
and polymorphic VT) induced during PVS (Group II). Mean follow-up was 27.8 ± 14.1 
months.
Results: Baseline characteristics were similar between Group I and Group II except for 
EF (25% vs 31%, p= 0.0001) and QRS width (123ms vs 109ms, p=0.04). 16 of 75 (21.3%) 
patients in Group I and 6 of 30 (20%) patients in Group II had an appropriate ICD therapy 
(p =0.88). Survival free from ICD therapy was similar between groups (p=0.54). There 
was no difference in mean number of appropriate ICD therapies administered (p =0.8). 
There was a trend toward increased all-cause mortality among patients in Group I by 
Kaplan Meier (p =0.08). However, when adjusted for age, EF and QRS duration, there 
was no difference in mortality between groups (p =0.45). Among patients for whom data 
was available, induced tachycardia cycle length demonstrated a trend toward predicting 
subsequent clinical ventricular tachyarrhythmia cycle length (R2 =0.22; p =0.058).
Conclusions: There is no difference in rates of appropriate ICD discharge or mortality 
between patients dichotomized by type of rhythm induced during PVS. This study 
provides evidence that the induction of VF and polymorphic VT are clinically meaningful 
and supports the current guidelines recommending ICD implantation in this population.
924-129 Effect of Bundle Branch Block on Microvolt T-Wave 
Alternans
Daniel P. Morin, Steven M. Markowitz, Suneet Mittal, Sei Iwai, Bindi K. Shah, Jim 
Cheung, Vivian Tan, David P. Dobesh, Dmitry Nemirovsky, Sandhya Dhruvakumar, 
Bruce B. Lerman, Kenneth M. Stein, Cornell University Medical Center, New York, NY
Background: Microvolt T wave alternans (TWA) has been proposed as a means of risk 
stratiﬁcation for sudden cardiac death (SCD). It is unknown whether bundle branch block 
inﬂuences TWA.
Methods: We evaluated 317 consecutive pts with CAD, NSVT, and LVEF < 40% (254 
[80.1%] men, age 66.5+10.7 years). Pts underwent TWA testing and EPS with up to three 
ventricular extrastimuli (VES) from two right ventricular sites. Positive EPS was deﬁned 
as inducibility of sustained monomorphic VT with up to triple VES, or VF or polymorphic 
VT with up to double VES. A physician blinded to the results of TWA and EPS examined 
each pt’s ECG for evidence of conduction delay.
Results: There was no difference in the TWA indeterminacy rate between normals and 
pts with left hemiblock (HB), LBBB, RBBB, or IVCD (all p>0.05). Excluding indeterminates, 
more pts with LBBB than normals had positive TWA (80% vs. 54%, p=0.02). There was 
a nonsigniﬁcant increase in the EPS positivity rate in the LBBB group (p=0.07). There 
was no signiﬁcant difference in the TWA positivity rate between normals and pts with 
left hemiblock, IVCD, or RBBB (p=0.56, 0.39, and 0.79 respectively), nor in EPS results 
between normals and pts with left hemiblock, IVCD, or RBBB (p=0.86, 0.33, and 0.42).
Conclusions: Compared with normals, TWA is more often positive in pts with LBBB, but 
not in pts with left hemiblock, IVCD, or RBBB. This may reﬂect either increased sensitivity 
or diminished speciﬁcity of TWA testing in the setting of LBBB.
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QRS 
width, ms
(mean, 
SD)
EF, %
(mean, 
SD)
TWA 
Pos
(n, %)
TWA 
Neg
(n, %)
TWA 
Ind
(n, %)
TWA
Pos/
(Pos+Neg) 
EPS 
Pos
(n, %)
EPS 
Neg
(n, %)
Normal (n=179, 
56.5%) 97.1 (11.5)
29.7 
(7.8)
69 
(38.5)
59 
(33.0)
51 
(28.5) 0.539
85 
(47.5)
94 
(52.5)
HB (n=42, 
13.2%)
100.5 
(10.5)
31.8 
(7.0)
16 
(38.1)
18 
(42.9)
8 
(19.0) 0.471
21 
(50.0)
21 
(50.0)
LBBB (n=37, 
11.7%)
148.3 
(17.7)
25.2 
(7.5)
20 
(54.1)
5 
(13.5)
12 
(32.4) 0.800
24 
(64.9)
13 
(35.1)
IVCD (n=31, 
9.8%)
126.7 
(14.1)
26.7 
(8.9)
17 
(54.8)
9 
(29.0)
5 
(16.1) 0.654
18 
(58.1)
13 
(41.9)
RBBB (n=28, 
8.8%)
145.2 
(19.0)
28.7 
(8.4)
9 
(32.1)
6 
(21.4)
13 
(46.4) 0.600
16 
(57.1)
12 
(42.8)
924-130 Sudden Cardiac Arrest with Normal Ejection Fraction: 
How Often Is Coronary Ischemia the Trigger?
Eric C. Stecker, Kyndaron Reinier, Celia Dervan, Tejwant Singh, Carmen Socoteanu, 
Karen Gunson, Jonathan Jui, Sumeet S. Chugh, The Heart Rhythm Research 
Laboratory, Oregon Health and Science University, Portland, OR
Background: A signiﬁcant proportion of sudden cardiac arrests (SCAs) may occur in 
patients with normal LV systolic function. Coronary ischemia is likely to be a precipitating 
factor, but the frequency of occurrence has not been evaluated in the general population.
Methods: All residents of Multnomah County, OR (Pop. 660,486; 2002-2005) who 
suffered SCA (sudden unexpected arrest within 1 hour of symptom onset) were identiﬁed 
via ﬁrst responders, medical examiner and local hospitals. The subgroup of patients that 
survived to hospital admission and had an assessment of LV ejection fraction (EF) by 
echocardiography or ventriculography within 48 hours were analyzed. EF was deﬁned as 
normal when ≥ 0.55, mild to moderately reduced when 0.36-0.54 and severely reduced 
when ≤ 0.35. Acute myocardial infarction (AMI) was deﬁned as ST elevation on EKG or a 
clinical diagnosis of NSTEMI by symptoms, EKG and serum markers. Ischemic symptoms 
were deﬁned as any pain above the waist or shortness of breath prior to SCA. Signiﬁcant 
obstructive CAD was deﬁned as any coronary stenosis ≥ 70% on coronary angiography 
performed within 48 hours of SCA.
Results: From a total of 202 SCA patients who survived to hospital admission, 55 (27%) 
had EF assessed after SCA (mean age 63±16 yrs, 47% female). LV EF was normal in 23 
(42%), mild to moderately reduced in 11 (20%) and severely reduced in 21 (38%). Overall, 
46 (84%) had either serum markers drawn or cardiac catheterization performed following 
SCA, leading to diagnosis of AMI or obstructive CAD in 32 (58%). Of the patients with 
normal EF, AMI was diagnosed in 11 (48%). AMI, ischemic symptoms or obstructive CAD 
on angiography were observed in 14 patients (61%). Five patients (22%) had no evidence 
of coronary ischemia despite detailed evaluation.
Conclusions: A substantial proportion (42%) of evaluated SCAs had normal LV EF 
and acute coronary syndromes/AMI were likely precipitants for the majority. However, 
in a small but distinct minority (22%), there was no evidence of coronary ischemia and 
alternative trigger factors merit further consideration.
924-131 Eplerenone Attenuates Ventricular Electrical 
Remodeling in Experimental Heart Failure: Mechanism 
of Reduced Risk of Sudden Cardiac Death with 
Aldosterone Blockade?
Bruce S. Stambler, Sunil C. Shroff, Nichole Martovitz, Kyungmoo Ryu, Case Western 
Reserve University, Cleveland, OH
Background Aldosterone blockade decreases sudden death in heart failure; however 
mechanisms underlying this beneﬁcial effect are unclear. We hypothesized that 
aldosterone blockade attenuates ventricular electrical remodeling in heart failure, which 
reduces ventricular tachyarrhythmia (VTA) vulnerability. This study evaluated efﬁcacy 
of eplerenone (EPL) to reduce remodeling of ventricular effective refractory periods 
(VERPs) and inducibility of VTAs in rapid ventricular pacing (RVP)-induced heart failure. 
Methods 13 dogs underwent RVP at 230 bpm and received oral EPL (50 mg/day, n=8) 
or placebo (PLB, n=5). After 5 weeks, VERPs and VTA inducibility were determined with 
programmed stimulation from 4 epicardial sites (left, right ventricular [LV, RV] apex and 
base) and mid-myocardial RV apex with up to 4 extrastimuli at 2 cycle lengths (400, 
300 ms). Results VERPs at epicardial LV apex and RV base and mid-myocardial RV 
apex were shorter and VERP dispersion was reduced in EPL vs. PLB RVP dogs. Among 
EPL RVP dogs, sustained VTAs were induced with 3.3±0.6 extrastimuli in 4 (50%) and 
could not be induced in 4 dogs. Among PLB RVP dogs, sustained VTAs were induced 
with 2.2±1.3 extrastimuli in 5 of 5 dogs. All VTAs were ventricular ﬁbrillation. LV volumes 
and ejection fraction did not differ in EPL vs PLB RVP dogs. Conclusions Selective 
aldosterone blockade with EPL attenuates electrical remodeling in heart failure reducing 
VERP prolongation and dispersion, which contributes to suppression of VTA inducibility. 
EPL + RVP
(n=8)
PLB + RVP
(n=5) p-value
Sustained VTAs (n) 4 5 0.10
VERP at 300 ms (ms)
Epicardial LV Base 194 ± 8 210 ± 10 >0.05
Epicardial LV Apex 181 ± 7 211 ± 29 <0.05
Epicardial RV Base 197 ± 9 222 ± 20 <0.01
Epicardial RV Apex 193 ± 12 205 ± 15 >0.05
Mid-Myocardial RV Apex 203 ± 8 236 ± 12 <0.05
VERP dispersion (ms)
Epicardial 22 ± 10 38 ± 16 <0.05
Transmural 7 ± 6 30 ± 8 <0.05
924-132 Myocardial Fibrosis assessed by Contrast-Enhanced 
Cardiovascular Magnetic Resonance and Prevalence of 
Malignant Ventricular Arrhythmias in Arrhythmogenic 
Right Ventricular Cardiomyopathy
Joao L. Petriz, Olga F. Souza, Lauro Pereira, Francisco M. Albanesi, Marcelo S. Hadlich, 
Clerio F. Azevedo, Carlos E. Rochitte, Jorge N. Moll, Barra DOR Hospital, Rio de 
Janeiro, Brazil, Rio de Janeiro State University, Rio de Janeiro, Brazil
Background: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a disease 
characterized by the replacement of the right ventricle (RV) myocardium by fatty and 
ﬁbrous tissue, leading to malignant ventricular arrhythmias (MVA). Contrast-enhanced 
cardiovascular magnetic resonance (CE-CMR) can well characterize areas of myocardial 
ﬁbrosis. We therefore investigated the association of myocardial ﬁbrosis documented by 
CE-CMR with the presence of MVA in ARVC patients (pts).
Methods: We studied 60 consecutive pts (26 males; mean age 37 ± 11 years) under 
investigation of ARVC based on the task force diagnosis criteria (Br Heart J. 1994; 
71(3): 215-8). MVA was deﬁned as sustained ventricular tachycardia (SVT) or ventricular 
ﬁbrillation that leads to aborted sudden death or SVT induced during electrophysiological 
study. CE-CMR was performed using a 1.5T magnet and the pulse sequence was a 
contrast-enhanced (gadolinium-based) fast gradient-echo with an inversion-recovery 
preparation pulse.
Results: Myocardial ﬁbrosis was detected in the RV in 5 pts (8.3%) and in all of these 
(100%) it was documented MVA. We did not ﬁnd out myocardial ﬁbrosis in 55 pts (91.7%) 
and MVA were not documented in these pts (p<0.01).
Conclusions: In this sample of pts under investigation of ARVC, the ﬁnding of myocardial 
ﬁbrosis assessed by CE-CMR was associated with MVA. These data suggest the potential 
usefulness of CE-CMR for early risk stratiﬁcation of ARVC.
CE-MRI: Fibrosis (high intensity signal) in RV free wall
924-133 Radiofrequency Catheter Ablation of Frequent, 
Idiopathic Premature Ventricular Complexes: Effects on 
Left Ventricular Function
Frank M. Bogun, Stephen Reich, Eric Good, Krit Jongnarangsin, Darryl Elmouchi, 
Joseph Marine, Petar Igic, Kristina Lemola, David Tschopp, Aman Chugh, Frank Pelosi, 
Hakan Oral, Fred Morady, University of Michigan Health System, Ann Arbor, MI
Background: Idiopathic premature ventricular complexes (PVCs) are considered to be 
associated with a benign long-term prognosis, even when frequent. However, some case 
reports have demonstrated a possible link between frequent PVCs and left ventricular 
(LV) dysfunction. In addition, frequent PVCs recently were demonstrated to be associated 
with increased LV dimensions and cardiomyopathy. 
Methods and Results: Among 46 patients with idiopathic, frequent PVCs (>10/hour), 
a reduced LV ejection fraction (mean 37±10%) was present in 16 (35%). Patients with 
decreased LV function had a greater PVC burden on a 24-hour Holter monitor than patients 
with normal LV function (37±14% versus 11±10% of all QRS complexes; P<0.0001). There 
was a signiﬁcant inverse correlation between the PVC burden and the ejection fraction 
before ablation (R=0.72, p<0.0001). The PVCs originated in the right ventricular outﬂow 
tract in 24/46 patients (52%), the left ventricular outﬂow tract in 8/46 patients (17%), and 
in other sites in 9/46 patients (20%). The PVC origin could not be determined in 5 patients. 
Ablation was completely successful in 37 patients (80%), partially successful in 4 patients 
(9%), and ineffective in 5 patients (11%). In patients with a decreased LV ejection fraction 
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before ablation, LV function became normal or improved in 13/16 patients, remained the 
same in 2/16 patients, and declined in 1/16 patients. None of the latter 3 patients had a 
completely successful outcome from catheter ablation.
Conclusion: Left ventricular dysfunction is common in the setting of frequent, idiopathic 
PVCs and may represent a form of cardiomyopathy that can be corrected by catheter 
ablation of the PVCs.
924-134 Increased Sudden Death Risk Conferred by LVH is 
Independent of Age and Left Ventricular Dysfunction: 
A Three-Year Community-Wide Study in Patients with 
Established Signiﬁcant Coronary Artery Disease
Celia Dervan, Tejwant Singh, Kyndaron Reinier, Carmen Socoteanu, Erin Wallace, Eric 
Stecker, Catherine Vickers, Karen Gunson, Jonathan Jui, Sumeet S. Chugh, Oregon 
Health and Science University, Portland, OR
Background: The Framingham Heart Study reported an association between increased 
LV mass/hypertrophy and sudden death that was independent of coronary risk factors. 
However, this relationship has not been evaluated in patients who suffer sudden cardiac 
death (SCD) in the presence of established signiﬁcant coronary artery disease (CAD).
Methods: In the ongoing Oregon Sudden Unexpected Death Study (Ore-SUDS), adult 
residents of the Portland, Oregon metro area (population 1,000,000) who suffered SCD 
were identiﬁed prospectively (2002-2005). The subgroup of consecutive SCDs that had a 
cardiac echo performed prior to, and remote from cardiac arrest was identiﬁed. For those 
that had CAD from medical records or autopsy, LV mass was calculated (American Society 
of Echocardiography modiﬁed equation, LV mass/body surface area). Comparisons were 
conducted with a geographically matched control group of subjects with known CAD, but 
no history of SCD, ventricular arrhythmia or syncope. A logistic regression model was 
employed to evaluate the relationship between SCD, LVH by increased LV mass, severe 
LV dysfunction (LV EF ≤35%) and age in patients with established CAD.
Results: LV mass was calculated for 163 SCDs of which 91 had deﬁnitive CAD (mean 
age 71, 29% female) as well as 100 controls (mean age 68, 32% female). Patients with 
severe aortic stenosis or hypertrophic cardiomyopathy were excluded from analysis (n=8; 
6 SCDs, 2 controls). Among SCD cases, 38% had LVH vs. 22% in controls (p=0.03). In 
the logistic regression model, LVH was independently associated with SCD (OR 2.0, 95% 
CI 1.0 - 3.9, p=0.04).
Conclusions: Increased LV mass/hypertrophy, in the absence of hypertrophic 
cardiomyopathy or aortic stenosis, doubles the risk of sudden cardiac death among 
residents of the general population that have known signiﬁcant coronary artery disease.
924-135 Gender Difference in the QT Interval and Ventricular 
Tachycardia or Fibrillation in MADIT II
Mark C. Haigney, Wojciech Zareba, David J. Krause, Scott McNitt, Philip Gentlesk, 
Robert E. Goldstein, Arthur Moss, Uniformed Services University, Bethesda, MD, 
University of Rochester, Rochester, NY
Background: Healthy women have longer QT intervals and more drug induced pro-
arrhythmia, yet those with ICDs have fewer episodes of VT/VF than men. We hypothesized 
that women with structural heart disease would have longer QT intervals but less QT 
variability and VT/VF compared to men. Methods: All MADIT II study patients not in 
atrial ﬁbrillation or paced had QT interval variability (QTV) assessed in 10 minute, resting 
digitized recordings at study entry. QT and heart rate were measured for each beat with 
a semi-automated method. “U” waves were included in the measure of the QT interval. 
QTV was normalized for mean QT (QTVN) or for HR variability (QTVI). Incidence of VT/
VF was determined by ICD interrogation. Results: There were 805 usable recordings 
(142 females); 462 received ICDs (86 females). Contrary to our hypothesis, there was no 
difference in mean or median QT (471 ms men; 469 ms women, p=0.11), QTc, or heart 
rate. QTVN was slightly lower in females than males (p<0.05) whereas QTVI (adjusted for 
heart rate variance) was slightly higher. The time until VT/VF was signiﬁcantly shorter in 
males in the top quartile (“high risk”) for both QTVI and QTVN (ﬁgure) than in women (VT/
VF at 2 years 45% in men vs. 19% in women). Conclusions: In patients with a depressed 
ejection fraction, increased QT variability is more predictive for VT/VF in males than 
females despite similar QT duration and QT variability. QT variability might be of particular 
importance in triggering arrhythmias in MADIT II type males, but not in females.
 
924-136 Isolated Potentials During Sinus Rhythm and Pace-
Mapping Within Scars as Guides for Ablation of Post-
Infarction Ventricular Tachycardia
Frank M. Bogun, Eric Good, Stephen Reich, Darryl Elmouchi, Petar Igic, Kristina 
Lemola, David Tschopp, Aman Chugh, Aman Chugh, Aman Chugh, Hakan Oral, Frank 
Pelosi, Fred Morady, University of Michigan Health System, Ann Arbor, MI
Background: Pace-mapping has been used in the scar border zone to identify the exit site 
of post-infarction ventricular tachycardia (VT). The purpose of this study was to identify 
VT isthmus sites by pace-mapping within scar tissue and to identify electrogram (EGM) 
characteristics that are helpful in identifying VT isthmus sites during sinus rhythm.
Methods: In 19 consecutive patients (18 men, mean age 66±9 yrs, mean EF 0.25±0.13) 
with recurrent post-infarction VT, a left ventricular voltage map was generated during 
sinus rhythm. Pace-mapping was performed at sites with abnormal EGMs or isolated 
potentials (IPs). Radiofrequency ablation was performed at isthmus sites as deﬁned by 
pace-mapping (perfect pace-map=12/12 matching ECG leads; good pace-map=10-11/12 
matching ECG leads) and/or entrainment mapping.
Results: A total of 81 VTs (mean cycle length 396±124 ms) were inducible. In 16 of the 
19 patients, a total of 41 distinct isthmus areas of 41 distinct VTs were identiﬁed and 
successfully ablated. Pace-mapping was performed at 681 distinct sites (mean EGM 
amplitude 0.48±0.67 mV, mean EGM width 91±52 ms). IPs were found more frequently 
at sites with good or perfect pace-maps than at sites with abnormal EGMs (p<0.0001). 
Pace-maps at 65% of sites displaying an IP were either perfect or good, compared to 
5% of sites with abnormal/fragmented EGMs (p<0.0001) Twenty-one isthmus sites were 
identiﬁed by perfect pace-maps, 14 by good pace-maps, and 6 by entrainment mapping. 
All but one displayed IPs during sinus rhythm. Furthermore, 22 of the 81 VTs (27%) 
for which no isthmus was identiﬁed became noninducible after ablation of a targeted 
VT. Of the remaining 18 VTs, 16 were induced in 3 patients in whom no isthmus could 
be identiﬁed. The 16 patients in whom ≥1 isthmus was identiﬁed and ablated were free 
of arrhythmic events during a mean follow-up of 10 months. Conclusions: During sinus 
rhythm, excellent or good pace-maps at sites of IPs within areas of scar identify areas of 
ﬁxed block that are protected and part of the critical isthmus of post-infarction VT. Shared 
common pathways may explain why non-targeted VTs may become noninducible after 
ablation of other VTs.
924-137 Effects of Verapamil on the Short-Term 
Electrophysiological Remodeling of Superior Vena 
Cava in Human
Chih-Sheng Chu, Kun-Tai Lee, Shou-Tsan Lee, Tsung-Hsien Lin, Ho-MIng Su, Wen-
Choi Voon, Sheng-Hsiung Sheu, Wen-Ter Lai, Kaohsiung Medical Univeristy Chung-Ho 
Memorial Hospital, Kaohsiung, Taiwan,ROC
Background: Electrophysiological remodeling (ER) of the atrium has been well described. 
Acute ER can be demonstrated by short term rapid atrial pacing. Whether this acute ER 
also occurred in the superior vena cava (SVC) and the pharmacological effects remained 
unknown.
Methods: Fifteen pts (8 F, mean 49±12 yrs) with supraventricular tachycardia were 
enrolled. After catheter ablation procedures, the effective refractory periods (ERP) of the 
high right atrium (HRA) and SVC were determined at pacing cycle length (CL) of 600 
(ERP600) and 400 (ERP400) msec, respectively, under intravenous (IV) esmolol infusion 
(150 ug/kg/min). The ERPs of the HRA and SVC were determined again each time 
right after 5 minutes (min) of rapid HRA and SVC pacing, respectively, at CL of 400 ms. 
Degrees of shortening of the ERPs right after pacing were represented as the acute ER 
of the atrium and SVC, respectively. The same protocols for determining the ER of HRA 
and SVC were repeated after IV verapamil (0.15 mg/kg).
Results: Under IV esmolol, the ERP600 of SVC was signiﬁcantly longer than that of HRA 
(265±20 vs 236±19 ms, P<0.05). Right after 5 min of HRA pacing at CL of 400 ms, 
both the ERP600 of HRA (236±19 vs 212±18 ms) and SVC (265±20 vs 239±19 ms) were 
signiﬁcantly shortened (P<0.05). In addition, right after 5 min of SVC pacing at CL of 
400ms, both the ERP600 of HRA (236±19 vs 215±22 ms) and SVC (265±20 vs 239±20 
ms) were also signiﬁcantly shortened (P<0.05). The identical acute ER of the HRA and 
SVC were also demonstrated at ERP400. After IV verapamil, the ERP600 of SVC was still 
longer than that of HRA (264±17 vs 241±24 ms, P<0.05). Right after 5 min of HRA pacing 
at CL of 400 ms, both the ERP600 of HRA (241±24 vs 220±27 ms) and SVC (264±17 vs 
240±17 ms) were also signiﬁcantly shortened. Furthermore, right after 5 min of SVC 
pacing at CL of 400 ms, both the ERP600 of HRA (241±24 vs 222±23 ms) and SVC 
(264±17 vs 243±18 ms) were also signiﬁcantly shortened. These acute ER of HRA and 
SVC were also demonstrated at ERP400 of HRA and SVC.
Conclusions: The acute electrophysiological remodeling of SVC can be demonstrated 
right after either HRA or SVC rapid pacing. Intravenous verapamil can not abolish this 
form of acute electrophysiological remodeling of SVC and HRA.
924-138 Neither Ramipril Nor Vitamin E Reduce the Incidence of 
Atrial Fibrillation. Results of the HOPE Study
Omid Salehian, Jeffrey Healey, Khalid Almerri, Khalid Alnemer, John Grover, Bruce 
Stambler, James Matthew, Johannes Mann, Iqbal Bata, Gilles Dagenais, Eva Lonn, 
McMaster University, Hamilton, ON, Canada
Background: Atrial ﬁbrillation (AF) is associated with signiﬁcant morbidity and mortality. 
Although a number of important risk factors for the development of AF have been 
identiﬁed, its pathophysiology is still not clear. Recently, the role of angiotensin receptor 
in the development of AF has been suggested with a number of clinical studies showing 
potential beneﬁt of angiotensin blockade either at the receptor level or inhibiting the 
converting enzyme. We set out to test this hypothesis using data from the HOPE study.
Methods: ECGs (at baseline, 2 years, and end of study) from 8334 pts enrolled in the 
HOPE study who were in sinus rhythm at enrollment were analyzed. The HOPE study 
enrolled patients aged ≥55 years with previous cardiovascular disease, or diabetes plus 
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one risk factor, no clinical evidence of heart failure and preserved left ventricular systolic 
function, randomized to one of the following: Ramipril, Vitamin E, their combination or 
matching placebos.
Results: Of the 8334 patients who were in sinus rhythm at enrollment, 177 (2.1%) 
developed AF over the follow-up period of 4.5 years. There was no statistically signiﬁcant 
difference in the proportion of patients who developed AF in the Ramipril and the placebo 
groups (2% vs 2.25%, p=NS). Univariate predictors of AF development were age, systolic 
blood pressure, history of hypertension, body mass index (BMI) and microalbuminuria. 
On multivariate logistic regression analysis only age (Odds ratio [OR] 1.55, 95% CI 1.33-
1.80, p<0.01), BMI (OR 1.21, 95% CI 1.05-1.42, p=0.01), and microalbuminuria (OR 1.50, 
95% CI 1.07-2.11, p = 0.02) were independent predictors of development of new onset 
AF. Ramipril had no protective effect on development of AF (OR 0.92, 95% CI 0.68-1.24, 
p=0.57). Vitamin E also showed no protective effect on development of AF (OR 0.86, 95% 
CI 0.64-1.16, p=0.33).
Conclusions: In high risk population use of the ACE inhibitor Ramipril or Vitamin E does 
not reduce the incidence of new onset atrial ﬁbrillation.
924-139 Does Reduction in Left Atrial Diameter During 
Antihypertensive Treatment Reduce New-Onset 
Atrial Fibrillation in Hypertensive Patients with Left 
Ventricular Hypertrophy: The LIFE Study
Kristian Wachtell, Eva Gerdts, Gerard Aurigemma, Kurt Boman, Björn Dahlöf, Sverre 
E. Kjeldsen, Lars H. Lindholm, Markku S. Nieminen, Michael H. Olsen, Vittorio Palmieri, 
Vasilios Papademetriou, Jens Rokkedal, Richard B. Devereux, Glostrup University 
Hospital, Copenhagen, Denmark, The Weill Medical Collegue of Cornell University, New 
York, NY
Background: It is unclear whether improvement of left atrial (LA) and ventricular (LV) 
structure results in reduction in new-onset atrial ﬁbrillation (AF). The aim of the present 
study was to examine whether LA diameter and LV mass at baseline and during 4.8 
years of antihypertensive treatment were related to changes in risk of new-onset AF in 
hypertensive patients with electrocardiographic LV hypertrophy.
Methods: We followed 939 hypertensive patients with electrocardiographic LV hypertrophy 
randomized to atenolol or losartan-based regimens in the LIFE Study for 4,450 patient-
years of follow-up with echocardiograms at enrolment and annually during treatment.
Results: New-onset AF occurred in 58 patients (13.1/1000 patient-years of follow-up). At 
baseline, patients with new-onset AF were older, had higher systolic blood pressure and 
heart rate as well as higher prevalence of LA dilatation, but had similar prevalences of 
LV hypertrophy and mitral or aortic valve disease. In univariate Cox analysis baseline LA 
diameter (HR=4.68 per cm increase [95%CI: 2.86-7.65], p<0.001) and LV mass (HR=1.11 
per 10 g/m2 increase [95%CI: 1.01-1.22], p<0.05) both predicted new-onset AF. In Cox 
analysis, LA diameter at baseline increased the risk of new-onset AF (HR=1.93 per 
cm higher [95%CI: 1.01-3.71], p<0.05) whereas reduction of in-treatment LA diameter 
reduced the risk (HR=0.23 per cm lower [95%CI: 0.14-0.38], p<0.001) with adjustment for 
baseline and in-treatment LV mass and systolic blood pressure.
Conclusion: LA diameter at baseline and especially during antihypertensive treatment 
was a strong predictor of new-onset AF independent of the level of arterial pressure and 
other covariates. We propose that monitoring LA diameter may contribute to prevention of 
AF during antihypertensive treatment by prompting further intervention directed towards 
blood pressure control and LA size reduction if LA dilatation is not reversed by initial 
treatment.
924-140 Prevention of Atrial Fibrillation Via Abrogation of the 
Renin-Angiotensin System: A Pooled Meta-Analysis of 
Randomized Controlled Clinical Trials
Mhamad B. Jibrini, Janos Molnar, Rohit Arora, Chicago Medical School, North Chicago, IL
Background: The renin-angiotensin-aldosterone system (RAAS) has emerged as 
an important hormonal system in the initiation and pathogenesis of atrial ﬁbrillation. 
Therefore, angiotensin-converting enzyme inhibitors (ACEIs) or angiotensoin receptor 
blockers (ARBs) may be novel drugs for the prevention of atrial ﬁbrillation (AF).
Methods: Eleven randomized controlled clinical trials were identiﬁed that meet the criteria 
for a meta-analysis and were used to estimate the efﬁcacy of ACEIs and ARBs in the 
prevention of AF, in different cardio-vascular subsets.
Results: Treatment with ACEIs or ARBs reduced the relative risk of AF in patients with 
hypertension by 23% (RR: 0.769, p<0.001, 95 CI 0.686 - 0.862) and by 11% in patients 
following myocardial infarction (RR: 0.898, p<0.05, 95 CI 0.814 - 0.992). Reduction in 
AF was greatest in patients following electrical cardio version (RR: 0.491, p<0.001, 95 
CI 0.334 - 0.720) and in patients with heart failure, (RR: 0.684, p<0.001, 95 CI 0.594 - 
0.787). Overall, inhibition of the RAAS reduced the relative risk of AF by 19% (RR: 0.810, 
p<0.001, 95 CI 0.759 - 0.865).
Conclusions: Our meta-analysis revealed that both ACEIs and ARBs signiﬁcantly reduce 
the risk of AF in subsets of patients with hypertension and post myocardial infarction 
patients. The beneﬁt in risk reduction was greatest in patients with heart failure and 
post electrical cardioversion. Further prospective randomized studies are necessary to 
evaluate this observation.
924-141 Irbesartan Reduces Left Atrial Stunning After Electrical 
Cardioversion of Atrial Fibrillation
Nikolaos Dagres, George Karatasakis, Fotios Panou, Georgios Athanassopoulos, 
Themistoclis Maounis, Elias Tsougos, Kallirrhoe Kourea, Dimitrios Th. Kremastinos, 
Dennis V. Cokkinos, Onassis Cardiac Surgery Center, Athens, Greece, University of 
Athens, Attikon University Hospital, Athens, Greece
Background. Left atrial (LA) stunning, the transient impairment of LA function, is 
responsible for an increased thromboembolic risk after cardioversion of atrial ﬁbrillation 
(AF). Angiotensin receptor blockers (ARBs) could inﬂuence LA stunning by attenuation of 
atrial remodeling. We studied the effect of Irbesartan.
Methods. We prospectively assigned 50 consecutive patients undergoing electrical 
cardioversion for AF with duration >4 weeks, into two groups: 25 patients were treated 
with Irbesartan for at least 2 weeks prior to cardioversion (Irbesartan group); 25 patients 
did not receive ACE-inhibitors or ARBs (control group). LA appendage emptying velocities 
(LAAEV) and LA spontaneous echo contrast (LASEC) were assessed immediately before 
and after electrical cardioversion by transesophageal echocardiography.
Results. There were no differences between the two groups concerning age (64±13 
vs 63±13 years), AF duration (20±18 weeks vs 20±19 weeks), underlying disease, 
LA diameter (46±7 vs 47±9 mm), LV dimensions and ejection fraction (47.7±11.6% vs 
49.7±14.5%)(p=NS for all parameters). After cardioversion, LAAEV showed no signiﬁcant 
reduction in the Irbesartan group (28±9 vs 25±13 cm/s before and afterwards, p=NS), 
whereas in the control group, LAAEV decreased from 34±15 to 16±6 cm/s (p<0.05). New 
or increased LASEC occurred in 8 patients (32%) in the Irbesartan vs 16 (64%) in the 
control group (p=0.048).
Conclusions. Irbesartan signiﬁcantly attenuates LA stunning after electrical cardioversion 
of AF. ARBs may represent an important supplementation in these patients.
924-142 Effects of Angiotensin II Type 1 Receptor Antagonist on 
Atrial Fibrillation Stability in Genetically Identical Goats
Panos E. Vardas, Hercules E. Mavrakis, Stavros I. Chrysostomakis, Heraklion University 
Hospital, Heraklion, Greece
Background: It has previously been reported that the blockage of angiotensin II prevents 
the electrical remodeling induced by short term rapid atrial pacing. However, the long-term 
effects of this blockage on atrial ﬁbrillation (AF) stability are still unclear. We hypothesized 
that a prospective experimental study that would investigate the effects of angiotensin II 
blockage on AF maintenance in genetic identical animals would be of importance.
METHODS: Five sets of twin goats divided into two groups were used. The ﬁrst group 
was kept in AF by burst pacing for 4 weeks, while the second was kept in AF and received 
a daily oral dose of 1,5 mg/kg of candesartan starting 1 week before pacing and for a 
subsequent period of 4 weeks. AF duration was determined by repeat induction of AF at 
right atrium by burst pacing at baseline and after maintaining AF for 24 hours, 1, 2 weeks, 
3 weeks and 1 month respectively.
RESULTS: In the baseline study, the duration of the ﬁrst induced AF episode was less 
than 15 seconds both in the candesartan (8±2 sec) and the control (9±3 sec) group. The 
mean number of bursts needed to induce AF episodes lasting more than 30 seconds 
were 17±8 bursts in the candesartan group and 6±4 bursts for the control group p<0.05). 
Surprisingly, in the ﬁrst 24 hours of the experiment, AF was not induced at all in 2 of the 
5 goats in the candesartan group.
Over time, atrial pacing caused a signiﬁcant increase in AF duration and a signiﬁcant 
decrease in the mean number of bursts needed to induce AF episodes lasting more than 
30 seconds in both groups compared to the baseline study. Sustained AF (>1200 ms) that 
required cardioversion was observed after 1 week in all 5 control goats. On the contrary 
sustained AF (>1200 ms) was observed during the second week in three goats from the 
candesartan group and in the third week in the two other goats. The mean duration of 
induced AF in the candesartan group was signiﬁcantly shorter compared to control group 
(1.545±.623 vs. 512±.227 sec, p<0.01) after 1 month.
Conclusion: Angiotensin II blockage by candesartan decreases AF stability in genetically 
identical goats.
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804 
Atrial Fibrillation:  
Pharmacology and Epidemiology
Monday, March 13, 2006, 7:00 a.m.-8:30 a.m.
Georgia World Congress Center, Room B406
7:00 a.m.
804-3 Efﬁcacy and Tolerance of RSD1235 in the Treatment of 
Atrial Fibrillation or Atrial Flutter: Results of a Phase III, 
Randomized, Placebo-controlled, Multicenter Trial
Craig Pratt, Denis Roy, Steen Juul-Møller, Christian Torp-Pedersen, Egon Toft, D. 
George Wyse, Tonny Nielsen, Soren Lind Rasmussen, on behalf of the ACT III 
Investigators, The Methodist Hospital/Methodist DeBakey Heart Center, Houston, TX, 
Montreal Heart Institute, Montreal, ON, Canada
Background: The efﬁcacy and safety of intravenous RSD1235 in conversion of atrial 
ﬁbrillation (AF) or atrial ﬂutter (AFL) to sinus rhythm (SR) were assessed. The primary 
endpoint was the proportion of patients (pts) with AF duration of 3 hours to 7 days with 
treatment-induced conversion to SR for a minimum of 1 minute within 90 minutes of 
dosing.
Methods: 276 pts were randomized 1:1 to RSD1235 or placebo and stratiﬁed by AF or 
AFL duration. Pts received placebo or 3 mg/kg RSD1235 for 10 minutes, followed by a 15-
minute observation period; a second 10-minute infusion of placebo or 2 mg/kg RSD1235 
was given if AF or AFL did not terminate. Incidence of adverse events, serious adverse 
events (SAE), vital signs, laboratory data, ECG, and Holter monitoring were assessed.
Results: 265 pts (131 placebo, 134 RSD1235) received at least 1 infusion of study drug. 
239 pts had AF, 23 had AFL, 11 did not receive study drug, and 3 had unknown baseline 
arrhythmia. 52% of RSD1235 pts (vs 4% in the placebo group) met the primary endpoint, 
with a median time to conversion of 8 minutes in the responders. 
Proportion of RSD1235 Patients Who Converted From AF to SR or 
had Termination of AF or AFL 
Duration of 
AF/AFL
3 hours to 7 days
(p<0.0001)†
3 hours to 45 days*
(p<0.0001)
8 to 45 days*
(p=NS)‡
Treatment 
Group Placebo RSD1235 Placebo RSD1235 Placebo RSD1235
AF N=843 (3.6%)
N=86
45 (52%)
N=121
5 (4.1%)
N=118
48 (41%)
N=37
1 (2.7%)
N=32
3 (9.4%)
AF/AFL N=923 (3.3%)
N=98
46 (47%)
N=131
5 (3.8%)
N=134
49 (37%)
N=39
1 (2.6%)
N=36
3 (8.3%)
* Termination of AF or AFL (deﬁned as absence of AF or AFL)
† p-value calculated using Cochran-Mantel-Haenszel test.
‡ p-value calculated using Fisher’s exact test.
SAEs occurred in 17 (13%) placebo and 14 (10%) RSD1235 pts in the 30-day follow-
up; 1 placebo and 3 RSD1235 pts experienced a treatment-related SAE. There were no 
torsades de pointes in the RSD1235 group. There was 1 death in a pt with critical aortic 
stenosis who received RSD1235. Transient dysgeusia (22%) and sneezing (19%) were 
the most common adverse events.
Conclusion: RSD1235 safely achieved a rapid and high rate of conversion of recent-
onset AF.
7:15 a.m.
804-4 Procainamide - Propafenone - Amiodarone: A 
Comparative Study of Their Efﬁcacy And Safety For the 
Conversion of Recent Onset Atrial Fibrillation
Nikolaos E. Igoumenidis, George E. Kochiadakis, Michael I. Hamilos, Mary E. Marketou, 
Nick C. Klapsinos, Emmanuel I. Skalidis, Panos E. Vardas, Heraklion University Hospital, 
Heraklion, Greece
Background: In a prospective, randomised, single blind, placebo-controlled study, we 
examined the effectiveness and safety of procainamide, propafenone and amiodarone, 
administered intravenously, for the restoration of sinus rhythm in recent onset atrial 
ﬁbrillation.
Methods: We studied 362 patients (183men) aged between 34 and 86 years (average 
age: 65+10 years) with atrial ﬁbrillation with duration < 48 hrs. Of these, 89 were given 
procainamide, 91 propafenone, 92 amiodarone and 90 placebo.
Results. The treatment was successful in 61 (68.53%) of the procainamide group (median 
time 3 hours), in 73 (80.21%) of the propafenone (median time 1 hour), in 82 (89.13%) of 
the amiodarone (median time 9 hours) and in 55 (61.11 %) of the controls (median time 
17 hours) (p<0.05 for all medicated groups compared to those who received placebo, 
p<0.05 for amiodarone and propafenone compared to the procainamide group).
Treatment was discontinued in one patient on amiodarone because of an allergic 
reaction and in four patients receiving propafenone because of excessive QRS widening. 
Conclusions. All 3 medications, when administered intravenously, are effective in the 
restoration of sinus rhythm in recent onset atrial ﬁbrillation. Amiodarone and propafenone 
are more effective, while procainamide and propafenone are faster.
7:30 a.m.
804-5 The Outcomes of Thyrotoxicosis Related New-Onset 
Atrial Fibrillation
Chung Wah Siu, Man Hong Jim, Annie Kung, Chu Pak Lau, Hung Fat Tse, The 
University of Hong Kong, Hong Kon SAR, Hong Kong
Introduction: Although thyrotoxicosis (TT) is a common cause for atrial ﬁbrillation (AF), 
the clinical outcomes of TT related new onset persistent AF remains unclear.
Methods and Results: Over 10-year period, 215 patients (pts) with TT with new onset-
AF were studied. 15 pts with pre-existing heart diseases were excluded. Among 200 pts 
with TT related AF, their mean age was 64±17 years (41% male). At presentation, 14 
pts (7%) had concomitant ischemic stroke (IS) and 77 pts (39%) developed congestive 
cardiac failure (CCF). Pts with IS had a higher prevalence of hypertension (HT) than those 
without IS (50 vs. 25%,p=0.04), but had no difference in age and sex (p>0.05). After mean 
follow-up of 45±37 months, 100 pts (50%) had spontaneous cardioversion (CV) at median 
time of 23 days. The median time to euthyroidism with anti-thyroid drug was 81 days. In 
univariate analysis, there were no signiﬁcant differences in pts with or without CV with 
respect to age, male gender and diabetes (Table). However, pts without CV had a higher 
prevalence of HT and CCF at the time of presentation, lower usage of beta-blockers, 
larger left atrial (LA) and and left ventricular (LV) size, and lower ejection fraction (EF) 
than those with CV (Table, P<0.05). Multivariate analysis demonstrated only LA is the 
independent predictor for CV (OR=3.9, P=0.01).
Conclusion: TT related AF is related to high incidence of IS and CCF at presentation. 
After control of TT, spontaneous CV can occur in up to 50% pts. The sole independent 
predictors of CV is smaller LA.
Baseline characteristics
Pts with CV Pts with no CV p-value
Age 64±16 64±17 0.99
Male 36 46 0.15
HT 11 20 0.01
DM 18 35 0.08
CCF 23 54 0.01
LA 4.1±0.7 3.6±0.7 0.01
LVEF 55±17 65±16 0.01
7:45 a.m.
804-6 Are There Gender Differences in Risk of Ischemic 
Stroke in Patients with Atrial Fibrillation Who Are 
Anticoagulated? Results from the AFFIRM Trial
Suma H. Konety, Sue A. Joslyn, Brain Olshansky, University of Iowa Hospitals and 
Clinics, Iowa City, IA, University of Northern Iowa, Cedar Falls, IA
Background: Atrial ﬁbrillation (AF) is a risk factor for ischemic stroke especially in the 
elderly but it is not clear if warfarin reduces risk of stroke in women with AF to the same 
extent as it does for men with AF.
Methods: Risk of ischemic stroke was evaluated in all 4,060 patients [men (M) n=2466, 
women (W) n=1594] enrolled in the AFFIRM trial. An actuarial analysis of time to ﬁrst 
ischemic stroke by gender was adjusted for stroke-risk variables namely age, heart 
failure, diabetes, hypertension, prior stroke, coronary artery disease; international 
normalized ratio (INR) level at last follow-up visit and randomization group (rate-control 
vs. rhythm-control).
Results:The randomization and patient follow-up (3.5 years, range 4-6 years) were similar 
in men and women. Ischemic strokes occurred in 4.2% of the patients (n=171/4060) of 
which 157 had at least one ischemic stroke. Strokes were more common among women 
(W=80, M=77; 5.0% vs. 3.1%, p=0.002). While there was no difference in time to ischemic 
stroke from randomization among men and women (M vs.W: 683 days vs. 782 days, 
p=0.24), the unadjusted risk for ischemic stroke was higher among women compared to 
men (Hazard Ratio [HR] = 1.64; 95% conﬁdence interval [CI]=1.19, 2.26). Warfarin was 
less prescribed in the rhythm-control group compared to the rate-control group (rhythm-
control - M vs.W: 68% vs. 71%, p=0.2; rate-control - M vs.W: 86% vs. 87%, p=0.7). After 
adjusting for the stroke-risk variables women were as likely as men to be prescribed 
warfarin (Odds Ratio [OR] = 1.12; 95% CI=0.95, 1.32). Even after adjusting for stroke-
risk variables and INR levels, the stroke risk for women was higher than for men (HR = 
1.59; 95% CI = 1.07, 2.35). Conclusions: : In the AFFIRM Trial, a study of patients with 
AF, women were at greater risk for ischemic stroke than men even after adjusting for 
known stroke-risk variables and INR levels. Prescription of warfarin was similar for men 
and women.
8:00 a.m.
804-7 Diabetes, Insulin, and the Prevalence of Atrial 
Fibrillation and Flutter in a Large Heart Failure 
Population
Somjot S. Brar, In-Lu A. Liu, Steven S. Khan, Adam Kotlewski, Albert Y-J Shen, Kaiser 
Permanente, Los Angeles, CA, UCLA School of Medicine, Los Angeles, CA
Objective: We sought to determine if differences exist in the prevalence of atrial 
ﬁbrillation and ﬂutter (AF) between diabetic insulin users, diabetic non-insulin users, and 
non-diabetics with heart failure.
Background: Insulin is thought to have some inﬂuence on atrial electrical activity. Whether 
there is a signiﬁcant association between insulin use and AF has not been well studied.
Methods: We identiﬁed 28,009 patients with HF using existing care management 
databases from January 1999 to March 2005. HF was identiﬁed by ICD-9 codes and/or 
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medication records, and AF by ICD-9 codes. Insulin use was obtained from pharmacy 
databases. Multiple logistic regression was used to explore the independent relationship 
between groups.
Results: The mean age for the entire cohort was 71 ±13 years. The prevalence of 
diabetes in the population was 45% (n=12,638). Of these, 37.6% (n=4,754) were insulin 
users. Ejection fraction was available for 7,350. Mean EF ±SD for non-diabetics, diabetic 
(-) insulin, and diabetic (+) insulin was 42 ±17%, 43 ±17%, 44 ±17% respectively. Multiple 
logistic regression models follow. 
Odds Ratio of AF by Diabetes Status and Insulin Use
Unadjusted Adjusted
Model 1 OR (95% CI) p-value OR (95% CI) p-value
Non-Diabetic 1.0 n/a 1.0 n/a
Diabetic (-) Insulin 1.09 (1.00-1.17) 0.04 1.04 (0.96-1.13) 0.36
Diabetic (+) Insulin 0.70 (0.64-0.77) <0.0001 0.81 (0.74-0.90) <0.0001
Model 2
Diabetic (-) Insulin 1.0 n/a 1.0 n/a
Diabetic (+) Insulin 0.80 (0.74-0.87) <0.0001 0.77 (0.71-0.84) <0.0001
Adjusted models included: age, gender, HTN, CAD, valvular surgery or valvuloplasty, rheumatic 
and non-rheumatic valvular disease, thyroid disease, COPD, education, and income.
Conclusions: Diabetic insulin users had signiﬁcantly less AF compared to diabetic non-
insulin users and non-diabetics. These results suggest insulin use may be protective 
against AF in patients with heart failure.
8:15 a.m.
804-8 A Novel Locus for Familial Atrial Fibrillation on 
Chromosome 10p11-q21
Qian Zhu, Paul G.A. Volders, Carl Timmermans, Petra Eurlings, Xiaoyan Su, Yvonne 
Arens, Li Li, Roselie Jongbloed, Min Xia, Luz-Maria Rodriguez, Yi Han Chen, Tongji 
University Hospital, Shanghai, People’s Republic of China, Academic Hospital 
Maastricht, Maastricht, The Netherlands
Background: Atrial Fibrillation (AF) is the most common cardiac arrhythmia encountered 
in clinical practice. It is a signiﬁcant public health problem in the United States, affecting 
2.2 million Americans. Familial clustering of AF indicates that the proﬁbrillatory changes in 
atrial tissue may be, at least partly, genetically determined. Recently, three chromosomal 
loci (i.e., 5p13, 6q14-16 and 10q22-24) and three K+-channel genes (i.e., KCNQ1, KCNE2 
and KCNJ2) have been found to be associated with familial AF. However, in most other AF 
cases the genetic basis is still poorly understood.
Methods: We analyzed a four-generation Dutch family in which AF segregated as an 
autosomal dominant trait. After the exclusion of linkage to 5p13, 6q14-16, 10q22-24, 
KCNQ1, KCNE2 and KCNJ2, a genome-wide linkage scan using 398 microsatellite 
markers was performed.
Results: Two-point LOD scores >1 at recombination fraction [θ] = 0.00 and a haplotype 
segregating with disease were demonstrated only across regions of chromosome 10. 
Subsequent ﬁne mapping gave a maximum two-point LOD score of 4.1982 at D10S568 at 
[θ] = 0.00. Distinct recombination in several individuals narrowed the shared region among 
all affected individuals to 16.4 cM on the Genethon map (ﬂanking markers: D10S578 
and D10S1652), corresponding to chromosome 10p11-q21. Several candidate genes 
reside in this region, which could be associated with AF, such as ion-channel regulators, 
connexins, signal transduction systems, and genes for cell proliferation, hypertrophy, 
differentiation and migration.
Conclusion: These results provide evidence of a novel gene for AF on chromosome 
10p11-q21.
ORAL CONTRIBUTIONS
810 
Predicting Cardiac Resynchronization 
Therapy Beneﬁt
Monday, March 13, 2006, 9:00 a.m.-10:30 a.m.
Georgia World Congress Center, Room B406
9:00 a.m.
810-3 Magnetic Resonance Imaging Based Characterization 
of Mechanical Dyssynchrony and Cardiac 
Resynchronization Therapy in Right Bundle Branch Block
Melissa J. Byrne, Robert H. Helm, Nael F. Osman, Marco A. S. Cordeiro, Ronald D. 
Berger, Henry R. Halperin, David A. Kass, Albert C. Lardo, Johns Hopkins University 
School of Medicine, Baltimore, MD
Background: Clinical cardiac resynchronization therapy (CRT) studies using bi-
ventricular (BiV) pacing suggest it is useful in patients with right bundle branch block 
(RBBB), even though lateral wall contraction is not typically delayed. However, it is still 
unclear if the left ventricular (LV) lead is required or if right ventricular (RV) pacing alone 
is sufﬁcient. The magnitude of CRT beneﬁt in pure RBBB with heart failure (HF) is also 
unknown. Accordingly, we tested the hypotheses that RBBB generates less dyssynchrony 
than left bundle branch block (LBBB), that CRT effects are accordingly smaller, and that 
RV-only pacing is as effective as BiV in RBBB+HF.
Methods: RBBB+HF or LBBB+HF were induced by radiofrequency ablation of the right 
or left bundle followed by atrial tachypacing (210 bpm) for 3 wks in 12 dogs (6 on each 
group). Single site and combined (BiV) conﬁgurations were randomly tested, and the 
functional response assessed by dP/dtmax. Mechanical dyssynchrony was assessed 
by MRI-tagging, and reported as a previously validated circumferential uniformity ratio 
estimate (CURE; 1 = synchronous, 0 = fully dyssynchronous).
Results: RBBB+HF were signiﬁcantly less dyssynchronous than LBBB+HF hearts 
(CURE, 0.78±0.03 vs. 0.58±0.09; p<0.05), while still more dyssynchronous than normal 
ones (CURE, 0.97±0.01; p<0.05) . In LBBB+HF, both LV-only and BiV pacing increased 
dP/dtmax and CURE (LV-only, dP/dtmax 24.3±1.20%, CURE, 31.1±10.93%; BiV, dP/dtmax 
26.98±5.22%, CURE, 46.34±12.69%), whereas in RBBB+HF, LV-only decreased function 
and synchrony (dP/dtmax, -5.12±1.78%; CURE, -8.69±3.23%). In RBBB+HF hearts, 
single site RV and BiV pacing similarly improved dp/dtmax (RV-only, 3.76±1.12%; BiV, 
5.53±1.14%; p=NS). However, CURE was only improved in these animals by single site 
RV pacing (RV-only, 9.09±4.07%; BiV, 2.93±4.20%; p<0.05).
Conclusions: RBBB+HF generates less mechanical dyssynchrony when compared 
with LBBB+HF. Both functionally and mechanically, single site and BiV pacing gave less 
beneﬁt in RBBB+HF as opposed to LBBB+HF. Single site RV pacing reduces RBBB+HF 
induced dyssynchrony more effectively than BiV pacing, suggesting that an LV lead is not 
necessary for RBBB+HF CRT.
9:15 a.m.
810-4 Deﬁnition of Optimal Left Ventricular Lead Position in 
Cardiac Resynchronisation Therapy Using Myocardial 
Deformation Imaging
Michael Becker, Theresa Kaminski, Andreas Franke, Peter Hanrath, Rainer Hoffmann, 
RWTH University Aachen, Aachen, Germany
Background. This study sought to assess if myocardial deformation imaging (MDI) 
allows deﬁnition of an optimal left ventricular (LV) lead position for improved effectiveness 
of cardiac resynchronisation therapy (CRT).
Methods. MDI based on tracking of acoustic markers within 2D echocardiographic 
images (GE Vingmed Ultrasound) was performed in 42 heart failure patients at baseline, 
7 days postoperatively and at 3 months. Ejection fraction (EF) and peak oxygen 
consumption (VO2max) were determined before and after CRT. In a 36 segment LV model 
based on 6 short axis views the segment with latest peak systolic circumferential strain 
was determined. Additionally, the segment with maximal temporal difference in peak 
strain on CRT to prior to CRT was deﬁned as the segment with greatest beneﬁt of the 
CRT-system and assumed to be location of the LV-lead. Optimal LV lead position was 
deﬁned as concordance or immediate neighbouring of the segment with latest myocardial 
deformation prior to CRT and the segment with maximal temporal difference in peak 
strain on-off CRT.
Results.19 patients showed optimal, 23 patients non-optimal position of the LV lead 
based on this deﬁnition. Preoperative EF and Vo2max were similar between patient 
with optimal and non-optimal LV lead position (EF 31.4±6.1% vs. 30.3±6.5%,VO2max 
14.5±1.8ml/min/kg vs. 14.2±2.1ml/min/kg). With CRT EF increased by 6.7±2.1% in the 
optimal LV lead position group vs 3.5±2.5% in the non-optimal group (p<0.001). After 3 
months there was greater increase of VO2max in the optimal compared to the non-optimal 
LV lead position group (2.3±0.9 ml/min/kg vs 1.2±0.6 ml/min/kg, p<0.001).
Conclusions. MDI is a new 2D echocardiography based imaging modality which allows 
detailed analysis of the myocardial contraction sequence. Optimal LV lead position in CRT 
deﬁned by MDI with the segment with latest contraction prior to CRT results in greater 
improvement in EF and Vo2max than non-optimal LV lead position
9:30 a.m.
810-5 Relationship of Tissue Doppler Dyssynchrony and 
Acute Hemodynamic Response to Later Reverse 
Remodeling After Resynchronization Therapy
Matthew S. Suffoletto, Maxime Cannesson, Masaki Tanabe, Samir Saba, John Gorcsan, 
III, University of Pittsburgh, Pittsburgh, PA
Background: Tissue Doppler (TD) dyssynchrony can predict response to resynchronization 
therapy (CRT), but the relationship of dyssynchrony to acute hemodynamic response and 
later reverse remodeling in the same patients (pts) remains unclear.
Methods: Thirty-three class III-IV heart failure pts (ejection fraction (EF) 27±7%, QRS 
duration 156±24 ms) were studied before, the day after, and 7 + 5 mo. after CRT. Baseline 
color TD dyssynchrony was deﬁned as > 65 ms difference in opposing wall peak systolic 
velocities from 12 segments in 3 apical views. Acute hemodynamic response was deﬁned 
as > 15% increase in Doppler stroke volume the day after CRT and reverse remodeling 
was deﬁned as > 15% increase in ejection fraction (EF) over baseline.
Results: An acute hemodynamic response occurred in 22 of 33 pts (67%), 19 of whom 
(86%) went on to show reverse remodeling 7+5 mo. after CRT (EF from 25+7% to 
34+11%, p<0.001). The 3 acute responders who had no late EF improvement also had 
no baseline dyssynchrony. Five of 11 (45%) of acute non-responders still went on to 
later reverse remodeling (EF from 30+4% to 39+6%, p<0.01). Baseline TD dyssynchony 
predicted late EF response with 92% sensitivity and 89% speciﬁcity. Speciﬁcity improved 
to 100% when combined with an acute hemodynamic response.
Conclusions: Dyssynchrony by TD is predictive of reverse remodeling after CRT. An 
acute hemodynamic response is predictive of later reverse remodeling when it occurs 
following CRT, but underestimates the potential for a later response. 
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9:45 a.m.
810-6 Effect of Postero-lateral Scar Tissue on Clinical and 
Echocardiographic Improvement Following Cardiac 
Resynchronization Therapy
Gabe B. Bleeker, Theodorus AM Kaandorp, Hildo J. Lamb, Paul Steendijk, Albert de 
Roos, Ernst E. van der Wall, Martin J. Schalij, Jeroen J. Bax, Leiden University Medical 
Center, Leiden, The Netherlands
Background Currently, one third of patients treated with cardiac resynchronization therapy 
(CRT) do not respond. Non-response to CRT may be explained by the presence of scar 
tissue in the postero-lateral left ventricular (LV) segments, which may result in ineffective LV 
pacing and inadequate LV resynchronization. In the current study the relationship between 
transmural postero-lateral scar tissue and response to CRT was evaluated.
Methods Forty consecutive patients with end-stage heart failure (New York Heart 
Association (NYHA) class III/IV), LV ejection fraction (EF) ≤35%, QRS duration >120 
ms, LBBB and chronic coronary artery disease were included. The localization and 
transmurality of scar tissue was evaluated with contrast-enhanced MRI. Next, LV 
dyssynchrony was assessed at baseline and immediately post-implantation using tissue 
Doppler imaging (TDI). Clinical parameters, LV volumes and LVEF were assessed at 
baseline and at 6 months follow-up.
Results Fourteen patients (35%) had a transmural (>50% of LV wall thickness) postero-
lateral scar. In contrast to patients without postero-lateral scar tissue, these patients 
showed a low response rate (14% vs. 81%, P<0.05) and did not improve in clinical or 
echocardiographic parameters. In addition, LV dyssynchrony remained unchanged after 
CRT implantation (84±46 ms vs. 78±41 ms, ns).
Patients without postero-lateral scar tissue and severe baseline dyssynchrony (≥65 ms) 
showed an excellent response rate of 95%, compared to patients with a postero-lateral 
scar and/or absent LV dyssynchrony (11%).
Conclusion CRT does not reduce LV dyssynchrony in patients with transmural scar 
tissue in the postero-lateral LV segments, resulting in clinical and echocardiographic non-
response to CRT.
10:00 a.m.
810-7 Left Ventricular Lead Positioning Over Infarcted 
Myocardium Results in Less Improvement in Ejection 
Fraction in Patients With Ischemic Cardiomyopathy 
Following Cardiac Resynchronization Therapy
William H. Sauer, Mathew Hutchinson, Sumeet K. Mainigi, Michael Toca, Leonard 
Ilkhanoff, Paveljit Bindra, Michael P. Riley, Edward P. Gerstenfeld, David J. Callans, 
Francis E. Marchlinski, Joshua M. Cooper, University of Pennsylvania School of 
Medicine, Philadelphia, PA
Introduction: Cardiac resynchronization therapy (CRT) reduces interventricular 
activation time and improves congestive heart failure symptoms. Not all appropriate 
patients, however, beneﬁt from CRT. We hypothesized that left ventricular (LV) lead 
positioning over infarcted myocardium would result in less improvement in LV ejection 
fraction (EF) compared to LV pacing over non-infarcted myocardium in patients with 
ischemic cardiomyopathy.
Methods: Patients with ischemic cardiomyopathy undergoing CRT were retrospectively 
analyzed to assess the relationship between lead position and improvement in left 
ventricular ejection fraction (LVEF). Areas of infarcted LV segments were identiﬁed with 
nuclear imaging and echocardiography prior to the implantation procedure. Final LV 
lead location was categorized into one of 17 myocardial segments using ﬂuoroscopic 
images in orthogonal views. Pre- and post-implant LV chamber dimensions and EF were 
measured by an echocardiographer blinded to the study.
Results: Of the 108 patients included in the analysis, there were 21 patients with LV lead 
positions located in an infarcted segment. The posterolateral wall was the most frequent 
site (23.7%), followed by the apical lateral wall (16.5%). The mean LVEF in this group of 
patients increased less than the remainder of the cohort (1.4 +/- 0.8% vs. 3.9 +/- 1.1%; 
P<0.01). Other clinical characteristics including age, gender, LV end diastolic dimension, 
and severity of mitral regurgitation were not associated with pacing-related improvement 
of the LVEF (P>0.05).
Conclusion: CRT using an LV lead positioned within an infarcted myocardial segment 
results in less improvement in LVEF compared to an LV lead positioned in a non-infarcted 
segments. These results hold important implications regarding optimal LV lead positioning 
and device programming in patients with ischemic cardiomyopathy.
10:15 a.m.
810-8 Robotic Epicardial Cardiac Resynchronization Is 
Superior to Endovascular Implantation in Promoting 
Reverse Remodelling
Ajay S. Shah, Rawa Sarji, Danny Pudpud, Donna Macmillan-Marotti, Sripal Bangalore, 
Anand Haridas, Afam Onuora, Sandhya Balaram, Joseph DeRose, Jonathan S. 
Steinberg, Farooq Chaudhry, St Lukes-Roosevelt Hospital Center, New York, NY
Background: Cardiac resynchronization therapy (CRT) has been shown to improve 
systolic function and cause reverse-remodeling in patients with advanced heart failure 
(HF). Robotically implanted epicardial lead placement is a rescue therapy in patients with 
failed endovascular implants. The relative efﬁcacy of robotically implanted epicardial lead 
placement versus endovascular lead placement has not been examined. A superior lead 
placement offers the theoretical beneﬁt of ideal site of lead placement.
Methods: Thirty seven patients (54% male) with advanced HF (NYHA-3.4±0.3, EF-19± 
8%) and optimized medical therapy, undergoing CRT (49% endovascular, 51% epicardial) 
formed the study cohort. Reverse- remodeling was assessed by changes in follow-up 
(9.7±4 months) 2D-trans thoracic echocardiographic parameters of left ventricular 
ejection fraction (LVEF), LV end-diastolic index (LVEDI) and LV end diastolic volume index 
(LVEDVI) were quantitatively evaluated.
Results: Patients receiving robotically implanted epicardial CRT demonstrated 
signiﬁcantly increased LVEF, decreased LVEDI, and decreased LVEDVI compared to 
patients receiving endovascular CRT (Figure).
Conclusion: Robotically implanted epicardial CRT -LV lead placement is superior 
to endovascular CRT -LV lead placement in inducing reverse remodelling for patients 
with advanced heart failure. This observation likely stems from greater ﬂexibility of lead 
placement by the robotic epicardial procedure.
ORAL CONTRIBUTIONS
813 
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Monday, March 13, 2006, 9:00 a.m.-10:30 a.m.
Georgia World Congress Center, Room B312
9:00 a.m.
813-3 Electrogram Features Are Superior to Clinical 
Characteristics for Predicting Atrial Fibrillation After 
Coronary Artery Bypass Graft Surgery
Matthew C. Wiggins, Edward P. Gerstenfeld, George Vachtsevanos, Brian Litt, School 
of Electrical and Computer Engineering, Georgia Institute of Technology, Atlanta, GA, 
University of Pennsylvania, Philadelphia, PA
Background: Atrial ﬁbrillation (AF) occurs in approximately 30% of coronary artery 
bypass graft (CABG) patients following surgery, increasing cost and morbidity. We 
hypothesized that quantitative features extracted from the surface ECG and atrial wire 
tracing could predict the risk of AF after CABG.
Methods: Patients were monitored with continuous Holter recordings from surface lead 
II and intracardiac right atrial electrograms for 48 hours following CABG. A single, ﬁve-
minute segment of ECG at 36 hours following surgery was extracted for analysis. P waves 
and QRS complexes were annotated and used to extract ECG segments (RR,RP,PR,PP) 
and heart rate variability measures from which 536 temporal, frequency, and nonlinear 
domain features were calculated. An evolutionary computing technique was used to 
train a k-Nearest-Neighbor (kNN) classiﬁer to determine the best features to assess AF 
risk. For comparison, the patients’ age, history of AF, beta-blocker withdrawal, and the 
presence of pulmonary disease were used as inputs to a linear AF risk score. An AF 
prediction threshold was assigned as the maximum of the product of the sensitivity and 
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speciﬁcity as found on the data’s receiver operating characteristic curve.
Results: Thirty-three patients (21 male, 11 with post-operative AF) were studied. The 
trained kNN classiﬁer identiﬁed two variables, the skewness of heart rate and the 
minimum of the RP segment’s median frequency, as predictors of post-operative AF. The 
algorithm, validated using a leave-one-out methodology, correctly classiﬁes 90.9% (30 of 
33) patients, with a sensitivity of 82% and a speciﬁcity of 96%. The clinical AF risk score 
produced an accuracy of 63.6% (21 of 33), signiﬁcantly inferior to the kNN classiﬁer.
Conclusions: Two combined indicators, based on surface and intracardiac electrogram, 
skewness of heart rate and the minimum of the RP segment’s median frequency, were 
superior to clinical characteristics for predicting AF after CABG. These ﬁndings, if 
validated prospectively, may be important for identifying patients at risk of developing 
AF after CABG.
9:15 a.m.
813-4 Which ECG Criteria for Left Ventricular Hypertrophy 
Best Predict Mortality?
Edward P. Havranek, Frederick A. Masoudi, Mori J. Krantz, Rebecca L. Hanratty, 
Raymond O. Estacio, Caroline Bublitz, John F. Steiner, Denver Health Medical Center, 
Denver, CO, University of Colorado Health Sciences Center, Denver, CO
Background: Many criteria have been proposed for assessing for the presence or 
absence of left ventricular hypertrophy using electrocardiography, but there is no 
consensus on which criteria are the most clinically meaningful.
Methods: We obtained baseline electrocardiographic data and 5-year mortality rates 
from the National Health and Nutrition Epidemiologic Survey (NHANES III). For each 
baseline electrocardiogram, we computed Cornell voltage, Cornell voltage adjusted for 
age, gender, and body mass, Cornell product, Sokolow-Lyons voltage, and Novacode 
estimate of left ventricular mass index. We created a correlation matrix among the criteria. 
For each of these ﬁve criteria we computed sensitivity and speciﬁcity for subsequent 
mortality by decile, and constructed receiver-operating characteristic (ROC) curves from 
these data. We compared the ﬁve criteria by c-statistic (the area under the ROC curve).
Results: There were 7,840 subjects with data available to calculate all ﬁve of the voltage 
criteria. Subjects were of mean age 60 years, 47% female, and had a mean systolic 
blood pressure of 133 mmHg. Correlations among the criteria varied widely, varying from 
0.94 for the comparison of the Cornell voltage and the Cornell product, and 0.35 for the 
comparison of the Cornell product and the Sokolow-Lyons voltage. C-statistics for each 
of the criteria were modest, but was signiﬁcantly greater for the adjusted Cornell voltage 
(0.562) than for the other criteria.
Conclusions: These results suggest that the adjusted Cornell voltage is the best of the 
electrocardiographic criterion for assessing for the presence of left ventricular hypertrophy among 
those tested, based on its superior discriminative capacity for the outcome of total mortality.
9:30 a.m.
813-5 Changes in Parasympathetic Tone Result in QT-RR 
Interval Hysteresis during Exercise and Recovery
Marc K. Lahiri, Jason Ng, Alan H. Kadish, Jeffrey J. Goldberger, Northwestern University 
Feinberg School of Medicine, Chicago, IL
Background: For matched RR intervals, the QT interval (QT) is shorter in recovery 
(REC) than in exercise (EX), a phenomenon known as QT hysteresis.
Methods: To evaluate the mechanism of QT hysteresis, 20 subjects (16M; age 61±11 years) 
underwent continuous ECG monitoring during 16 min of submaximal EX on a stationary 
bicycle followed by 30 min of REC. Session #1 was performed under normal physiologic 
conditions; in session #2, parasympathetic blockade (PB) with atropine was performed at 
end exercise. Beat to beat QT and RR intervals were measured and median ﬁltered. Three 
QT-RR interval data sets were analyzed: 1) During EX (without PB); 2) During REC without 
PB; 3) During REC with PB (REC+PB). Hysteresis area was deﬁned as the area between 
the QT-RR linear regression lines for EX and REC in the range of measured RR intervals. 
When the REC line was below that of EX, the area was considered negative.
Results: The minimum RR with EX was 522±76ms. QT-RR slope during REC (0.20±0.07) 
was different than those during both EX (0.33±0.08, p<0.0001) and REC+PB (0.34±0.08, 
p<0.0001), with no difference between EX and REC+PB. QT hysteresis was present at 
baseline (area -2.6±3.2 103ms2); after PB, hysteresis area was positive and differed 
signiﬁcantly from REC without PB (1.9±3.5 103ms2, p<0.0001).
Conclusions: “QT hysteresis” is due to differential parasympathetic effects in EX and 
REC, rather than an intrinsic ionic mechanism. QT hysteresis may provide an index of 
parasympathetic effects on cardiac repolarization in REC. 
9:45 a.m.
813-6 Three Optimally Placed Electrodes Versus 12-Lead 
ECG for Detecting Myocardial Occlusion Ischemia by 
Bayesian Classiﬁcation
Juhani Dabek, Helena Hänninen, Heikki Väänänen, Matti Stenroos, Mats Lindholm, 
Ilkka Tierala, Lauri Toivonen, Helsinki University Central Hospital, Laboratory of 
Biomedical Engineering, Espoo, Finland
Background: Body surface potential mapping (BSPM) was recorded during balloon 
angioplasty of following coronary arteries: left anterior descending (LAD) in 9, left 
circumﬂex (LCX) in 6, and right coronary artery (RCA) in 7 patients. BSPM was applied to 
ﬁnd a limited number of leads to differentiate between the culprit coronary arteries.
Methods: Around forty heartbeats during ischemia were used from each patient. ST-
segment amplitude was measured 60 ms after the J-point. The classiﬁcation was based 
on the multidimensional Bayesian method, assuming a Gaussian distribution. For 
identiﬁcation of the best lead sets, the leave-one-out cross-validation method was used. 
The model was trained by utilizing 21 patients’ data whilst using the 1 remaining patient’s 
data for testing. This was repeated 22 times by having each patient’s data once in the 
testing group and the others in the training group. Combinations of 3 leads from the 120 
BSPM leads were thus tested, totalling in 280840 combinations. As a criterion for the 
goodness of a 3 lead set, the average percentage of correctly classiﬁed data was used.
Results: For the best test set, the criterion equalled 81,8 %, and the next best one 80,0 
%. The electrodes of the optimal lead set were located on the midsternal line 5 cm below 
the standard leads V1-V2, 10 cm below lead V3, and 5 cm above the dorsal lead V9. From 
the 12-lead ECG, using 8 independent leads (V1-V6, I, and II), the classiﬁcation result by 
the same method was 43,2 %.
Conclusions: Combination of optimally located 3-lead set, identiﬁed by Bayesian 
classiﬁcation, accurately identiﬁed the culprit coronary artery in myocardial occlusion 
ischemia. Compared to the 12-lead ECG, this optimal lead set covered the inferior frontal 
chest and the dorsal chest, which represent RCA and LCX supply areas.
10:00 a.m.
813-7 ECG-Based Method for Identifying KvLQT1/KCNE1 
or HERG Mutation in Patients With The Long QT 
Syndrome
Martino Vaglio, Jean-Philippe Couderc, Scott McNitt, Wojciech Zareba, Arthur J. 
Moss, Heart Research Follow-Up-Program, University of Rochester Medical Center, 
Rochester, NY
The clinical course and the precipitating risk factors in the congenital long QT syndrome 
(LQTS) are genotype speciﬁc. Among LQTS mutations, KvLQT1/KCNE1 (LQT1) and 
HERG (LQT2) mutations have the higher likelihood of recurrent cardiac events and their 
diagnosis is crucial to reduce their associated risk of sudden death.
Twelve-lead ECG Holter were recorded in 48 LQT1 (21.6±12.2 yrs, 34 f) and 24 LQT2 
genotyped patients (22.4±8.7 yrs, 19 f). The cardiac beats were grouped based on 
heart rate (HR), scalar and vectorial repolarization factors were compared for similar 
HR. The QT, QTapex and the Tpeak to Tend interval (TpTe) were measured. Principal 
Component Analysis (PCA) was computed and early, late and total duration of T-loops 
was measured.
Average RR intervals were similar between LQT1 (906±193 msec) and LQT2 (904±211 
msec) patients. The Table provides the results for the repolarization factors.
level of signiﬁcance * p<=0.001
HR: 75 - 77.4 (bpm) RR (msec) QT (msec) TpTe (msec) Tamp(mV) LTD(msec)
LQT1 (n=44) 788.3±2.0 443.5±29.6 84.6±9.5 0.41±0.17 27.5±3.6
LQT2 (n=23) 787.9±3.1 453.4±40.8 110.6±33.5* 0.15±0.20* 34.3±9.3*
Binary logistic regression analysis were used to design models for discriminating LQT1 
from LQT2 pts. T-wave amplitude and TpTe from lead II were selectioned. The model 
correclty identiﬁed 93.2% of LQT1 and 82.6 % of LQT2 patients. Adding late T-loop 
duration (LTD) slightly increased the classiﬁcation of LQT1 pts to 95.5%.
While QT intervals were prolonged in LQT1 and LQT2 patients, T-wave amplitude and 
transmural dispersion (TpTe) were different between the two groups. Our discriminant 
model could separate LQT1 from LQT2 patients using the phenotypic expressions of their 
respective mutation on the surface ECGs.
10:15 a.m.
813-8 Novel Computer Assisted Measurement of 
Electrocardiographic P Terminal Force to Predict 
Elevated Left Ventricular End Diastolic Pressure
Eunyoung Lee, Barbara J. Drew, Ronald H. Selvester, Daniel M. Schindler, Andrew D. 
Michaels, University of California, San Francisco, San Francisco, CA
Background: P terminal force (PTF) in ECG leads V1 or V2 provides a non-invasive 
measure of left atrial pressure and volume overload. The classic calculation of PTF 
(PTFCL) involves multiplying peak negative P amplitude with maximal P negative duration, 
which may over-estimate the actual P negative area. We evaluated a novel calculation 
of actual P negative area (PTFNov) using the integral of each point in P terminal negative 
area. We hypothesized that PTFNov is superior to PTFCL to distinguish normal (≤15mmHg) 
vs elevated (>15 mmHg) left ventricular end diastolic pressure (LVEDP).
Methods: Both methods were calculated using computer-assisted measurement software 
(Inovise Medical, Inc., Portland, OR). PTFNov and PTFCL were measured in 96 adults in 
sinus rhythm who underwent left heart catheterization.
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Results: Mean age 62±14 (24-90), CAD (71%), acute coronary syndrome (17%), LVEDP 
>15mmHg (46%). LVEDP had a higher correlation coefﬁcient with PTFNov compared to 
PTFCL (Table, p<0.01 for all values). Using either measurement method, lead V1 was 
superior to V2 in estimating LVEDP. With 70% sensitivity and 70% speciﬁcity, a PTFNov 
>3000 µV-ms was predictive of elevated LVEDP (OR: 5.8, 95% CI: 2.4-14.2, p<0.01).
Conclusions: Computer-assisted measurement of the P negative area is superior to the 
classic PTF measurement to predict elevated LVEDP. A PTFNov >3000 µV-ms is indicative 
of left ventricular ﬁlling pressure overload.
Point biserial correlation between PTF and LVEDP, using two methods of PTF 
PTFNov PTFCL 
V1 V2 V1 or V2 V1 V2 V1 or V2
LVEDP .435 .310 .409 .355 .277 .330
POSTER SESSION
947 
Deﬁbrillation/Implantable Antiarrhythmia 
Devices
Monday, March 13, 2006, 9:00 a.m.-12:30 p.m.
Georgia World Congress Center, Hall B1
Presentation Hour: 11:00 a.m.-Noon
947-123 Do Ventricular Tachyarrhythmias From a Failing Heart 
Need More Energy to Convert?
F. Roosevelt Gilliam, Leslie A. Saxon, Emile G. Daoud, Michael A. Lee, Dong Li, Yunlong 
Zhang, Claudio D. Schuger, Duke University Medical Center, Durham, NC, Guidant 
CRM, St. Paul, MN
Background: Clinical trials have demonstrated that cardiac resynchronization therapy 
deﬁbrillators (CRT-D) have improved outcome in heart failure (HF) patients and reduced 
mortality. However, there is an increasing trend of implanting high-energy (HE) devices 
due to a concern that ventricular tachycardia (VT) or ventricular ﬁbrillation (VF) in a failing 
heart may require higher energy to convert. This study compared the conversion rates in 
patients with CRT-Ds to those with implantable cardioverter deﬁbrillators (ICD).
Methods: This report retrospectively analyzed independently induced VT/VF episodes 
from 13 recently completed ICD and CRT-D trials. All episodes had a shock programmed 
as the ﬁrst therapy. Four most commonly used test energy levels were selected with 
highest energy level of 21J, which had at least a 10J safety margin for a 31J device. The 
conversion rate was calculated at each energy level. Chi-square test was used when 
comparing the conversion rate between ICD and CRT-D groups.
Results: A total of 1257 ICD and 743 CRT-D patients with 6351 and 1686 independently 
induced VT/VF episodes for each group were analyzed. There were signiﬁcant differences 
in age (p=0.01), gender (p=0.0026), NYHA (p<0.0001) and EF (p<0.0001) between 
groups. There was no difference of arrhythmia types distribution between the groups 
(p>0.05). The overall conversion rate for all energy levels for the CRT-D group (89%) was 
higher than the ICD group (86%)(p=0.004). However, there were no differences of the 
conversion rates between CRT-D and ICD at the 11J (86% vs. 82%), 14J (86% vs. 85%) 
and 21J (85% vs. 88%) energy levels (p>0.05). Signiﬁcance was observed only at 17J 
(88% vs. 92%, p=0.002).
Conclusions: Despite the presence of more advanced HF, there does not appear to 
be a higher energy requirement for CRT-D recipients, at implant testing, compared to 
ICD patients to terminate induced VT/VF. A standard energy CRT-D may be sufﬁcient 
for the majority of HF patients and a HE device may only be required for a proven high 
DFT patient.
947-124 Practices and Opinions of Morticians Regarding 
Postmortem Implantable Device Analysis and Retrieval
James N. Kirkpatrick, Susan S. Kim, Subbuah Rajaguru, Michael S. Panutich, Martin C. 
Burke, Bradley P. Knight, University of Chiacgo, Chicago, IL
Background: Recent recalls of implantable cardiac rhythm management devices have 
cast a spotlight on the need for improved postmortem device analysis and retrieval. The 
purpose of this study was to determine current practices regarding management of 
implantable devices in deceased persons.
Methods: Funeral home phone numbers were obtained from the yellow pages of a large 
metropolitan area. The embalmer or funeral director of each funeral home was contacted 
by phone and asked to complete a survey. Questions involved current practices and 
opinions regarding postmortem device interrogation and explantation.
Results: Of 56 potential subjects contacted, only 2 declined to participate. Amount 
of experience averaged 24 years (range = 2-55 years) with an annual volume of 374 
deceased persons (range = 25-3000 persons). The mean proportion of deceased 
persons with an implantable device was 11% (range = <1 to 38%). Only 4 subjects recall 
a deceased person undergoing postmortem device interrogation. Among those persons 
with an implanted device, the mean proportion who had the device removed was 33%. The 
most common reason for device removal was in preparation for cremation. The subjects 
routinely handled the explanted devices by placing them in medical waste (n=22), or by 
donating the devices to an organization involved in refurbishment for animal use or for 
human use in developing nations (n=13). 5 subjects stored the devices onsite. Only 2 
subjects recall returning at least one device to the manufacturer. 83% of respondents 
thought it would be feasible to interrogate devices in the funeral home routinely; and 93% 
said it would be possible to remove and return all devices to the manufacturer.
Conclusions: Implantable devices are rarely interrogated or returned to the manufacturer 
after a patient dies. However, funeral directors and embalmers believe routine interrogation 
and device retrieval is feasible. There appears to be signiﬁcant potential for improved 
postmortem implantable device analysis.
947-125 Effect of Different Cardiac Resynchronization Therapy 
Pacing Modalities on Ventricular Tachycardia/
Ventricular Fibrillation Events in Heart Failure Patients
Michael Gold, Michael Mollerus, David De Lurgio, Joseph Strakna, Lindsay Fleming, 
Clarence Cumming, Medical University of South Carolina, Charleston, SC, Guidant, St. 
Paul, MN
Background: Studies of cardiac resynchronization therapy (CRT) using simultaneous 
biventricular (BiV SIM) pacing have demonstrated improved clinical outcomes. While 
previous BiV SIM studies have reported a neutral effect on ventricular tachycardia/
ﬁbrillation (VT/VF), little has been published on the potential for proarrhythmic effects of 
two investigational CRT modalities [sequential biventricular (BiV SEQ) and left ventricular 
(LV-CRT)] as studied in the DECREASE-HF clinical trial.
Methods: This clinical trial randomized patients on a 1:1:1 basis to BiV SIM, BiV SEQ, or 
LV-CRT for a six-month period. Time to ﬁrst VT/VF event was estimated with the Kaplan-
Meier method and the event rates for BiV SEQ and LV-CRT were compared to BiV SIM 
and tested with the log-rank test.
Results: There were 360 patients enrolled of whom 342 were implanted and 306 were 
randomized. Patients had a mean age of 67 years, mean LVEF 23%, 67% male, mean 
QRS of 166 ms, and 64% ischemic with mean follow-up duration of 10.9ϒ4.2 months. 
There were no signiﬁcant differences in baseline characteristics between groups. The 
Kaplan-Meier curves for each study arm are shown below. There were no statistically 
signiﬁcant differences in VT/VF event rates for the alternate CRT modalities when 
compared to control.
Conclusions:
The BiV SEQ and LV-CRT modalities do not appear to have a proarrhythmic effect when 
compared to simultaneous BiV SIM CRT. Further prospectively designed studies are 
necessary to conﬁrm this ﬁnding.
947-126 Stepped Deﬁbrillation Waveform Is Substantially More 
Efﬁcient Than the 50% Tilt Biphasic
Mark W. Kroll, Karlheinz Seidl, Chris Moulder, Gabriel Mouchawar, Cristoph Stoeppler, 
T. Becker, K. Donges, T. Kleeman, U. Weise, E. Anskey, H. Burnett, Russell A. Denman, 
Herzzentrum, Ludwigshaven, Germany, Prince Charles Hospital, Brisbane, Australia
Introduction: There is a clinical need for a method of reducing the deﬁbrillation 
threshold (DFT) in the highest DFT patients. The stepped waveform has demonstrated 
superior deﬁbrillation performance over the biphasic waveform in animal studies and 
computer modeling. It has three parts: the ﬁrst portion is positive and equivalent to 2 
capacitors in parallel, the second is positive with the capacitors in series, and the last 
portion is negative, also with the capacitors in series. The increased efﬁciency is due 
to the capacitor stepping approximating an ascending waveform that, in turn, couples 
energy more efﬁciently with the passive cardiac membrane response.
Method: We measured the delivered energy DFT in 17 patients in a dual-site study with 
both a control biphasic and the stepped waveform using a Malkin 4-shock protocol. The 
control waveform was a 50%/50% tilt biphasic in both phases truncated exponential as 
this is the most commonly implanted waveform today. The stepped waveform had its 3 
durations determined by the theoretical cardiac membrane time constant of a 3.5 ms. All 
shocks were delivered using an arbitrary waveform deﬁbrillator, which was programmed 
to mimic two 220 µF capacitors (110 µF in series).
Results: The median DFT was reduced by 35% from 11.6 J to 7.5 J J (p=.03). On 
average, the stepped waveform was able to deﬁbrillate as well as the 50% tilt biphasic 
with 28% more energy. The shocking resistance was 53.2 ± 8.7 ohms. The beneﬁt of the 
stepped waveform had a negative correlation with the resistance (r2 = 0.21) suggesting 
that the capacitance values chosen for the stepped waveform were close to optimal for a 
30 ohm resistance but that a smaller capacitance value could give even better DFTs for 
resistances of > 50 ohms.
Conclusions: The stepped waveform shows signiﬁcant promise for the clinical problem 
of high DFT patients in this very preliminary study. Further studies are warranted to guide 
in the optimization of the usage and parameters of this waveform.
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947-127 Natural History of Hemodialysis Patients Receiving an 
Implantable Cardioverter Deﬁbrillator for Secondary 
Prevention
David P. Dobesh, Kenneth Stein, Suneet Mittal, Sei Iwai, Bindi Shah, James Cheung, 
Vivian Tan, Dmitry Nemirovsky, Sandhya Dhruvakumar, Bruce Lerman, Stephen 
Markowitz, New York Presbyterian - Weill Cornell Medical Center, New York, NY
Background: Hemodialysis (HD) patients have increased risk of cardiovascular mortality 
as compared to the general population. Not infrequently, patients experience either 
syncope or sudden cardiac death (SCD) at dialysis from which they are revived. The role 
of an implantable cardioverter-deﬁbrillator (ICD) in these patients is undeﬁned.
Methods: We retrospectively reviewed the data of all patients referred to our 
electrophysiology laboratory between 1998 and 2005 who experienced syncope or 
cardiac arrest during or within 6 hours following hemodialysis. Device interrogation 
strips were reviewed when available. The social security death index was used to obtain 
mortality data.
Results: We identiﬁed 20 patients with cardiac arrest (16) or syncope (3) at hemodialysis. 
Five received a pacemaker for clear documentation of a bradyarrhythmias and were 
excluded from analysis. Fifteen received an ICD of whom 7 had documented ventricular 
tachycardia (VT) and 4 had ventricular ﬁbrillation (VF). Of patients receiving an ICD ten 
were male, seven had an ejection fraction <=35% and seven had no signiﬁcant coronary 
disease. Nine of ﬁfteen patients underwent electrophysiologic testing. Six patients had no 
inducible VT despite four of them having documented VT or VF. Three were inducible for 
VT. There was a 63% mortality in the ICD population at 2 years.
Conclusion: Hemodialysis patients who experience syncope or SCD at dialysis have a 
high mortality despite implantation of an ICD.
947-128 Impact of Left Ventricular Mass and Diameter on 
Deﬁbrillation Thresholds in Patients with Implantable 
Cardioverter Deﬁbrillators
Dhanunjaya R. Lakkireddy, David J. Burkhardt, Kay Ryschon, Dimpi Patel, Rohit 
Bhateja, Subramanya Prasad, Sergio Thal, Ashok Kondur, Oussama Wazni, Mohammed 
Kanj, Kenneth Civello, Robert Schweikert, Walid Saliba, Mandeep Bhargava, Mauricio 
Arruda, Mina Chung, Bruce Wilkoff, Patrick Tchou, Andrea Natale, Cleveland Clinic 
Foundation, Cleveland, OH
Objective: This study studies the impact of LV mass and diameter on deﬁbrillation 
thresholds (DFT) in patients undergoing implantable cardioverter deﬁbrillator (ICD) 
surgery.
Methods: Consecutive patients who underwent ICD implantation at the Cleveland 
Clinic Foundation between 1995 and 2001 were studied. Baseline demographic, clinical 
characteristics of patients who had high DFTs (≥ 21 J) and low DFTs (≤ 20J) were 
compared. DFTs were determined at the end of implantation in a roving fashion until 
two successful deﬁbrillations are achieved with adequate safety margin of atleast 10J. 
Multivariate regression analysis was performed to identify predictors of high DFTs from 
this large cohort.
Results: Of the entire study population 13% (305/2430) had high DFTs and 87% 
(2125/2430) had low DFTs. Patients with high DFTSs were younger (64 vs 66 yrs, 
p<0.001), had higher BMI (29 vs 28, p=0.03), greater left ventricular internal diastolic and 
systolic diameters (6.5/6 vs 5.2/4.9, p<0.001); thicker interventricular septum/posterior 
wall (1.3/1.2 vs 1.2/1.1, p<0.05); larger left atria (4.8 vs 4.6 cm, p<0.001), larger mid 
descending aortic diameter (3.6 vs 3.3 cm, p<0.001), lower EF (24% vs 26%, p,0.001), 
wider QRS (149 vs 134 msec, p<0.001), males (92% vs 83%, p,0.001) and dilated 
cardiomyopathy ( 36% vs 13%, p<0.001). A ROC curve demonstrated 655 gm as the cut 
off which consistently predicted high DFTs. Patients with LV mass >655 gm had higher 
incidence of high DFTs (75%vs25%, p=0.001) compared to those with LV mass ≤ 655 gm. 
By multivariate analysis LV mass, LVIDD, QRS duration, LVEF & DCM were found to be 
an independent predictor of high deﬁbrillation thresholds.
Conclusion: Patients with larger and heavier hearts have higher deﬁbrillation thresholds.
947-129 Does Gender Alter the Efﬁcacy of Implantable 
Cardioverter Deﬁbrillators?
Nickole N. Henyan, Efﬁe L. Gillespie, Kara Smith, Jeffrey Kluger, C. Michael White, Craig 
I. Coleman, Hartford Hospital, Hartford, CT, University of Connecticut, Storrs, CT
Background: Implantable Cardioverter Deﬁbrillators (ICDs) are a life saving therapy for 
many patients with cardiovascular disease at increased risk of fatal arrhythmias. Since 
men consistently comprise the majority of the study population (up to 85%) in clinical 
trials, the beneﬁt to women is unknown. We conducted a meta-analysis of primary 
prevention ICD trials to evaluate the beneﬁts in men and women.
Methods: A systematic literature search was conducted from 1966 through September 
2005 to identify primary prevention trials of ICDs in patients with cardiovascular disease. 
The primary outcome measure was death from any cause in males and females. Trials 
were included if they met the following criteria: 1) randomized controlled trials versus 
standard of care 2) ICD used as primary prevention in a well-described protocol, and 3) 
data provided on risk of death for both male and female patients.
Results: Eleven trials were identiﬁed, with ﬁve satisfying the inclusion criteria. Upon 
meta-analysis, the risk of death from any cause was reduced by 29% in male patients 
who received ICD therapy compared to control, adjusted hazard ratio (HR) 0.71 (95% 
CI 0.54 to 0.94) but not among female patients, HR 0.86 (95% CI 0.66 to 1.12). Since 
the COMPANION trial evaluated the combination of pacemaker with ICD therapy we 
conducted a separate analysis without the inclusion of this study. Male patients receiving 
ICD therapy demonstrated a 28% reduction in risk of death from any cause HR 0.72 (95% 
CI 0.5 to 1.04) while female patients demonstrated a reduction of only 7% HR 0.93 (95% 
CI 0.69 to 1.24).
Conclusion: Females do not derive the same degree of mortality beneﬁt from ICDs for 
primary prevention as their male counterparts.
947-130 Polynomial Modeling of Ventricular Shock Electrogram 
for Rhythm Discrimination in Implantable Devices
Jeffrey L. Williams, Vladimir Shusterman, Samir Saba, University of Pittsburgh, 
Pittsburgh, PA
Background: Inappropriate shocks continue to be a problem for patients with 
implantable deﬁbrillators (ICD). We evaluated a simple polynomial model of ventricular 
electrograms (EGM) to discriminate between supraventricular (SVT) and ventricular (VT) 
tachyarrhythmias in low computational power implantable devices.
Methods: Six sets of EGM from patients having both SVT and VT documented during a 
single ICD interrogation were included. The cardiac cycle was analyzed off-line in 2 parts, 
QR and RQ segments, which were modeled separately using 3rd-order and 6th-order 
polynomial equations, respectively.
Results: Eighteen of 24 QR and 25 of 43 RQ coefﬁcients for SR and SVT were found to 
be signiﬁcantly (p<0.05) different than the corresponding coefﬁcient during VT. Percent 
change from SR in the zero-order QR coefﬁcient was signiﬁcantly higher for VT compared 
to SVT episodes (217±76% versus 49±16%, p<0.001). Using a cut-off value of 2-fold 
(100%) change from SR, the zero-order coefﬁcient of the QR segment was able to 
completely separate VT from SVT in the same patient (Figure). Higher order QR and RQ 
segment coefﬁcients were less useful for rhythm discrimination.
Conclusions:Our data demonstrate the feasibility of simple polynomial equations that 
reproduce the depolarization and repolarization phases of human ventricular shock EGM 
and reliably discriminate between SVT and VT while preserving computational simplicity. 
This method deserves further testing in a larger number of patients.
947-131 Risk Factors for Ventricular Arrhythmias in Heart 
Failure Patients
David B. De Lurgio, Elyse Foster, Bradley P. Knight, Emory Crawford Long Hospital, 
Atlanta, GA, Guidant Corporation, St. Paul, MN
Background: Identifying baseline characteristics that indicate which heart failure patients 
(pts) are at highest risk for ventricular arrhythmias (VT/VF) may be beneﬁcial to physicians 
in determining treatment options.
Methods: Pts participating in the Device Evaluation of CONTAK® RENEWAL® 2/4/4HE and 
EASYTRAK® 2: Assessment of Safety and Effectiveness in Heart Failure (DECREASE-
HF) Study were included in this retrospective analysis. Univariate and Multivariate Cox 
Proportional Hazards Regression (PHR) Analyses were used to evaluate baseline 
characteristics that were related to subsequent VT/VF episodes.
Results: The baseline characteristics of the 360 patients enrolled in the DECREASE-HF 
study were typical of a CRT-D indicated population (67% male, mean age = 67 yrs, mean 
LVEF 23%, mean QRS = 166ms, 64% ischemic). Of the 342 patients implanted with a 
CRT-D device, 45 patients had at least one episode of VT/VF that received appropriate 
device therapy. Table 1 presents the relationship between baseline characteristics and 
time to ﬁrst VT/VF episodes. Signiﬁcant multivariate predictors of VT/VF are higher 
LVEDD, lower pulse pressure and history of AF.
Table 1: Cox Proportional Hazards Model for Time to First VT/VF
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All patients implanted, N=342 
Variable Hazard Ratio (95% C.I.)
P-
value
Multivariate 
Hazard
P-
Value
Age >= 68 years 0.79 (0.44, 1.43) 0.44 - -
LVEF < 23% 1.84 (1.00, 3.35) 0.05 - -
LVEDD >= 66 mm 2.54 (1.31, 4.94) 0.006 2.51 (1.28, 4.89) 0.007
LVESD >= 55 mm 2.16 (1.15, 4.08) 0.02 - -
PR Interval >= 190 ms 1.53 (0.84, 2.78) 0.16 - -
QRS Duration < 160 ms 0.73 (0.35, 1.51) 0.39 - -
BSA >= 2 m2 0.97 (0.54, 1.75) 0.92 - -
BMI < 28 kg/m2 1.12 (0.62, 2.01) 0.71 - -
Systolic BP < 120 mmHg 1.12 (0.62, 2.01) 0.70 - -
Diastolic BP < 70 mmHg 0.93 (0.52, 1.67) 0.81 - -
Pulse Pressure < 50 mmHg 1.96 (1.07, 3.58) 0.03 1.97 (1.06, 3.65) 0.031
Mean Arterial Pressure < 86 mmHg 1.00 (0.56, 1.79) 0.99 - -
Heart Rate < 71 bpm 0.94 (0.52, 1.69) 0.83 - -
BUN >= 22 mg/dL 0.89 (0.27, 2.93) 0.85 - -
Creatinine >= 1.2 mg/dL 1.00 (0.55, 1.79) 0.99 - -
BUN/Creatinine Ratio >= 18 1.16 (0.36, 3.81) 0.80 - -
QOL >= 56 units 1.06 (0.58, 1.93) 0.85 - -
Peak VO2 < 12.5 ml/kg/min 1.11 (0.61, 2.03) 0.72 - -
VE/VCO2 Slope >= 36 1.38 (0.76, 2.48) 0.29 - -
GFR < 60 0.79 (0.44, 1.42) 0.43 - -
Male 2.89 (1.29, 6.48) 0.01 - -
No ACE/ARB 0.98 (0.41, 2.31) 0.96 - -
No Beta Blocker 1.16 (0.56, 2.42) 0.68 - -
No ACE/ACB or No Beta Blocker 0.90 (0.44, 1.81) 0.76 - -
Spironolactone 0.71 (0.38, 1.33) 0.28 - -
No ACE/ACB or No Beta Blocker or No 
Spironolactone 1.51 (0.75, 3.06) 0.25 - -
No Digoxon 0.74 (0.41, 1.34) 0.33 - -
Diuretic 1.00 (0.42, 2.35) 0.99 - -
Non-loop Diuretic (with or without 
Loop) 0.27 (0.04, 1.98) 0.20 - -
No Loop Diuretic (or Loop and Non-
loop) 0.69 (0.31, 1.55) 0.37 - -
Type III Antiarrhythmic 1.69 (0.81, 3.51) 0.16 - -
Ischemic 1.59 (0.82, 3.07) 0.17 - -
Non-Speciﬁc Conduction Disorder 2.25 (0.95, 5.32) 0.06 - -
NYHA IV at Implant 0.66 (0.09, 4.76) 0.68 - -
Monomorphic VT 1.46 (0.72, 2.95) 0.29 - -
No Polymorphic VT 1.07 (0.15, 7.76) 0.95 - -
Non-Sustained VT 2.42 (0.96, 6.15) 0.06 - -
VF 1.18 (0.47, 3.00) 0.72 - -
Atrial Tachycardia 1.93 (1.03, 3.63) 0.04 - -
History of AF 2.02 (1.02, 3.99) 0.04 2.46 (1.23, 4.92) 0.011
Renal Disease 0.99 (0.44, 2.21) 0.97 - -
Conclusions: In heart failure patients receiving CRT-D, higher end-diastolic dimension, 
lower pulse pressure, and a history of AF are at greater risk for occurrence of VT/VF.
947-132 Predictors of Mortality in Patients Receiving 
Implantable Deﬁbrillators
Chirag Sandesara, Brian Olshansky, John D. Day, Chris Mullin, Darin R. Lerew, 
University of Iowa, Iowa City, IA, Utah Heart Clinic, Salt Lake City, UT
Introduction: Speciﬁc risk factors predict mortality of patients with heart disease but 
clinical outcome predictors for patients at risk for arrhythmic death who receive implantable 
deﬁbrillators (ICDs) are not known. Hypothesis: Clinical characteristics identify risk 
of death in patients receiving ICDs. Methods: The INTRINSIC RV trial enrolled 1528 
patients requiring ICD implantation. Logistic regression analysis was used to assess 
the relationship between 19 clinical variables identiﬁed at enrollment and mortality. 
Associations between clinical characteristics and survival were assessed by univariate 
and multivariate analyses. Results: Univariate attributes: older age, lower mean 
systolic blood pressure, New York Heart Association functional class, atrial ﬁbrillation, 
congestive heart failure, and diabetes predicted one-year mortality (p <0.01 for each). In 
a multivariate model, older age (p=0.01), atrial ﬁbrillation (p=0.02), lower mean systolic 
blood pressure (p=0.02), and diabetes (p=0.03) were associated with increased mortality. 
Functional class and congestive heart failure were not predictors in the multivariate 
model. Of note, Body Mass Index (BMI) and presence of coronary artery disease did not 
predict mortality in either model. Conclusion: Clinical characteristics predict mortality in 
a large ICD database. Remarkably, BMI, coronary artery disease, congestive heart failure 
and hypertension did not predict mortality in this population.
 
Mortality Risk Factors
Risk factor Survivors(n=1472)
Deaths
(n=56)
Univariate
P-value
Multivariate
P-value
Gender, % male 81.2 71.4 0.0720 0.1879
Age, years (mean ± SD) 65.2±11.9 69.8±10.6 0.0048 0.0144
BMI, kg/m2 (mean ± SD) 28.5±6.3 27.9±7.4 0.4899 0.7389
Systolic BP, mm Hg (mean ± SD) 128.3±22.3 118.7±21.3 0.0017 0.0231
NYHA, % III/IV 22.4 41.1 0.0015 0.2963
Dilated cardiomyopathy 69.2 75.0 0.3537 0.2450
Atrial ﬁbrillation 10.9 25.0 0.0017 0.0214
Congestive heart failure 36.6 57.1 0.0024 0.3806
Hypertension 50.4 62.5 0.0783 0.1205
Diabetes 26.8 46.4 0.0016 0.0343
Coronary artery disease 67.1 69.6 0.6855 0.8855
 
947-133 Deﬁbrillation Thresholds in Patients with Hypertrophic 
Cardiomyopathy
Scott W. Burke, William H. Spencer, III, J. Lacy Sturdivant, Robert Leman, Christopher 
D. Nielsen, J. Marcus Wharton, Michael R. Gold, Medical University of South Carolina, 
Charleston, SC
Background: Implantable deﬁbrillators (ICD) are used for the prevention of sudden 
cardiac death (SCD) in high-risk patients with hypertrophic cardiomyopathy (HCM). 
Deﬁbrillation thresholds (DFT) have been reported to be elevated in this population with 
older lead systems, presumably due to a high left ventricular mass index.
Methods: We analyzed 38 consecutive patients with HCM who had an ICD implanted 
with a left pectoral dual coil lead, active can system. Biphasic DFT was determined with 
a uniform step-down protocol. The control group was 38 patients with left ventricular 
dysfunction who underwent ICD implantation over the same time period with the same 
lead system and testing protocol.
Results: The HCM group was 66% male and 87% of patients had undergone alcohol 
septal ablation for outﬂow tract obstruction. The HCM group was younger (46+15 vs. 
63+14 years, p=0.001) and had more females (34% vs. 17%). Left ventricular mass 
index (216+56 g/m2 vs. 167+62 g/m2, p=0.01) and ejection fraction (62+6% vs. 35+13%, 
p<0.0001) were higher in the HCM group as expected. The mean DFT was similar 
between the HCM and control groups (10.7+5.4 joules vs. 10.7+5.6 joules) with no 
perioperative complications or failed deﬁbrillations noted. 97% of patients in both groups 
had a DFT <20 joules.
Conclusions: Increased left ventricular mass index does not predict higher DFT in HCM patients. 
ICD implantation can be safely performed in this population with normal output devices.
947-134 Utility of Electronic Reprogrammable Vectors in 
Biventricular Devices
Salem N. Sayar, J Lacy Sturdivant, Scott Burke, Robert B. Leman, J Marcus Wharton, 
Jessica Yarborough, Michael R. Gold, Medical University of South Carolina, Charleston, SC
Background:Cardiac resynchronization therapy (CRT) Is often limited by high left 
ventricular (LV) pacing thresholds or diaphragmatic stimulation. With bipolar LV leads, the 
pacing conﬁguration can Be altered, but the utility of such programmable pacing vectors 
has Not been evaluated previously.
Methods:We prospectively studied 28 consecutive patients With NYHA III symptoms 
undergoing CRT therapy. Mean age was 65 +/- 10 years and 68 % were male. QRS duration 
was 153 +/- 27 milliseconds; LV ejection fraction was 22 +/- 7 %. The LV lead was placed 
in an optimal position ﬂuoroscopically and then all 4 pacing conﬁgurations were evaluated 
using the LV tip, ring, and right ventricular coil as anode. Standard pacing parameters and 
diaphragmatic stimulation threshold were measured. The nominal Tip-to-ring (TtR) pacing 
conﬁguration was compared With the best capture threshold conﬁguration.
Results:Pacing parameters Are shown in the table. Eleven (39%) patients had evidence 
of diaphragmatic stimulation at or near capture threshold in one or more pacing 
conﬁgurations, including 5 in the TtR conﬁguration. Diaphragmatic stimulation was 
prevented in all patients in at least one conﬁguration. Estimated battery life was also 
prolonged by 0.13 years.
Conclusions:Programmable pacing vectors can facilitate LV lead placement by 
minimizing diaphragmatic stimulation and reducing pacing thresholds. This results in a 
modest prolongation of battery life. 
Pacing 
Threshold 
(Volt)
Pacing 
Impedance 
(Ohm)
Current 
(milliampere)
R-waves 
(millivolt)
Estimated Battery 
Life (years)
Tip to Ring 
Conﬁguration 
(control)
2.1+/- 1.1 1061.6 +/- 344
2.01 +/- 
1.38
19.28 
+/- 13.2 6.5
Best Capture 
Threshold 
Conﬁguration
1.1+/- 0.7 588.7 +/- 174 1.89 +/- 1.24
14.66 
+/- 8.8 6.63
T-test P<0.001 P<0.001 P=0.52 P=0.01
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947-135 Cardiac Resynchronization Therapy Reduces the Need 
for Shocks in Patients With Automated Implantable 
Cardioverter Deﬁbrillators
Nathan M. Segerson, Feras M. Bader, Scott Walker, Roger A. Freedman, University of 
Utah, Salt Lake City, UT
Introduction: Cardiac resynchronization therapy (CRT) improves cardiac performance in heart 
failure. However, there are conﬂicting data on the effects of CRT on the frequency of ventricular 
arrhythmias. We tested the hypothesis that in patients with previously implanted cardioverter 
deﬁbillators (ICDs) who meet established criteria for CRT, upgrading to CRT-deﬁbrillators (CRT-
Ds) reduces the frequency of ventricular tachyarrhythmias requiring shocks.
Methods: We conducted a retrospective analysis of all patients who had undergone 
upgrades from ICDs to CRT-Ds at our institution (N=39). We recorded the frequency 
(before and after upgrade) of ventricular arrhythmias requiring shock from ICD stored 
diagnostics, and assessed the change in frequency using a nonparametric Wilcox signed 
rank test. Additionally, QRS duration, ejection fraction, and functional class were assessed 
at the time of upgrade. The use of beta-blockers and antiarrhythmics was ascertained at 
the time of ICD implantation and at upgrade. All of these variables were analyzed for 
association with changes in shock frequency using a linear regression model.
Results: Upgrading from ICDs to CRT-Ds reduced the frequency of ventricular 
tachyarrhythmias requiring shocks by 76%. ICD diagnostic data were assessed for an average 
of 37 months prior to upgrade and 15 months after upgrade. The mean number of episodes 
per year decreased from 0.71 before upgrade to 0.17 after (p<0.01). In the linear regression 
model, QRS duration prolongation (beta=-0.01, p<0.001) and ejection fraction at the time 
of upgrade (beta=-0.06, p=<0.001) demonstrated independent effects on the reduction in 
shock frequency. Beta-blocker use increased from 24% before ICD implantation to 84% at the 
time of upgrade, but was not independently associated with the change in shock frequency 
(p=0.67). The prevalence of antiarrhythmic use did not change (52 vs. 50%).
Conclusions: In patients who meet criteria for CRT, upgrading their ICD to a CRT-D 
results in a reduction in ventricular tachyarrhythmias requiring shock. Patients with greater 
QRS prolongation and higher ejection fraction at the time of CRT-D upgrade experienced 
the greatest reduction.
947-136 Internal Cardiac Deﬁbrillators With Right Ventricular 
Outﬂow Tract Lead Do Not Require Deﬁbrillation 
Threshold Testing At Routine Device Replacement
Himabindu Bandaru, Kimberly Anne Oleson, Randy A. Lieberman, Harper University 
Hospital/ Wayne State University, Detroit, MI
Background: The right ventricular outﬂow tract (RVOT) is increasingly selected for pacing 
to reduce right ventricular pacing-mediated dyssynchrony in ICD(I) or CRT-D(D) patients. 
Acute safety of sensing, pacing and deﬁbrillation thresholds (DFT) using RVOT-placed 
leads has been established. Chronic DFT results of RVOT-placed leads are limited.
Methods: We retrospectively analyzed DFT data from 62 consecutive patients (63% 
male, Age: 67.3 ± 10.9 years) undergoing routine ICD or CRT-D device replacement. 
At implant, 58% presented with CAD with mean LVEF of 32%. All patients had the right 
ventricular lead previously implanted in the RVOT. 50% of patients received a CRT-D 
device and the remaining 50% received an ICD. The mean duration between implant and 
replacement is 3.5 ± 1.9 years.
Results: 
Acute DFT (J) N= pts with CHRONIC DFT(J)
Devices DFT N = pts <6 <10 <12 <15 <18 <20 >24
CRT-D
< 6
12 8 3 1 0 0 0 0
ICD 10 7 3 0 0 0 0 0
CRT-D
< 10
9 2 5 1 0 1 0 0
ICD 5 3 0 2 0 0 0 0
CRT-D
<12
4 1 2 0 0 0 1 0
ICD 5 5 0 0 0 0 0 0
CRT-D
<15
1 0 1 0 0 0 0 0
ICD 5 1 3 0 1 0 0 0
CRT-D
<18
2 1 0 0 0 1 0 0
ICD 2 1 0 0 0 1 0 0
CRT-D
<20
3 2 1 0 0 0 0 0
ICD 3 0 1 0 1 0 1 0
CRT-D
<24
0 0 0 0 0 0 0 0
ICD 1 0 0 0 0 0 1 0
Conclusion : Chronic DFT data from 62 consecutive patients suggest that patients with 
acute DFT <24J do not require additional DFT testing at routine device replacement. ICD 
and CRT-D RVOT lead DFTs are stable through an average follow-up of 3.5 years. Even 
though 4.8% (<12% with 95% conﬁdence) of DFTs were shown to have increased by > 5J 
at device replacement, 100% (>95.3% with 95% conﬁdence) of acute DFT < 24J met the 
10J safety margin for a 35J device at follow-up. With the recent expansion of indications for 
use of deﬁbrillators, prospective studies to characterize long-term DFTs are warranted.
947-137 Risk for Early Heart Failure Hospitalization or Death 
After Cardiac Resynchronization Therapy
Andrew Kaplan, Kira Q. Stolen, Christopher M. Mullin, Guidant Corporation, St. Paul, MN
Background: Cardiac resynchronization therapy (CRT) has been associated with 
reductions in heart failure symptoms, hospitalization, and mortality in numerous previous 
clinical studies. Nonetheless, even after the addition of CRT to optimal medical therapy,
clinical events continue to occur. The reasons are not well characterized. Methods: The 
CRT Renewal Registry is an ongoing study of patients who have received CRT pacing 
or deﬁbrillator therapy. Of 1232 patients enrolled and receiving devices, 96 patients 
experienced a heart failure hospitalization or death within 90 days of enrollment. Clinical 
factors were evaluated in an attempt to identify predictors of events. Results: Descriptive 
statistics for each group are shown in the table below. Odds ratios are calculated for 
one standard deviation difference (approximately 11 years for age and 9% for ejection 
fraction). Conclusion: Advanced age and diminished ejection fraction are associated 
with persistent risk for heart failure hospitalizations and/or death in the short term after 
CRT therapy. Whether other risk factors will emerge will be examined in longitudinal 
follow-up in the registry. 
No Early Event
(n=1136)
Had Early Event
(n=96)
Age (years) 70±11 73±10
Gender (% male) 72 68
BMI 29±6 27±6
Caucasian 81 86
NYHA III/IV 88 88
Prior arrhythmia 16 16
Ejection Fraction (%) 25±9 23±8
Systolic BP 123±19 120±19
Diastolic BP 70±12 67±1
Odds Ratio 95% CI
Age 1.37 1.09-1.72
Ejection Fraction (%) 0.76 0.59-0.96
947-138 Is Pulmonary Vein Isolation (PVI) a Better Therapeutic 
Option than Atrioventricular Node Ablation (AVNA) 
and Direct Current Cardioversion (DCC)? Mortality 
Differences in Patients with Atrial Fibrillation
Dhanunjaya R. Lakkireddy, Dimpi Patel, Kay Ryschon, Sergtio Thal, Oussama Wazni, 
Subramanya Prasad, Mohammed Kanj, Claude Elayi, Atul Verma, Mandeep Bhargava, 
Robert Schweikert, David Burkhardt, Walid Saliba, Jennifer Cummings, Mina Chung, 
Mauricio Arruda, Patrick Tchou, Andrea Natale, Cleveland Clinic Foundation, Cleveland, OH
Background: PVI is an effective therapeutic option for the treatment of symptomatic 
AF who failed medical therapy. The mortality differences between PVI and conventional 
treatments like AVNA with pacing or DCC with anticoagulation is not known.
Methods: Patients aged 60-80 years who underwent PVI (n=138) were compared to 
age matched patients who had AVNA (n=133) and DCC (n=139) between 1996 -2004. 
The baseline clinical characteristics, short-term (< 2 months) and late (>2 to 12 months) 
recurrence rates and mortality rates were compared for the 3 treatment types. Mortality 
information was derived from hospital records and national death index.
Results: The mean age of patients who had DCC, PVI and AVNA was 70.2, 70.6 and 
70.3 years respectively. The baseline characteristics and comorbidities were comparable. 
The short-term (13% vs 25%vs 37%, p<0.001), late recurrence rates (9% vs 54% vs 48%, 
p<0.001), stroke/transient ischemic attacks (4% vs 5% vs 18%, p<0.001) and mortality 
rates (1.4% vs 31% vs 15%, p<0.001) were signiﬁcantly lower in PVI group than DCC 
and AVNA groups respectively. The Kaplan-Meyer survival curves for the three types of 
treatments are shown below. There was a small but signiﬁcant improvement in LA size (∆ 
-0.18±0.29cm) and LVEF (∆ 3±9%) in PVI group. Multivariate regression analysis showed 
low LVEF (p<0.001) and type of treatment (p<0.02) to be predictive of mortality.
Conclusion: PVI has very low mortality, stroke and early/late recurrence rates compared 
to DCC and AVNA. 
947-139 Presence and Type of Provocable Non Pulmonary 
Triggers for Atrial Fibrillation: Inﬂuence of Gender and 
Arrhythmia Presentation
Fermin Garcia, Erica Zado, Jonathan S. Sussman, David Lin, Sanjay Dixit, Edward 
Gerstenfeld, Joshua Cooper, Andrea Russo, David Callans, Francis Marchlinski, 
University of Pennsylvania Healthcare System, Philadelphia, PA
Background: In patients (pts) undergoing atrial ﬁbrillation (AF) ablation non pulmonary 
vein (NPV) triggers can be observed with isoproterenol infusion (ISO) or following 
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cardioversion of AF. The frequency and type of NPV trigger in patients with paroxysmal 
(PAF) versus persistent or permanent AF has not been determined.
Methods: Provocative maneuvers were used to identify PV and NPV triggers in 755 
consecutive pts referred for PV isolation including 440 pts with PAF, 279 pts with 
persistent AF, and 36 pts with permanent AF. Provocation attempts before and repeated 
after AF ablation (PV Isolation and/or focal ablation of NPV triggers) included: 1) ISO 
to 20 mcg/min, 2) cardioversion of spontaneous or induced AF and 3) cardioversion of 
AF on 1-3 mcg/min of ISO. Simultaneous multipolar recordings from RA, CS PV ostia 
and LA conﬁrmed NPV trigger initiating AF. In all pts, programmed atrial stimulation was 
performed to identify AVN reentrant tachycardia (AVNRT).
Results: NPV triggers were noted in 113 pts (15%) and 34 of 182 women (19%) versus 
79 of 573 (14%) of men (p=NS). NPV triggers occurred in 74 pts with PAF (17%), 38 pts 
with persistent AF (14%) and 1 pt with permanent AF (3%) (p<0.1). AVNRT as a potential 
trigger for AF was noted in 27 pts (4%) including 22 (5%) with PAF versus 4 (1.5%) with 
persistent or 1 (2.7%) with permanent AF (p< 0.05).
Conclusions: NPV triggers for AF provocable by the described maneuvers are 1) seen in 
~ 15% of women (18%) and men (14%) undergoing AF ablation and 2) although non PV 
triggers including AVNRT tend to be more commonly observed in patients with PAF these 
triggers can also be identiﬁed in pts with persistent or even permanent forms of AF. These 
data have important implications for ablation strategies for AF control.
947-140 Effects of Catheter Ablation for Atrial Fibrillation on Left 
and Right Atrial Volume and Function
Samer Dibs, Jonathan Hsu, Kevin Cohoon, George Wu, Travis Sincleair, Scott Pereles, 
James Carr, Haris Subacius, Alan Kadish, Jeffrey Goldberger, Northwestern Memorial 
Hospital, Chicago, IL
Background: Atrial ﬁbrillation (AF) may result in atrial enlargement and dysfunction. 
Effects of AF catheter ablation on LA size and function are unknown.
Methods: Pts referred for AF ablation underwent MRI pre- (MR1) & post-ablation (MR2). 
Using TrueFISP cine imaging on a 1.5-Tesla Siemens Sonata, contiguous 6-mm slices 
were acquired in the standard 4-chamber view. Maximum and Minimum LA & RA volumes 
were measured. Emptying Fraction (EF) was calculated as (Max Volume - Min Volume)/
Max Volume.
Results: MR1 & MR2 were obtained 2±4 wks pre- & 15±10 wks post-ablation in 36 pts 
(54±9 yrs, 31 M, 27 paroxysmal). Ablation was successful in 20 pts who had SR on both 
MR’s (SS) & in 8 pts who had AF on MR1 & SR on MR2 (FS). Ablation was unsuccessful 
in 5 SS pts, 1 FS pt, & 2 other pts. LAMax decreased with ablation from 118±8 ml to 
107±7 ml (p<0.05), with no signiﬁcant effect of rhythm category or ablation outcome. 
RAMax tended to decrease with ablation from 114±9 ml to 103±7 ml (p=0.06). Whereas 
LAEF & RAEF did not signiﬁcantly change in SS pts, they increased in FS pts (Fig) from 
14±3% to 35±4% (p<0.001) & from 9±3% to 36±4% (p<0.001). While pre-ablation LA & 
RA EF’s were lower in FS pts compared to SS pts (p<0.001), they were not signiﬁcantly 
different post-ablation.
Conclusions: Catheter ablation for AF results in reduction of LA and RA volumes. 
Ablation in pts with baseline SR does not adversely impact atrial function. Pts with 
baseline AF have depressed atrial function that improves after ablation to a similar level 
as those with baseline SR.
947-141 Characteristics of Cavotricuspid Isthmus-Dependent 
Flutter Following Left Atrial Ablation of Atrial 
Fibrillation
Aman Chugh, Rakesh Latchamsetty, Hakan Oral, Darryl Elmouchi, David Tschopp, 
Scott Reich, Petar Igic, Kristina Lemola, Tammy Lemerand, Eric Good, Frank Bogun, 
Frank Pelosi, Jr., Fred Morady, University of Michigan, Ann Arbor, MI
Background: Patients who have previously undergone ablation of atrial ﬁbrillation (AF) may 
experience cavotricuspid isthmus-dependent (CTI) ﬂutter during follow-up. The purpose 
of this study was to describe the effects of left atrial (LA) ablation on the characteristics 
of CTI ﬂutter. Methods: Fifteen patients (Age=54±9 years, EF=0.50±0.10, LA=4.4±0.3 
cm) underwent ablation of CTI ﬂutter late after LA ablation of AF. The electrocardiogram 
(ECG), biatrial activation patterns, and LA voltage maps during ﬂutter were analyzed. 
Thirty patients who underwent ablation of CTI ﬂutter without prior LA ablation served as 
controls. Results: The mean cycle lengths of CTI ﬂutter in the study and control groups 
were 253±26 ms, and 235±29 ms, respectively (p=0.05). In patients with prior LA ablation, 
mapping revealed counterclockwise (CCW) activation around the tricuspid valve in 12/15 
patients (80%) and clockwise (CW) activation in 3/15 patients (20%). In lead aVL, the 
ﬂutter waves were negative in 9 of the 15 study patients (60%) compared with 1 of the 30 
controls (3%; p<0.001). The ﬂutter waves in the inferior leads were upright in 9 of the 15 
patients (60%) with prior LA ablation and in none of the controls (p<0.001). The upright 
ﬂutter waves in the inferior leads in patients with CCW ﬂutter corresponded to craniocaudal 
activation of the right atrial free wall. LA activation contributed little to the genesis of the 
ﬂutter waves in these patients because of a signiﬁcant reduction in bipolar LA voltage 
(0.44 ± 0.20 mV versus 1.54 ± 0.19 mV in patients with biphasic/negative ﬂutter waves; 
p<0.001). The earliest LA activation occurred in the inferoposterior region during CCW 
ﬂutter and in the anterosuperior aspect during CW ﬂutter, consistent with conduction over 
the coronary sinus and Bachmann’s bundle, respectively. Flutter termination and CTI 
block were achieved in all patients (100%). Conclusions: CTI ﬂutter that occurs after LA 
ablation of AF often has atypical ECG characteristics because of altered LA activation. In 
patients presenting with atrial ﬂutter following LA ablation, entrainment mapping should 
be performed at the CTI even if the ECG is uncharacteristic of CTI ﬂutter.
947-142 Microreentry as a Mechanism of Focal Atrial 
Tachycardia
Steven M. Markowitz, Sei Iwai, Kenneth M. Stein, Suneet Mittal, Bindi K. Shah, Bruce B. 
Lerman, Cornell University Medical College, New York, NY
Background: Most focal atrial tachycardias (AT) in humans demonstrate characteristics 
consistent with automaticity or triggered activity, including suppression or termination 
with adenosine. While microreentry may account for some cases of human AT, this entity 
remains poorly deﬁned.
Methods: In 56 consecutive pts (28 F, 60±15 yrs), 59 ATs demonstrated focal activation 
with the CARTO electroanatomical mapping system. Adenosine was administered to each 
case in incremental doses until the AT terminated or AV block occurred. Electrograms 
at the sites of origin were characterized in terms of fractionation, morphology, and 
activation.
Results: Of 59 focal atrial tachycardias, 5 (8%) were insensitive to adenosine (doses 6-
12 mg). Pts with adenosine-insensitive focal AT were older (73 vs 60, p<0.05) and more 
likely to have coexisting AF (5/5 vs 5/51) compared to pts with adenosine-sensitive AT. 
In all cases of adenosine-insensitive focal AT, highly fractionated, low-amplitude, mid-
diastolic potentials were present at the sites of origin, with local electrogram durations of 
81-186 msec (comprising 29-64% of the AT cycle length). Concealed entrainment was 
demonstrated at these sites in 3/3 cases. These tachycardias originated in the posterior 
wall of the LA or pulmonary veins (N=3) or the RA (N=2). Focal radiofrequency ablation at 
these sites terminated AT in each case.
Conclusions: Electrogram characteristics and response to adenosine in these ATs 
are consistent with small reentrant circuits, with dimensions below the resolution of the 
mapping system. These data provide evidence that microreentry is a mechanism of focal 
AT and has an electropharmacological proﬁle that differs from AT due to automaticity and 
triggered activity.
947-143 Effects of Two Different Catheter Ablation Techniques 
on Spectral Characteristics of Atrial Fibrillation
Kristina Lemola, Michael Ting, Priya Gupta, Jeffrey N. Anker, Aman Chugh, Eric Good, 
Scott Reich, David Tschopp, Petar Igic, Darryl Elmouchi, Krit Jongnarangsin, Frank 
Bogun, Frank Pelosi, Jr., Fred Morady, Hakan Oral, University of Michigan, Ann Arbor, MI
Background: Circumferential pulmonary vein ablation (CPVA) and electrogram-guided 
ablation (EGA) are 2 different techniques that have been used to eliminate atrial ﬁbrillation 
(AF). Spectral analysis may identify rotors that perpetuate AF. The effects of CPVA and 
EGA on the spectral characteristics of AF have not been described, and whether there 
is any association between changes in dominant frequency (DF) and clinical outcome 
is unknown.
Methods: In 71 consecutive patients (age=57±9 years), CPVA (29) or EGA (42) was 
performed for paroxysmal (42) or persistent (29) AF. During EGA, complex electrograms 
characterized by a short cycle length, fractionation, and/or continuous electrical activity 
were targeted. Lead V1 and bipolar electrograms recorded in the left atrium and coronary 
sinus were analyzed to determine the DF of AF before and after ablation.
Results: The DF in the left atrium was higher in patients with persistent (5.83±0.86 Hz) 
than paroxysmal AF (5.33±0.76 Hz, P=0.03). There was a frequency gradient from the 
left atrium (5.51±0.81 Hz) to the coronary sinus (5.20±0.80 Hz, P<0.001). CPVA and 
EGA resulted in a similar decrease in DF (19±17% vs 17±15%, P=0.5). During a mean 
follow-up of 10±7 months after a single ablation procedure, the change in DF after CPVA 
was similar among patients who did and did not have recurrent AF. There was a signiﬁcant 
association between an acute decrease in DF after EGA and freedom from recurrent AF, 
but only in patients with persistent AF (19±14% versus 3±6%, P=0.02).
Conclusions: Both CPVA and EGA decrease the DF of AF, consistent with elimination of 
rotors. Whereas the efﬁcacy of EGA is associated with a decrease in DF in patients with 
persistent AF, the efﬁcacy of CPVA is independent of changes in DF. This suggests that 
CPVA and EGA eliminate different mechanisms operative in the genesis of persistent AF.
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Deﬁbrillation and Resynchronization 
Devices
Monday, March 13, 2006, 11:00 a.m.-12:30 p.m.
Georgia World Congress Center, Room B312
11:00 a.m.
818-3 Comparison of Heart Failure Adverse Event Rates 
Between Alternative Cardiac Resynchronization 
Therapy Pacing Modalities
Imran Niazi, Steven Higgins, Satish Goel, Clarence Cumming, Lindsay Fleming, St. 
Luke’s Medical Center, Milwaukee, WI, Guidant, St. Paul, MN
Background: Clinical trials have shown right ventricular pacing to increase heart failure (HF) 
symptoms while other trials have shown simultaneous biventricular (BiV SIM) decreasing 
HF related symptoms. The DECREASE-HF trial compared two other investigational 
methods of Cardiac Resynchronization Therapy (CRT), sequential BiV (BiV SEQ) and LV 
Only (LV-CRT), to the conventional BiV SIM method. It is unknown whether LV-CRT or BiV 
SEQ pacing could be associated with an increase in HF related events.
Methods: The data were analyzed retrospectively for the number of pts experiencing 
a HF related event to determine the impact of pacing modality. In this trial, HF events 
included dyspnea, hypotension, and weight gain, among others. Fisher’s exact test was 
used to compare differences across arms for each HF related event due to the low rates 
and a p-value was calculated.
Results: Of the 360 enrolled pts, 342 were implanted and 306 were randomized with 
mean age of 67 yrs, mean LVEF 23%, mean QRS 166ms, 67% were male, and 64% had 
an ischemic etiology. Pts were randomized to BiV SIM (101), LV-CRT (101) or BiV SEQ 
(104). Of these, 16 BiV SIM pts (18 events), 24 LV-CRT pts (39 events), and 19 BiV SEQ 
(33 events) experienced a HF event. There was no statistically signiﬁcant difference in 
the number of pts with a HF related event (p=0.36) though there were more events in the 
LV-CRT and BiV SEQ arms as several patients had multiple events.
Conclusions: In the DECREASE-HF study, less than 20% of pts experienced a HF 
related event in the six-month follow-up period. These results suggest that LV-CRT and 
BiV SEQ when compared to BiV SIM do not signiﬁcantly increase the risk for HF related 
events as compared to reports with right ventricular pacing. Thus, when troubleshooting 
a CRT device, the use of LV-CRT or BiV SEQ pacing should not be associated with an 
increase in HF symptoms.
11:15 a.m.
818-4 Relationship Between Renal Function, Risk of Sudden 
Cardiac Death, and Beneﬁt of the Implanted Cardiac 
Deﬁbrillator in Post Myocardial Infarction Patients With 
Left Ventricular Dysfunction
Ilan Goldenberg, Arthur J. Moss, Scott McNitt, Mark L. Andrews, Wojciech Zareba, 
W. Jackson Hall, Henry Greenberg, Robert B. Case, University of Rochester Medical 
Center, Rochester, NY, Columbia University College of Physicians and Surgeons, New 
York, NY
Background: The implanted cardioverter deﬁbrillator (ICD) has been shown to reduce the 
risk of sudden cardiac death (SCD) in patients with ischemic left ventricular dysfunction by 
67%. However, data on the relationship between renal function and SCD in this population 
are limited, and the effect of renal dysfunction on ICD beneﬁt has not been determined.
Methods: We performed a retrospective analysis of the outcome associated with renal 
dysfunction, as determined by estimated glomerular ﬁltration rate (eGFR), in patients 
enrolled in the Multicenter Automatic Deﬁbrillator Implantation Trial-II (MADIT-II).
Results: Multivariate analysis in conventionally treated patients showed that for each 
10 unit reduction in eGFR the risk of all-cause mortality and SCD increased by 16% 
(p=0.005) and 17% (p=0.03), respectfully. Deﬁbrillator therapy was associated with a 
survival beneﬁt in each eGFR category ≥35 ml per min per 1.73 m2 (overall risk reduction, 
all-cause mortality: 32%; p=0.01, SCD: 66%; p<0.001), while no ICD beneﬁt was shown 
among patients with eGFR <35ml per min per 1.73 m2 (all-cause mortality: hazard ratio 
[HR]=1.09; p=0.84, SCD: HR=0.95; p=0.95).
Conclusions: In high-risk cardiac patients enrolled in MADIT-II, there was a signiﬁcant 
increase in the risk of SCD with declining renal function. Deﬁbrillator therapy was associated 
with a signiﬁcant survival beneﬁt among study patients with mild to moderate or no renal 
disease, while no beneﬁt was shown among patients with more advanced renal dysfunction.
11:30 a.m.
818-5 Is There a Role for Implantable Cardioverter-Deﬁbrillator 
Therapy for the Primary Prevention of Sudden Death in 
Patients With Chronic Kidney Disease?
Phillip Cuculich, Jose M. Sanchez, Roger Kerzner, Scott Greenberg, Jay Sengupta, 
Jane Chen, Mitchell Faddis, Marye Gleva, Bruce Lindsay, Timothy Smith, Barnes-Jewish 
Hospital; Washington University School of Medicine, Saint Louis, MO
Background: Patients with chronic kidney disease (CKD) are at increased risk for 
sudden death (SD). Little is known about implantable cardioverter-deﬁbrillator (ICD) use 
for primary prevention of SD in this large, high-risk population. This retrospective study 
evaluated the outcome of primary prevention ICD therapy in patients with CKD.
Methods: A total of 229 consecutive patients with ischemic or nonischemic cardiomyopathy 
underwent ICD implantation for primary prevention of SD. Patients were stratiﬁed by CKD, 
deﬁned by serum creatinine > 2 mg/dl or dialysis use. End point was mortality.
Results:  CKD was identiﬁed in 35 of 229 patients (15.3%). Baseline characteristics 
of patients with and without CKD were similar except for decreased use of angiotensin 
converting enzyme inhibitors and angiotensin receptor blockers in CKD patients (74.3% 
vs. 93.3%, p = 0.002). There were 33 deaths during a follow-up period of 55.5 ± 6.3 
months: 17 of 35 CKD patients (48.6%) and 16 of 194 control patients (8.2%). Kaplan 
Meier analysis veriﬁed a signiﬁcant mortality difference (p < 0.00001). Cox regression 
analysis controlling for age, sex, comorbidities, ejection fraction and medication showed 
CKD to be the strongest independent predictor of death (hazard ratio = 10.5; conﬁdence 
interval, 4.8-23.1; p = 0.0001).
Conclusions:  In patients receiving an ICD for primary prevention of SD, CKD signiﬁcantly 
reduced long-term survival. The impact of primary prevention ICD therapy is markedly 
reduced in patients with CKD.
11:45 a.m.
818-6 Cardiac Resynchronization Device Placement During 
Hospitalization for Heart Failure is Associated With a 
Signiﬁcant Improvement in Early Clinical Outcomes
William T. Abraham, Barry Greenberg, Gregg C. Fonarow, Nancy M. Albert, Karen 
Chiswell, Wendy Gattis Stough, Mihai Gheorghiade, Christopher O’Connor, Jie-Lena 
Sun, Clyde Yancy, James B. Young, OPTIMIZE-HF Investigators and Hospitals, The Ohio 
State University Heart Center, Columbus, OH
Introduction: CRT devices with or without ICD have demonstrated beneﬁt in heart failure 
(HF) patients and are recommended by current guidelines. However, little is known about CRT 
placement during a HF hospitalization and its association with early clinical outcomes.
Methods: OPTIMIZE-HF is a registry/performance improvement program for pts 
hospitalized with HF. 60-90 day post discharge follow-up (f/u) data were prospectively 
collected in a pre-speciﬁed 10% sample. Multivariable analysis was performed for 60-90 
day f/u death and death + rehospitalization.
Results: 5791 pts from 91 hospitals were included in this analysis. 132 pts (2.3%) 
underwent placement of CRT during hospitalization (1.5% CRT only and 0.8% w/ CRT-D). 
Pts receiving CRT were of similar age and more likely to be male and have an ischemic 
etiology. Length of stay (LOS) and inhospital mortality were 6.4 / 5.6 days and 1.3 / 3.8% 
in those receiving and not receiving CRT device therapy. During 60-90 day f/u there were 
signiﬁcantly less rehospitalizations in CRT pts and a trend for lower mortality (Table 1). 
After multivariable risk adjustment, CRT placement remained associated with signiﬁcantly 
lower rates of death and/or rehospitalization OR 0.38 95% CI 0.23-0.62, P<0.0001.
Conclusions: CRT device placement at the time of HF hospitalization, while associated 
with a modest increase in LOS, appears to be safe and was associated with a signiﬁcantly 
lower risk of death or rehospitalization during the ﬁrst 60-90 days post hospital discharge.
 
Table 1: Patient Characteristics and Clinical Outcomes
Parameter Total PatientsN=5791
No CRT
N=5659
CRT
N=132 P Value
Mean Age (years) 72.1 72.2 71.4 0.2586
Female (%) 48.8 49.1 34.1 0.0006
Ischemic etiology (%) 42.0 41.6 60.6 <0.0001
Mean EF (%) 36.9 37.2 24.3 <0.0001
Creatinine, mean (mg/dL) 1.6 1.6 1.7 0.0004
BNP mean, admission (pg/dL) 1305 1300 1558 0.0616
Death since discharge (%) 8.3 8.3 6.2 0.3735
Rehospitalized since discharge (%) 29.6 29.9 18.2 0.0036
Death or rehospitalization since 
discharge (%) 36.2 36.6 22.3 0.0008
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818-7 Multicenter Experience with 1,355 Failed and Recalled 
Implantable Cardioverter Deﬁbrillators
Robert G. Hauser, David L. Hayes, Andrew E. Epstein, Stephen C. Vlay, David S. 
Cannom, Susan L. Song, Minneapolis Heart Institute Foundation, Minneapolis, MN
Background: Despite the widespread and growing use of implantable cardioverter-
deﬁbrillators (ICD), little information is available regarding their clinical performance, failure 
modes, or the impact of advanced pacing functions on ICD reliability and longevity.
Methods: We conducted a 6-year prospective multicenter study of ICD pulse generators 
that failed or required replacement due to manufacturers recalls. ICD failure (F) was 
deﬁned as removal from service because the ICD was not functioning according to the 
manufacturer’s speciﬁcations. A recalled ICD was a normally functioning device that was 
prophylactically replaced as the result of a manufacturers recall.
Results: Between 1998-2005, 1,220 ICDs failed and 135 ICDs were recalled and 
replaced at 9 participating centers. The average implant times (AIT) of failed and recalled 
ICDs were 4.4+/-1.5 and 1.7+/-0.8 years respectively. AIT for single chamber (SR)) and 
dual chamber (DR) ICDs with rate responsive (RR) and cardiac resynchronization (CRT-
D) pacing capabilities were signiﬁcantly less than single chamber (S) and dual chamber 
(D) ICDs without RR: SR-2.5+/-1.7; DR-3.4+/-1.3; CRT-D-1.9+/-0.9; S-4.8+/-1.5; D-5.1+/-
0.9 (P<0.001). Overall, ICDs were removed for: normal battery depletion (>3 yrs)-73%; 
premature battery depletion (<3 yrs)-9%; electronic or housing failure-6%, and recalls-
10%. Compared to ICDs without RR or CRT-D capabilities, ICDs with RR or CRT-D 
failed earlier due to battery depletion (P<0.001) and they were signiﬁcantly more prone 
to unexpected electronic or housing F (9% vs 5%; P=0.008) and manufacturers recalls 
(25% vs 1%;P<0.0001). Major device-related adverse events included death (n=2), failure 
to convert VT/VF (n=6), and inappropriate shocks (n=11).
Conclusions: Based on our analysis of failed and recalled devices, the performance 
of ICDs, particularly those offering advanced pacing capabilities, has been adversely 
affected by early battery depletion, electronic or housing failure, and manufacturers 
recalls. These ﬁndings suggest that a national registry is needed to accurately estimate 
ICD longevity and to determine the incidence of unexpected failure modes.
12:15 p.m.
818-8 Implantable Cardioverter-Deﬁbrillator FDA Recalls 
and Safety Alerts: Prevalence and Impact on Patient 
Mortality
Arthur C. Kendig, Mohammed Khan, Patrick J. Tchou, David O. Martin, Andrea Natale, 
Bruce L. Wilkoff, J David Burkhardt, Mandeep Bhargava, Mina K. Chung, Cleveland 
Clinic Foundation, Cleveland, OH
Background: Recently several implantable deﬁbrillators (ICDs) have been recalled by 
the FDA. With more ICDs being implanted, recalled or subjected to safety alerts, we 
studied the impact on patients and mortality associated with ICD recalls/alerts.
Methods: ICDs ﬁrst implanted 8/96-5/04 at the Cleveland Clinic and subjected to FDA 
class I, II or III recalls or manufacturer safety alerts were identiﬁed. A recall/alert was 
categorized as potentially life threatening, predictable or with a software indicator or ﬁx. 
Survival analyses were performed to test association of recall/alert status with mortality.
Results: In 1644 patients (age 63±13, 78% male), 695 (41.8%) had an ICD subject to 
FDA recall or manufacturer safety alert (Figure). Overall mortality was 28.7% (follow-
up 1299±819 days). With FDA class I or II recalls or safety alerts, mortality was 26.8% 
(p=NS). Compared to 30.1% mortality with no recall/alert, mortality was 31.1% with FDA 
class I (p=NS) and 24.1% with class II recalls (p=0.016), 37.7% with safety alerts (p=NS), 
25.7% with life-threatening recall/alerts (p=0.08), 31.8% with predictable alerts (p=NS), 
24.2% with software indicators (p=0.03), and 21.4% with software ﬁxes (p=0.02). Kaplan-
Meier analyses comparing no recall/alert to recall/alert groups showed no signiﬁcant 
differences in mortality.
Conclusions: CD recalls or safety alerts impact over 40% of patients. However, having 
an ICD that is recalled or under a safety alert was not associated with higher mortality. 
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969-123 Reduced Ventricular Volumes and Improved Systolic 
Performance with Cardiac Resynchronization Therapy: 
A Comparison of Simultaneous Biventricular Pacing vs. 
Sequential Biventricular Pacing vs. Left Univentricular 
Pacing
Rajni K. Rao, Esperanza Viloria, Jill Schafer, David De Lurgio, Elyse Foster, University of 
California, San Francisco, San Francisco, CA
Background: Cardiac resynchronization therapy (CRT) is a proven treatment for systolic 
heart failure. The DECREASE-HF Trial is the ﬁrst randomized, double-blind study 
comparing simultaneous biventricular (SimBiV), sequential (Seq) BiV (left and right 
ventricular stimulation is offset), and left univentricular (LV) pacing. Seq BiV pacing and 
LV only pacing are currently under investigation as part of this study.
Methods: 360 patients were enrolled and 342 were successfully implanted with a CRT 
system. Of these, 306 were randomized to LV, SimBiV, or SeqBiV pacing in a 1:1:1 ratio. 
Inclusion criteria were: NYHA III or IV HF, EF <35%, QRS >150 ms, and a life expectancy 
>6 mo. Exclusions were: prior CRT, other pacing indications, and beta-blocker treatment 
for <90 days. Data were analyzed using a longitudinal method.
Results: The mean baseline LV end-diastolic volume (LVEDV = 229 + 4 mL), LV end-
systolic volume (LVESV=167 + 4 mL) and ejection fraction (EF=28% + 0.4) did not differ 
among groups. All groups had similar signiﬁcant improvements in EF and myocardial 
performance index (MPI) at 6 months. The SimBiV group had the greatest reduction in 
LVEDV and LVESV although LVESV improved in all groups.
* p-value <0.05 (baseline vs. 6 mo); § p=0.02 for sim BiV vs. LV only
LV Only Sequential Simultaneous
Change in LVEDV (mL) -5 +/- 5 -8 +/- 5 -20 +/- 5*§
Change in LVESV (mL) -14 +/- 4* -19 +/- 4* -27 +/- 4*§
Change in LVEF (%) 5.7 +/- 0.8* 6.9 +/- 0.8* 7.4 +/- 0.8*
MPI -0.1 +/- 0.02* -0.11 +/- 0.02* -0.13 +/- 0.02*
Conclusions: All groups exhibited a reduction in LV volumes as well as an improvement 
in systolic performance. The greatest improvement was seen in the simultaneous BiV 
group. LV only pacing was associated with more modest beneﬁts.
969-124 Radial Artery Pulse Wave Analysis Corresponds to 
Echo Doppler Measures of Cardiac Function in Patients 
Undergoing Atrioventricular and Ventriculo-Ventricular 
Optimization of Biventricular Pacemaker
Asim M. Raﬁque, Tasneem Z. Naqvi, Cedars-Sinai Medical Center, Los Angeles, CA, 
UCLA School of Medicine, Los Angeles, CA
Background: Echo-guided optimization of biventricular (Biv) pacemaker post cardiac 
resynchronization therapy (CRT) has been shown to provide incremental improvement 
in cardiac function and patient (pt) functional class. Routine application of echo-guided 
optimization is however limited due to time and expertise required and lack of appropriate 
reimbursement. SphygmoCor (SCor) device (AtCor Medical) can measure left ventricular 
(LV) systolic function as ejection duration (ED) via applanation tonometry of the radial 
artery (aa). We examined whether LV ED by SCor will correspond with echo Doppler 
parameters of cardiac systolic and diastolic function and synchrony during atrioventricular 
(AV) and ventriculo-ventricular (VV) pacemaker optimization.
Methods: We performed blinded simultaneous echo Doppler and SCor radial aa 
tonometry at different AV (40-300 ms), and VV delays (nominal, 20 &40 ms, LV or RV pre-
exited), LV only pacing, A-pacing, A-sensing and during native rhythm in 42 pts (67±14 
yrs, 32 M), LVEF 0.38±0.08, 3±5 days post CRT.
Results: 252 measurements (mean of 6/pt) of echo Doppler and SCor radial aa pulse 
waveform were made at above pacemaker settings. Correlation of SCor radial aa ED with 
echo Doppler variables was as follows: LV outﬂow velocity times integral r=0.78, p<0.001, 
myocardial performance index (MPI) r=0.81, p<0.001, echo systolic ejection period 
r=0.87, p<0.001, pulsed wave mitral inﬂow ﬁlling time, r=0.50, p<0.001, E-duration(dur), 
r=0.42, p<0.001 and A-dur, r=0.69, p<0.001. Using MPI as gold standard for cardiac 
function, the sensitivity and speciﬁcity of SCor ED was 83% and 81%. Optimal VV delay 
was concordant between echo and SCor in all pts. Optimal AV delay was concordant 
between echo and SCor in 72% of pts and in 28% of pts difference between echo and 
SCor optimal AV delay was 20±5 ms. Mean SCor ED during native rhythm was 222±50 
ms and during bivpacing with optimal AV and VV delay was 270±45 ms .
Conclusions: Assessment of cardiac function by SCor radial aa tonometry corresponds 
to indices of cardiac function derived from echo Doppler. This non-invasive, simple and 
objective technique may be used for Biv pacemaker programming in pts who have 
undergone CRT.
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969-125 Integration of Three-Dimensional Coronary 
Venous Angiography with Three-Dimensional 
Echocardiography for Biventricular Device Implantation
Moussa C. Mansour, Jagmeet Singh MD P. Singh, Anwer Qureishi, Sham Sokka, Robert 
Manzke, Volker Rasche, Michael H. Picard, Jeremy N. Ruskin, Massachusetts General 
Hospital, Boston, MA, Philips Medical Systems, Boston, MA
Background: The rate of non-responders after resynchronization therapy (CRT) is 20-
30%. While the concept of CRT is a functional one, the choice of the optimal coronary 
sinus (CS) branch for the left ventricular (LV) lead is anatomical, with most operators 
targeting a lateral branch. We investigated the feasibility of integrating data from 3D CS 
angiography, with functional data from 3D echo to help determine the optimal CS branch 
for LV lead placement. Methods and Results: In ﬁve patients undergoing CRT device 
implantation, 3D echo, and a parametric display of time-to-maximum excursion of the LV 
segments were obtained. During the procedure, a rotational angiogram of the CS was 
performed followed by a 3D reconstruction of the CS tree. Off-line integration of the 3D 
echo with the 3D angiogram involved the use of ﬂuoroscopic skin makers to register the 
3D angiogram with the patient’s chest, and an optical tracking system to register these 
markers with the echo probe. Retrospective integration of the 3D data was possible in 
all patients to allow the identiﬁcation of the CS branch closest to the segment of latest 
contraction. In-vitro validation studies using a heart model revealed that the resulting error 
of the registration process is 1.8±1.1 mm. Conclusion: Integration of 3D angiography 
data of the coronary venous tree with 3D ultrasound functional information is feasible. 
This has the potential to facilitate the choice of the optimal site for LV lead placement and 
increase the efﬁcacy of biventricular pacing.
969-126 Incidence of Left Ventricular Dysfunction After 
Pacemaker Implantation for Complete Heart Block
Mark A. Iler, Katherina Tillan, Tingfei Hu, Anthony A. Bavry, Bruce L. Wilkoff, Mina K. 
Chung, Cleveland Clinic Foundation, Cleveland, OH
Background: Cardiac dyssynchrony caused by right ventricular pacing is of growing 
concern. The DAVID trial showed that patients with left ventricular dysfunction who are 
paced from the right ventricle after deﬁbrillator implantation have a worse outcome than 
those whose pacemakers are programmed to allow intrinsic conduction. The incidence 
of worsening left ventricular function in patients who receive pacemakers for complete 
heart block is unknown.
Methods: Patients who underwent pacemaker implantation for complete heart block 
were identiﬁed from a clinical database. Those who had pre-operative and post-operative 
echocardiograms were then analyzed for the endpoints of worsening left ventricular 
function and mortality.
Results: A total of 805 patients were identiﬁed, of which 486 had an available follow-
up echocardiogram and were included for ﬁnal analysis (age 67 ± 14 yrs, 57% male, 
33% coronary disease). Included patients had slightly higher LVEF than those who were 
excluded (49 vs 48%, p=0.009) but were similar with respect to other characteristics and 
overall mortality. Mean LVEF decreased from 49 ± 13% to 47 ± 14% after a median of 
13 months (p<0.001). A decrease in LVEF (by at least 5%) after implantation occurred 
in 46% of all patients, including 54% of those who had normal left ventricular function 
(LVEF≥ 50%) at baseline. A clinically signiﬁcant decrease (deﬁned as at least 10%) 
occurred in 29% of all patients and 33% of those with normal baseline function. Only 
older age (HR 1.03, 95% CI 1.01-1.05, p=0.004) and lower baseline LVEF (HR 1.03, 
95% CI 1.01-1.04, p=0.001) were independent predictors of mortality. While a decrease 
in LVEF after pacing did not independently predict mortality, patients whose LVEF did not 
decrease had a better prognosis (HR 0.95, 95% CI 0.92-0.99, p=0.017).
Conclusion: The development of left ventricular dysfunction after pacemaker 
implantation for complete heart block is common, including a third of patients with normal 
function at baseline. Careful follow-up of these patients to assess for clinical worsening 
due to dyssynchrony is warranted.
969-127 Does Left Bundle Branch Block Indicate a Better 
Response to Cardiac Resynchronization Therapy 
in Heart Failure Patients with Echocardiographic 
Evidence of Mechanical Asynchrony?
Qing Zhang, Yat Sun Chan, Jeffrey WH Fung, Chi Kin Chan, Gabriel WK Yip, Leo CC 
Kum, Eugene B. Wu, Pui Wai Lee, Yat Yin Lam, Skiva Chan, Li Wen Wu, Cheuk Man Yu, 
The Chinese University of Hong Kong, Hong Kong, People’s Republic of China
Background: It is unknown whether patients with pre-existing systolic asynchrony 
behave differently after CRT if they have different QRS pattern.
Methods: Fifty-three patients receiving CRT were included, who had echocardiographic 
evidence of systolic asynchrony with “Asynchrony Index” (Ts-SD) ≥32ms by TDI. They 
were divided into 2 groups: those with baseline LBBB (group 1, N=30) or without (group 
2, N=23), and the efﬁcacy of CRT at 3-month was compared.
Results: Reverse remodeling was achieved by reduction of both LVEDV (145±67 vs 
182±72cm3) and LVESV (93±54 vs 135±62cm3), and gain in EF (37±9 vs 27±9%) (all 
p<0.001). Responders were found in 42 patients (81%) where the reduction of LVESV 
exceeded 15%. Group 1 and group 2 had similar degree of intraventricular asynchrony 
at baseline reﬂected by Ts-SD (45±7 vs 43±11ms) and atrioventricular asynchrony by 
PR interval (192±39 vs 188±36ms) (both p=NS), though the QRS duration was different 
(168±28 vs 115±24ms, p<0.001). However, more responders were found in group 1 (87 
vs 74%, P<0.05), and the degree of reverse remodeling was better in group 1 than group 
2 (Table). Clinical improvement was comparable (Table).
Conclusions: LBBB seems to indicate a better response of reverse remodeling after 
CRT in patients with intraventricular asynchrony assessed by echocardiography. Further 
investigations are needed in order to help patient selection and response prediction for CRT.
Table. Comparison of changes in Echo and Clinical Parameters between Group 1 & 2
Parameters Group 1 Group 2 P value
LVEDV,% -26±17 -14±12 0.005
LVESV,% -36±19 -23±15 0.008
Ejection fraction, % 12±8 8±6 0.07
Ts-SD, ms -12±14 -10±16 NS
NYHA class -0.8±0.6 -0.9±0.5 NS
Quality of life score -16±15 -6±26 NS
6-Min hall walk, m 56±65 30±103 NS
 
969-128 Ventricular Dyssynchrony Assessment With Equilibrium 
Radionuclide Angiography Phase Analysis Predicts 
Outcome After Cardiac Resynchronization Therapy
Jacopo Dalle Mule, Marco Mazzella, Maria Liberata Di Sipio, Eugenio Moro, Baldovino 
Sponga, Pasquale Perrone Filardi, UO Cardiologia Ospedale del Cadore, Pieve di 
Cadore, Italy, UO Medicina Nucleare Ospedale San Martino, Belluno, Italy
Background: Electromechanical ventricular conduction disorders worsen the prognosis 
of heart failure patients. Cardiac resynchronization therapy (CRT) with pacing results 
in reverse remodeling, improvement in systolic left ventricular (LV) function, clinical 
response and prognosis of patients with advanced chronic congestive heart failure. 
However, 20% to 30% of patients are clinically non responders, with avoidable costs and 
exposure to unnecessary risks. We assessed the prognostic value of residual ventricular 
dyssynchrony (Dys) in patients who underwent biventricular pacing.
Methods: We evaluated 61 patients (age 65 ±7 years old) with LV ejection fraction (EF) 
≤ 35%, QRS ≥120 ms, NYHA class 3 or 4 despite optimal medical therapy, end diastolic 
volume 104 ±14 ml/m2; intraventricular Dys in the LV was 50 ±17o pre and 41 ±21o post 
CRT, interventricular Dys was 32 ±26o pre and 35 ±30o post CRT. Patients were assessed 
with equilibrium gated radionuclide ventriculography and with echocardiography before, 
and 6 months after CRT. Events (death, hospitalization for worsening heart failure) were 
appraised during Follow-Up.
Results: During the mean Follow-Up of 27 months, 15 patients were hospitalized and 
9 died. The presence of LV intra ventricular (V) but not inter V Dys was identiﬁed as an 
independent predictor of cardiac events (change in -2 Log likelihood 33,875; p <0.0001), 
independent of the LV EF value and QRS width. Multivariate analysis showed that LV end 
diastolic volume, ischemic etiology and the degree of LV intra V Dys signiﬁcantly correlated 
with events. A cut off value of 37o for LV Dys yielded a sensitivity of 80% and speciﬁcity 
of 74% to predict LV reverse remodelling (reduction in EDV >15%) at receiver operator 
characteristic curve analysis; furthermore, it had a sensitivity of 62% and a speciﬁcity of 
96% to predict a LV EF improvement (> 5 units). Patients with intra V Dys in the LV ≤ 37o at 
the 6-month phase analysis after CRT had an excellent prognosis (4% event rate) at the 
Follow-Up, as compared with a 62% event rate in patients with Dys > 37o.
Conclusions: Patients with dyssynchrony < 37 o in the LV after CRT have a favorable 
response and show an excellent prognosis at Follow-Up.
969-129 Inﬂuence of Location of Scar Tissue in Cardiac 
Resynchronization Therapy
Annemieke H. Jansen, Jan Melle van Dantzig, Frank Bracke, Hans C. Post, Harry van 
den Bosch, Berry van Gelder, Albert Meijer, Kathinka H. Peels, Catharina Hospital, 
Eindhoven, The Netherlands
Background: Gadolinium-enhanced CMR can identify myocardial scar tissue. We 
investigated if a transmural posterolateral (PL) infarction is of inﬂuence on the acute 
hemodynamic effect and occurrence of left ventricular (LV) reverse remodeling after 
cardiac resynchronization therapy (CRT).
Method: There were 49 pts (36 male, age 69 ± 7 years). QRS duration was 167 ± 
28 ms, LV-ejection fraction 22 ± 8 % and LV end diastolic volume 249 ± 97 ml. The 
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extent of hyperenhanced tissue on MRI with a 17-segment model was graded 0 to 4 
(0: 0%; 1:1-25%; 2: 25-50%; 3:50-75%; 4:75-100%). LVdP/dt max (37 pts) was derived 
invasively with a 0,014”sensor-tipped pressure guide wire to optimize atrio-ventricular 
and interventricular delay and determine acute response. LV reverse remodeling was 
measured by echocardiography as LV end-systolic volume decrease (LVESV∆) after 3 
month biventricular pacing.
Results: 13 pts had grade 3 or 4-scar tissue posterolateral.10 pts had scar tissue at 
another location and 16 pts had no scar. The hemodynamic beneﬁt and LV reverse 
remodeling response after CRT is given for the different groups in the table. 
LV dP/dt max. ∆ (%) LVESV ∆ (%)
PL scar 14 ± 12 (n=11) 0.2 ± 8
Non PL scar 33 ± 17 (n=8) 12 ± 8
p 0.01 0.0009
PL scar 14 ± 12 (n=11) 0.2 ± 9
Viable 29 ± 18 (n=19) 25 ± 17
p 0.02 < 0.0001
Non PL scar 33 ± 17 (n=8) 12 ± 8
Viable 29 ± 18 (n=19) 25 ± 17
p ns P=0.02
Conclusion: The acute hemodynamic beneﬁt of CRT measured by invasive LVdP/dt max 
and the occurrence of LV reverse remodeling after 3 months pacing is strongly inﬂuenced 
by PL scar tissue . Infarct at other location had less inﬂuence on LV reverse remodeling in 
contrast to viable tissue although still signiﬁcantly reduced the LV volume.
969-130 The Haemodynamic Response to Changes in 
Atrioventricular and Interventricular Delay of Cardiac 
Resynchronization Therapy Closely Fits a Parabola, 
Which May Allow More Efﬁcient Optimization
Zachary I. Whinnett, Justin E.R. Davies, Keith Willson, Charlotte H. Manisty, Anthony W. 
Chow, Rodney A. Foale, D.Wyn Davies, Alun D. Hughes, Jamil Mayet, Darrel P. Francis, 
Imperial College London and St Mary’s Hospital, London, United Kingdom
Background: Little is known about the characteristics of the haemodynamic response 
curves to changes in atrioventricular (AV) an interventricular (VV) delay of cardiac 
resynchronization therapy. In this study we assess in detail these characteristics and 
compare the magnitude and relative importance of adjustment in AV and VV delay.
Methods and Results: 36 different combinations of AV and VV delay were tested using 
digital photoplethysmography (Finometer) with repeated alternations, to measure systolic 
blood pressure relative to a reference pacing conﬁguration (SBPrel), in ﬁfteen patients with 
cardiac resynchronisation devices for heart failure.
Changing AV and VV delay both had a curvilinear effect. However, AV delay had a 
signiﬁcantly larger effect compared with changes in VV delay (range of SBPrel 21 versus 
4.2mmHg p<0.001).
The curve of response to AV delay ﬁtted extremely closely to a parabola (average R2=0.99, 
average residual variance 0.8mmHg2). The response to VV delay was signiﬁcantly less 
curved (quadratic coefﬁcient 67 versus 1194 mmHg·s-2 p=0.003) and therefore although 
the residual variance was equally small (0.8mmHg2) the R2 value was 0.7.
Conclusions: Changing AV and VV delay results in a curvilinear acute blood pressure 
response. This shape ﬁts very closely to a parabola, which may be valuable information 
in developing a streamlined clinical protocol. VV delay adjustment provides an additional, 
albeit smaller, haemodynamic beneﬁt to AV optimisation.
969-131 Normalization of Left Ventricular Ejection Fraction After 
Cardiac Resynchronization Therapy Is More Frequent in 
Patients With Non-Ischemic Cardiomyopathy
William H. Sauer, Sumeet K. Mainigi, Mathew Hutchinson, Jonathan S. Sussman, 
Fermin C. Garcia, Rupa Bala, Ralph J. Verdino, Andrea M. Russo, Francis E. 
Marchlinski, Joshua M. Cooper, University of Pennsylvania School of Medicine, 
Philadelphia, PA
Introduction: Cardiac resynchronization therapy (CRT) reduces interventricular activation 
time and improves congestive heart failure symptoms. However, only a small portion of 
patients will have complete normalization of measured echocardiographic parameters. 
We sought to characterize these patients.
Methods: The cohort of patients undergoing CRT at the University of Pennsylvania Health 
System was retrospectively analyzed to assess the potential relationships between lead 
position, clinical characteristics and normalization of left ventricular ejection fraction 
(LVEF). Final LV lead location was categorized into one of 17 myocardial segments using 
ﬂuoroscopic images in orthogonal views. Pre- and post-implant LV chamber dimensions 
and EF were measured by an echocardiographer blinded to the study.
Results: Of the 163 patients included in the analysis, there were 19 patients (11.7%) 
with an echocardiogram demonstrating an LVEF > 50% after implantation (pre and post 
implant: LVEF 24.5 +/- 12.7%, 57.2% +/- 4.8 %). Of these, 16 (88.9%) had non-ischemic 
cardiomyopathy vs. 33.7% in the remainder of the cohort (P<0.01). The other 3 patients 
who had normalization of LVEF had infarctions localized to the inferior wall of the LV wall 
and an average LVEF of >30% prior to implantation. All 19 patients (100%) had an LV lead 
position on the lateral free wall of the LV vs. 81% of the remaining cohort (P<0.01). There 
were no other signiﬁcant clinical predictors of LVEF normalization including age, sex, 
severity of mitral regurgitation, LV end diastolic dimension, and QRS duration.
Conclusions: Normalization of LVEF is seen in a minority of patients treated with CRT 
and is almost exclusively observed in patients with non-ischemic cardiomyopathy with 
lead positions on the lateral wall of the LV.
969-132 Evaluation of Left Ventricle Pressure Derivative 
Enhanced by Multi Site Pacing in Patients With Heart 
Failure
Keiji Inoue, Yumi Otsuki, Norikazu Takechi, Kenji Suzuki, Yoshiharu Nishibori, Akiko 
Matsuo, Tetsuya Tanaka, Hiroshi Fujita, Naoto Inoue, Kyoto Second Red Cross Hospital, 
Kyoto, Japan
Background:One of the essential point of cardiac resynchronization therapy is 
improvement of left ventricle (LV) pressure derivative (dP/dt). However, evaluation of dP/
dt augmented by pacing multi site is not well-established. We assessed the LV pressure 
derivative maximum (LV+dP/dt) and minimum (LV-dP/dt) under various pacing modes 
including biventricular pacing, right ventricle (RV) bifocal pacing and trisite stimulation in 
heart failure cases.
Methods:Thirty cardiac failure patients were studied by cardiac catheterization. LV+dP/dt 
and LV-dP/dt were measured during atrial pacing as control atrial-ventricular sequential 
stimulation at a rate of 80 beats/min. Atrial-ventricular delay was ﬁxed at 100 msec. The 
measurements of dP/dt during atrial-ventricular sequential stimulation at same rate were 
made under the following stimulation mode: RV apex, RV outﬂow, LV lateral, RV bifocal 
(RV apex + RV outﬂow), biventricular1 (RV apex + LV lateral), biventricular2 (RV outﬂow 
+ LV lateral), trisite (RV apex + RV outﬂow + LV lateral).
Results:The average of baseline LV+dP/dt and LV-dP/dt were 748mmHg/sec and -
781mmHg/sec. RV apex pacing decreased LV+dP/dt by 25% signiﬁcantly(p<0.05). 
LV+dP/dt during RV outﬂow pacing showed no change compared with control. LV lateral, 
RV bifocal, biventricular1, biventricular2 and trisite pacing increased LV+dP/dt by 32%, 
24%, 35%, 36% and 34%, respectively (p<0.05). Biventricular1, biventricular2 and trisite 
pacing increased absolute value of LV-dP/dt by 20%, 19% and 27%, respectively (p<0.05) 
while other pacing mode decreased these data. Trisite pacing increased absolute value 
of LV-dP/dt more than biventricular pacing. There was no remarkable difference of data 
between biventricular1 pacing and biventricular2 acing.
Conclusions:RV apex stimulation impaired LV function, whereas RV outﬂow pacing 
preserved LV function. RV bifocal pacing provided a modest but favorable effect. LV 
lateral, biventricular and trisite pacing showed better performance in systolic phase than 
the control equally. Trisite pacing demonstrated additional effect on diastolic function.
969-133 Coronary Sinus Lead Extraction Is Safe Even With 
Prolonged Lead Inplant Duration
James D. Davenport, Christine Saari, Steven P. Kutalek, Hahnemann University 
Hospital, Philadelphia, PA
Background: With a continual increase in the inplantation of cardiac resynchronization 
devices for severe left ventricular (LV) dysfunction, the need for extraction of coronary 
sinus (CS) leads has become more frequent. Published data in this area is sparse; risk 
of procedure unclear. This study reports our institution’s experience in the removal of 
CS leads.
Methods: We prospectively evaluated extraction of LV CS pacing leads over a 38 month 
period (8/02 - 10/05). Operators clinically experienced in the lead extraction performed the 
procedures, using standard extraction tools as required to remove all device hardware.
Results: 29 CS leads were extracted. The patient group included 22 males and 7 females 
aged 63 to 85 years. Inplant duration ranged from 2 days to 27 months. Indications for lead 
extraction were: generator and/or lead infection with or without concurrent bacteremia (n 
= 23), lead malfunction or diaphramatic pacing (n= 4 ), pocket errosion (n = 1 ), and heart 
transplant (n = 1 ). Lead models: 25 were unipolar CS leads, 3 were bipolar CS leads, 
and one was a bipolar model number 4024 lead placed in the CS. All leads had passive 
ﬁxation mechanisms. Leads were explanted using the superior approach in all patients, 
except for one lead tip removed femorally from the innominate vein. All CS leads were 
removed with manual traction alone except for one removed with a locking stylet and Byrd 
dilating sheath secondary to adherence of the lead tip to the tricuspid valve. Predominate 
areas of ﬁbrosis occurred in the superior vena cava at crossing points with other leads. 
There were no complications related to the removal of the CS leads themselves; however, 
2 patients experienced transient hypotension during extraction of other leads.
Conclusions: Removing CS leads that have been in place for prolonged periods, even 
greater than 2 years can be accomplished without complications, usually with direct 
traction. Rarely, extraction tools may be needed. Main areas of lead ﬁbrosis occurs along 
the venous walls outside the CS.
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969-134 Development of Venous Stenosis and Occlusion After 
Pacemaker Implantation
Petri J. Korkeila, Kai Nyman, Juhani Koistinen, Pasi Karjalainen, Antti Ylitalo, Juha Lund, 
K. E. Juhani Airaksinen, Turku University Central Hospital, Turku, Finland, Satakunta 
Central Hospital, Pori, Finland
Background: Electrodes in central veins are known to predispose to venous obstruction. 
Although usually asymptomatic, venous stenosis may render electrode removal or 
replacement a difﬁcult task. This is the ﬁrst study to assess changes in venous caliber in a 
prospective fashion based on contrast venography (Vg) before and after pacemaker (PM) 
or cardioverter-deﬁbrillator (ICD) implantation.
Methods: 150 (mean age 67; 61% male) consecutive patients referred for implantation 
of a ﬁrst PM or ICD were enrolled, and followed for 6 months. A successful ipsilateral 
Vg was done both at baseline prior to device implantation and at 6-month follow-up in 
137 (91%) patients. Measurements of minimum (Dmin) and maximum (Dmax) vessel 
diameters were obtained from both Vgs. A stenosis was deﬁned as a 50 % diameter 
reduction in a venous segment. We implanted a total of 232 electrodes: 47 (34.3%) single 
lead, 85 (62.0%) 2-lead and 6 (4.4%) 3-lead systems.
Results: Mean baseline venous diameters were 10.6 mm (Dmin) and 17.8 (Dmax), 
which did not change signiﬁcantly during the follow-up. At six months a stenosis was 
present in 14 (10 %) patients, whose average venous minimum diameter had reduced 
to 4.6 mm (38% of the baseline diameter). In 12 of 14 patients the stenosis developed at 
the same site where the vessel was narrowest at baseline. Complete venous occlusion 
with collateral vein development was seen in 5 (3.6 %) patients. None of the 19 patients 
with stenosis or occlusion exhibited any local symptoms. Clinical predictors for the 
development of stenosis were the presence of atrial ﬁbrillation, obesity, higher NYHA 
class at baseline and older age among women.
Conclusions: This is the ﬁrst systematic prospective study to assess the changes in 
venous caliber after pacemaker or ICD implantation. The incidence of signiﬁcant venous 
narrowing or complete obstruction was 14 % in this material.
969-135 Antibiotic Proﬁlaxis is Essential in Surgical Procedures 
of Cardiac Implantable Devices
Martino Martinelli, Julio C. Oliveira, Silvana A D Nishioka, Tania Varejão, David Uip, 
Anísio A A Pedrosa, Eduardo A. Sosa, Roberto Costa, José A F Ramires, Heart Institute 
(InCor) University of São Paulo Medical School, São Paulo, Brazil
Background: Antibiotic prophylaxis in artiﬁcial cardiac stimulation (ACS) surgical 
procedures is an unsolved question. There are few published data, once deﬁnitive 
conclusions require a large population protocol. Conﬂicting results of small studies are not 
enough to establish an evidence-based clinical orientation. The aim of this study was to 
evaluate the effects of preventive antibiotic administration previous to surgical procedures 
concerning ACS and also to determine eventual predictive correlations.
Methods: Patients with pacemaker or cardioverter-deﬁbrillator surgical procedures 
indication were selected in a large-scale, double blind, randomized (1:1) trial. Two 
groups were compared: GI- Cefazolin (1,0g- single dose) versus GII- placebo. Venous 
administration was performed immediately before surgery. Follow-up was performed 10 
days, 1, 3 and 6 months after hospital discharge. Primary end point was infectious signals 
at pulse generator pocket or systemic infection related to the procedure. Estimated 
sample size was of 1000 patients, considering infection incidence of 2% (α -error of 5%, 
power of 90%). Statistical analysis used the following tests: chi-square, Fischer’s exact, 
Wilcoxon and logistic regression.
Results: The security committee interrupted the trial after inclusion of 649 patients due to 
differences between groups in favor of the antibiotic arm (GI: 2 patients infected - 0.63%; 
GII: 11 patients infected - 3.28%; RR=0.19; p=0.016). Clinical features were similar 
between both groups and the following markers were identiﬁed by univariate analysis: 
non-use of preventive antibiotic; implant procedures (versus generator replacement); 
presence of post-operative haematoma and procedure duration (all with p<0,05). 
Multivariate analysis identiﬁed the non-use of antibiotic (p=0.03) and the post-operative 
haematoma (p=0.02) as independent predictors of infection. Occurred 15 deaths being 
none related to infections.
Conclusions: Antibiotic prophylaxis reduces signiﬁcantly infectious complications in ACS 
procedures. The presence of local haematoma identiﬁes patients with high risk of post-
operative infections.
969-136 Device Erosions Are Not Associated With Systemic 
Infections
Vivian Tsai, Henry Chen, Henry H. Hsia, Paul J. Wang, Amin Al-Ahmad, Stanford 
University Medical Center, Stanford, CA
Background: Implantable pacemakers (PPM) and deﬁbrillators (ICD) can be complicated 
by infection and device erosion. It is unclear if the clinical features of patients who have 
device erosion differ from those without erosion.
Methods: We retrospectively examined the records of all patients who had explantation of 
a pacemaker or deﬁbrillator from January 2000 to May 2005. We examined demographic 
variables including age, gender and body mass index (BMI) as well clinical variables 
related to the erosion and procedural variables. Chi square analysis was used to compare 
the distribution of discrete variables.
Results: 74 patients had infected PPM or ICDs. The mean age was 68 years, the 
majority (n=54) were male. Of the 74 cases, 30 (41%) developed infection complicated 
by erosion, of which 8/26 (31%) cases were related to AICDs and 22/46 (48%) related 
to pacemakers. Device erosion was signiﬁcantly associated with absence of a systemic 
infection (3/30(10%)) as opposed to patients without erosion (21/44 (48%)) p=0.007. All 
other variables were similar between the two groups.
Conclusions: Infections associated with erosion appear to be associated with a 
decreased risk of systemic infection, as compared to those without erosion. This ﬁnding 
may have implications in the timing of device re-implantation.
Characteristics of patients with device erosion and non-erosion
Erosion (n=30) Non-Erosion (n=44) p value
Fever 0 (0%) 4 (9%) NS
Elevated WBC 2 (7%) 10 (23%) NS
Positive blood cultures 3 (10%) 21 (48%) p=0.007
 
969-137 A Comparison of Bleeding Complications Associated 
With Warfarin and Coumadin Among Patients 
Undergoing Device Implantation
Byron J. Colley, III, Anbukarasi Maran, J. Nappi, J. L. Sturdivant, R. B. Leman, J. M. 
Wharton, M. R. Gold, The Medical University of South Carolina, Charleston, SC
BACKGROUND: The management of patients on chronic anticoagulation (AC) undergoing 
device implantation is controversial. Common strategies include discontinuing warfarin, 
bridging with heparin until oral anticoagulation can be restarted or maintaining chronic 
warfarin therapy. Little is known regarding the risk of bleeding complications with these 
different approaches. METHODS: All patients who underwent device implantation over 
a 33 month period were retrospectively reviewed. These patients were categorized into 
3 groups: heparin (continuous heparin administration initiated within 24 hours of device 
implantation), continued warfarin or no AC. Bleeding complications were deﬁned as 
hematoma or bleeding requiring evacuation, transfusion or hospitalization prolongation. 
RESULTS: The study included 1,355 consecutive patients (908 men, 447 females, mean 
age 66) who underwent device implantation. This included 75 patients bridged with 
heparin, 134 maintained on warfarin (mean INR 2.0, +/- 0.55) and 1,146 on no AC. There 
were 12 bleeding complications in the heparin group (16%), 6 in the warfarin group (4.5%) 
and 2 in the absence of AC (<0.2%) during the immediate postoperative period, yielding 
statistically signiﬁcant differences between groups (Table). CONCLUSION: If AC cannot 
be stopped safely, then maintaining warfarin is preferred to bridging with heparin.
 
Bleeding Complications
Heparin Warfarin Neither
Bleeding Complications 
% (N) 16%
* 4.5%# 0.2%
Notes
*p<0.007 vs warfarin, 
p<0.001 vs neither
#p<0.001 vs 
neither NA
 
969-138 Permanent His Bundle Pacing Does Not Induce 
Dyssynchrony. An Intrapatient Comparison
Domenico Catanzariti, Massimiliano Maines, Giuseppe Vergara, Giuseppe Vergara, 
Rovereto (TN), Italy
Background:Beneﬁts of A-V synchrony during DDD right ventricular apical (RVA) 
pacing are neutralized by induction of ventricular dyssynchrony (VD). Only a few data are 
reported about Direct His Bundle pacing (DHP) inﬂuence on ventricular synchronism. Aim 
was to assess the capability of DHP to prevent pacing-induced VD comparing DDD- (or 
VVI- in case of AF) RVA pacing with DDD-(or VVI-) DHP in the same pts cohort.
Methods: 20 pts (mean age 77±7.8 yrs) with narrow QRS (<120 ms) and HV interval 
(<65 ms) underwent permanent DHP for “brady-tachy syndrome” (11) or suprahissian 
II/III-degree AV Block (permanent AF 5, AVN ablation 1). In 10 pts a back-up RVA pacing 
lead was used; pts were alternatively paced using either permanent DHP or RVA pacing. 
In the remaining 10 pts temporary DDD-(or VVI-) RVA pacing was performed through a 
femoral vein. A 4.1 F screw-in lead (Medtronic, Select Secure) was ﬁxed in His position, 
guided by endocardial pacemapping and unipolar HB potentials. Echocardiographic (E) 
and PW tissue Doppler imaging (TDI) analysis assessed VD during either DHP or RVA 
pacing: interventricular mechanical delay (IVD) between the onset of each systolic ﬂow, 
septal to left posterior wall motion delay (SPWD), and maximal difference between the 
longest and the shortest segmental electromechanical delay (deﬁned as the time to onset 
of the systolic TDI wave), among the left ventricle basal segments (TDIMD). In 6 pts 
higher voltage pacing (2.34±1.32 V vs 1.2±0.54 V;x 0.5ms) resulted both in DHP and 
adjacent ventricular inﬂow septum pacing (DH+SP). A-V interval was optimized for each 
pacing site, using the same pacing rate. 
Results: Permanent DHP was obtained in all 20 pts. Indexes of D were drastically 
reduced during DHP (or DH+SP) in comparison to RVA pacing (p<0.05). TDI-DHP, 
TDI-RVA and TDI-DH+SP were 18.3±11.1, 42.5±26.2 and 16±6.7 ms respectively. IVD-
DHP, IVD-RVA and IVD-DH+SP were 1.3±14.5, 40.7±12.4, and 9.4±9.1 ms respectively. 
SPWD-DHP, SPWD-RVA and SPWD-DH+SP were 51.4±39.2, 152.5±70.5 and 67±39.3 
ms respectively. No difference was observed between DHP and combined DH+SP.
Conclusions: DHP (also fused with adjacent septum capture) prevents pacing-induced VD.
969-139 Aviodance of Left Ventricular Dyssynchrony Detected 
by Tissue Doppler Echocardiogrphy by Permanent 
Right Ventricular Septal Pacing in Patients With High-
Grade Avtrioventricular Block
Hung-Fat Tse, Yui- Ming Lam, Man-Oi Tang, Vella Tsang, Chung-Wah Fung, Chu-Pak 
Lau, The University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong
Background: Prior studies suggested that permanent right ventricular apical (RVA) 
pacing induced left ventricular (LV) dyssynchrony and impaired LV function. Whether 
alternative right ventricular septal (RVS) pacing can avoid this long-term deleterious 
effects of permanent pacing remain unclear.
Methods: We randomised 26 pts with high-grade atrioventricular block (AVB) without 
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structural heart diseases to receive either RVA (n=13) or RVS (n=13) pacing during DDD 
pacemaker implantation. Radionuclide ventriculography (MUGA scan) and tissue Doppler 
echocardiography were performed at 24 months after pacemaker implantation to assess 
LV function and LV mechanical synchrony. LV synchrony was assessed by a 6-basal, 6-
mid segmental model and measure the time to peak sustained systolic velocity (TS).
Results: Pts with RVS pacing had a signiﬁcantly narrow QRS duration than those with 
RVA pacing (145±4 vs. 165±5 ms, P=0.04), but a similar baseline LV ejection fraction on 
MUGA scan (56±5 vs. 54±3%, P=0.7). At 24 months, RVS pacing is associated with a 
signiﬁcantly higher LV ejection fraction (55±3 vs. 47±5%, P=0.03) and more homogeneous 
LV contraction as shown by closing time of TS among all 12 segments (Figure 1, P<0.05) 
and a lower range and standard deviation of TS (Figure 2, P<0.05).
Conclusions: The results of this study demonstrated that long-term RVS pacing can 
avoid LV dyssynchrony as observed in RVA pacing and preserve LV function in pts with 
high grade AVB.
969-140 Atrial Versus Dual Chamber Pacing in Sinus Node 
Disease
Piotr Rucinski, Andrzej Kutarski, Maciej Latek, Bogumil Kaminski, Iwona Rucinska, 
Leszek Wdowiak, Medical University of Lublin, Lublin, Poland, Warsaw School of 
Economics, Warsaw, Poland
Background: Sinus Node Disease (SND) is a common indication for implantation of a 
permanent pacemaker. There is a good evidence to support atrial pacing rather than 
ventricular based pacing but there is some risk of subsequent atrioventricular block 
development. In such cases upgrade of atrial pacemaker (AAI) to dual-chamber (DDD) is 
necessary, what creates additional costs of therapy. The aim of the study was to compare 
costs of primary DDD pacing system implantation to primary AAI implantation, in pts 
without DDD indications at the time of ﬁrst implantation, taking into account the future 
necessity of AAI to DDD upgrade in some cases.
Methods: The data of 752 patients with SND who had AAI implanted between 1993 and 
1997 were identiﬁed. The records of patients were examined to ﬁnd cases that required 
further procedure to upgrade AAI to dual chamber. Observational period: 5,0 - 10,0 (mean 
7,4 y.). The cost comparison analysis was based on deterministic model in the time 
window of 10 years. Model assumptions: Pacemaker battery longevity: AAI - 8 y.; DDD - 6 
y.; linear pacing costs depreciation; discount rate 5%. The costs were calculated from the 
public health care payer perspective. Sensitivity analysis was performed for upgrade to 
DDD rate and procedure costs.
Results: The rate of upgrade to DDD was 19,1% within mean 7,4 y. period in the studied 
population. The projected to 10 years rate of upgrade was 25,8%. Cost of primary DDD 
strategy was 4719 USD PPP (Purchasing Power Parity). Cost of current strategy (primary 
AAI) was 3804 USD PPP, and cost of hypothetical (ideal) strategy in which all patients 
that would need upgrade in the future were identiﬁed before implantation was 3505 USD 
PPP. Primary DDD would become equal to primary AAI strategy if upgrade rate was 56% 
or more. The lower relative DDD costs the lower was the equality upgrade rate, and the 
higher absolute differences the more beneﬁcial was AAI strategy.
Conclusions: Implantation of AAI pacemaker in patients with SND without DDD indications 
is cost saving comparing to DDD implantation in each patient. Better identiﬁcation of 
patients who will need future upgrade to DDD may bring additional savings.
969-141 Evolution of Left Ventricular Function in Pediatric 
Patients With Permanent Right Ventricular Pacing 
for Isolated Congenital Heart Block: A Medium Term 
Follow-Up
Radu-Gabriel Vatasescu, Tchavdar N. Shalganov, Dora Paprika, Laszlo Kornyei, Zsolt 
Prodan, Gabor Bodor, Andras Szatmari, Tamas Szili-Torok, Hungarian Institute of 
Cardiology, Budapest, Hungary
Background: RVA pacing can be detrimental on LV function in a signiﬁcant number of 
adults. Effects in children are still controversial. We aimed to assess the evolution of left 
ventricular (LV) systolic function in children with right ventricular apical (RVA) pacing for 
isolated congenital heart block (ICHB) and to identify possible predictors of LV function 
deterioration.
Methods: LV shortening fraction (LV SF) and QRS width were retrospectively assessed in 
45 children with RVA pacing for ICHB: before pacemaker (PM) implantation, immediately 
after and then regularly during a follow-up of 58.69±45.23 months. Patients were 
categorized as stable and deteriorator according to an arbitrarily chosen cut-off point of 
≥7% decrease in LV SF.
Results: Overall LV SF did not change signiﬁcantly (41.42%±8.21 before pacing, 
39.77%±7.03 immediately after PM implant, 37.43%±9.91 with chronic pacing, p=NS). 
Deteriorators (n=13) had signiﬁcantly higher baseline heart rate (57.5±8.7 bpm vs 
46.9±10.5 bpm, p<0.05) and baseline LV SF (46.17±8.13% vs. 38.4±6.4%; p<0.05), 
a signiﬁcantly higher proportion of them being implanted before 2 years of age: 8 of 
13 (61.5%) vs 5 of 25 (20%) in the stable group (p<0.05). Deteriorators had a higher 
incidence of an initial epicardial lead and narrower native QRS.
Conclusions: Permanent RVA pacing for ICHB does not necessarily affect LV function in 
children. The risk for deterioration of LV function seems to be higher in children with higher 
baseline heart rate and better baseline LV SF, especially with pacing at a younger age, a 
narrower native QRS and RVA epicardial pacing site.
969-142 Baseline Systolic Blood Pressure Predicts Response 
to Cardiac Resynchronization Therapy in Heart Failure 
Patients
Naveen L. Pereira, Sara M. Levy, Barathi Sethuramen, Onajefe Nelson-Twakor, Michael 
R. Gold, Medical University of South Carolina, Charleston, SC
Background: Despite the use of speciﬁc selection criteria, about one-third of patients 
with chronic heart failure (HF) do not beneﬁt from cardiac resynchronization therapy 
(CRT). Systolic blood pressure (SBP) is a simple measurement, and serves as a major 
prognostic indicator in HF which is used to determine patient tolerability and eligibility 
for speciﬁc therapy. The effect of baseline SBP on subsequent response to CRT in HF 
patients has not been previously described.
Methods: We studied 126 patients enrolled in a prospective, multicenter, randomized 
double-blind controlled trial, the Resynchronization for Hemodynamic Treatment for Heart 
Failure Management (RHYTHM) study. Patients were required to have NYHA Class III/IV 
HF, LVEF ≤ 35%, QRS ≥ 150ms, and an indication for an ICD. They were divided into two 
groups based on pretreatment SBP: Group 1 (n=47) with SBP < 110mmHg and group 2 
(n=79) with SBP>110mmHg. The effect of CRT on six-month study endpoints of peak oxygen 
consumption (VO2), exercise duration, and quality of life was evaluated within each group.
Results: Baseline characteristics were similar between the CRT OFF and CRT ON groups 
within groups 1 and 2. At 6 months, patients in group 1 with CRT ON had a signiﬁcant 
increase in SBP compared with CRT OFF (13 mmHg, p=0.002), while patients in group 
2 had no signiﬁcant change in SBP compared to baseline. Patients in group 1 with CRT 
ON also had a signiﬁcant improvement in peak VO2 (1.6 ml/kg/min, p=0.01), exercise 
time (3.3 min, p=0.004) and quality of life (19 points, p=0.03) compared with those with 
CRT OFF. In contrast, group 2 patients with CRT ON or CRT OFF showed no signiﬁcant 
difference in any of these endpoints.
Conclusion: Patients with severe HF and low pretreatment SBP show a greater functional 
beneﬁt from CRT than those with high pretreatment SBP. Baseline SBP can potentially 
identify responders to CRT.
969-143 Lack of Association Between QRS Duration and 
Cardiac Asynchrony in Candidates for Cardiac 
Resynchronization Therapy
Stylianos Tzeis, George K. Andrikopoulos, Dimosthenis Avramidis, Konstantinos 
Triantafyllou, Vassiliki Tsagou, Panagiotis Politis, Konstantinos Kappos, Antonis S. 
Manolis, Evangelismos Hospital, Athens, Greece
Background: Although QRS duration has been widely used for the selection of candidates 
for cardiac resynchronisation therapy(CRT), echocardiographic markers of cardiac 
dyssynchrony (CD) have been demonstrated to accurately identify CRT responders. We 
evaluated the association of QRS duration with CD in a cohort of consecutive patients, 
hospitalised for refractory to medical treatment heart failure.
Methods: We studied 52 consecutive patients who were candidates for CRT based on 
clinical criteria. The majority of the studied patients were males (83%) and suffered from 
ischemic cardiomyopathy (56%). The maximum QRS duration was measured by four 
experienced cardiologists and the inter- and intraventricular electromechanical delay (ED) 
were estimated by Doppler and TDI echocardiography.
Results: In univariate analysis, patients with prolonged QRS duration (≥130ms) had 
signiﬁcantly higher interventricular ED and lower LVEF. However, the septal to lateral 
intravenrticular ED did not differ signiﬁcantly between the two study groups. In multivariate 
analysis adjusted for age, gender, LVEF, LVDD, NYHA stage and the existence of LBBB, 
prolonged QRS duration was not found to be signiﬁcantly and independently associated 
with either interventricular or intraventricular ED.
Conclusions: In this study population of consecutive patients hospitalised for refractory 
heart failure, who were candidates for CRT, prolonged QRS duration was not an 
independent predictor of cardiac asynchrony. 
Baseline characteristics in relation to QRS duration
QRS<130ms
(n=19) QRS≥130ms (n=33) p value
QRS (ms) 112±10 163±25 <0.001
Age (yrs) 67±13 65±10 0.625
ΝΥΗΑ 2.7±0.8 2.9±0.7 0.242
LVDD (mm) 59±5 64±10 0.058
LVEF (%) 35±8 28±8 0.009
Interventricular delay 4±16 27±31 0.004
Intraventricular delay 80±43 65±33 0.174
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Arrhythmias: Models and Basic Science
Monday, March 13, 2006, 4:00 p.m.-5:00 p.m.
Georgia World Congress Center, Room B407
4:00 p.m.
826-3 High-Septal Pacing Reduces Electrical Remodeling  
and Arrhythmogeneity in the Chronic Atrioventricular 
Block Dog
Stephan K.G. Winckels, Morten B. Thomsen, Peter Oosterhoff, Avram Oros, Jet 
Beekman, Nico Attevelt, Leo Kretzers, Marc A. Vos, University Medical Center, Utrecht, 
The Netherlands
Background: Ventricular electrical remodeling (VER) in chronic AV block has 3 
contributors: bradycardia, altered activation, and lack of AV synchrony. Studies in AV 
block rabbits paced from the right ventricular apex suggest that the extent of rate drop is 
the main factor in VER. With high-septal pacing (HSP) in AV block dogs, the relevance of 
preserved activation in VER was elucidated. Methods: AV block dogs were either paced 
from the high ventricular septum near the His-bundle at the lowest captured rate (n=7, 
HSP) or kept at idioventricular rate with uncontrolled activation (n=14, C). Measurements 
under anaesthesia at 0 and 4 weeks were: left and right ventricular monophasic action 
potential duration (LV and RV MAPD), RR, and RT-time. Arrhythmogenic response was 
tested at 4 weeks by 25 µg/kg IKr blocker dofetilide iv. Results: At 0 weeks both groups 
were comparable (table), but not after 4 weeks of similar bradycardia: values increased 
more in C than HSP. RT increased 34±23% in C, but only 15±15% in HSP, P≤0.05. 
Interventricular dispersion of repolarization (LV-RV MAPD) increased only in C. Torsade 
de Pointes arrhythmias were induced in 29% in HSP vs 78% in C, P=0.14. Enhanced 
arrhythmogenesis was also seen using variables like the mean number of arrhythmias 
per dog: C 13±16 vs HSP 1±2 arrhythmias/10min, P≤0.05. Conclusion: HSP reduces 
the magnitude of VER and arrhythmogeneity in AV block dogs, suggesting that altered 
activation has a larger role in generation of VER than previously assumed.
Table: 
Data: means ± SD (ms) 0 weeks 4 weeks
Ctrl RR 1190 ± 300 1344 ± 262 *
n=14 RT 273 ± 19 363 ± 61 *
LV MAPD 262 ± 23 369 ± 54 *
RV MAPD 239 ± 19 310 ± 52 *
LV-RVMAPD 17 ± 10 60 ± 31 *
HSP RR 1173 ± 203 1406 ± 205 *
n=7 RT 278 ± 22 317 ± 36 * $
LV MAPD 269 ± 20 302 ± 36 * $
RV MAPD 241 ± 17 275 ± 17 * $
LV-RVMAPD 28 ± 11 27 ± 10 $
* P≤0.05 vs 0 weeks $ P≤0.05 vs C
4:15 p.m.
826-4 Heat Shock Proteins Prevent Atrial Tachycardia 
Remodeling and Atrial Fibrillation Promotion
Bianca J.J.M. Brundel, Akiko Shiroshita-Takeshita, Xiao Yan Qi, Denis Chartier, Robert 
H. Henning, Harm H. Kampinga, Stanley Nattel, Montreal Heart Institute, Montreal, PQ, 
Canada, University of Groningen, The Netherlands
Background: There is evidence that heat shock proteins (HSPs) protect against atrial 
ﬁbrillation (AF) in a variety of clinical paradigms. We evaluated the effect of HSP induction 
in a paced atrial cell-line (HL-1) model of tachycardia-remodeling and on AF-promotion 
by atrial tachycardia-induced remodeling in dogs. Methods: We studied the effects of 
tachypacing in HL-1 cells (3 Hz, 0-4 hrs) on Ca2+ transients (CaT) and cell shortening 
(CS), with and without HSP-inducing pre-treatments using a mild heat shock (20 min 43°C 
+ 16 h 37°C) or the heat shock stress response co-inducer geranylgeranylacetone (GGA, 
10 µM, 2 hrs before and during pacing). In vivo, dogs were subjected to atrial tachypacing 
at 400 bpm for 7 days in the absence (n=5) and presence of GGA treatment (120 mg/
kg/day, n=5), starting 3 days before and continued throughout tachypacing. Results were 
compared to a non-paced control group (n=5). Results: In HL-1 cells in vitro, tachypacing 
signiﬁcantly and progressively reduced CaT up to 79% after 4 hours of pacing. In parallel, 
CS was reduced to 68% at 4 hours. Either HS pre-treatment or GGA treatment before 
and during pacing almost completely prevented tachycardia-induced reductions in CaT 
and CS. In dogs in vivo, atrial tachypacing increased the mean duration of induced AF 
from 23±13 seconds to 816±402 seconds (*P<0.01) and increased atrial vulnerability (% 
of atrial sites inducing AF by single extrastimuli) from10 to 56%*, while decreasing the 
atrial effective refractory period (ERP) from 121±7 to 67±7 ms*. In vivo treatment with 
GGA increased HSP expression and suppressed all these tachypacing-induced changes: 
with GGA, the mean duration of AF after 7-day tachypacing was 35±11 seconds, atrial 
vulnerability was 18±5 %, and ERP was 101±2 ms. Conclusions: Augmentation of HSP 
expression protects against tachycardia-induced reductions in cell shortening and Ca2+ 
transients in vitro and prevents the electrophysiological and AF-promoting consequences 
of atrial tachycardia in vivo. These ﬁndings support the hypothesis that HSP may be an 
important endogenous suppressor of AF-promoting remodeling and provide a rationale 
for HSP system manipulation for therapeutic prevention of AF.
4:30 p.m.
826-5  Possibility of Electrical Bridging over AV Groove by the 
Artiﬁcial Epicardiac Accessory Pathway in a Rat Model 
of Atrio-Ventricular Block
Toshiaki Sato, Shunichiro Miyoshi, Koutarou Fukumoto, Akira Furuta, Yuji Itabashi, 
Shinichiro Kira, Nobuhiro Nishiyama, Seiji Takatsuki, Kyoko Soejima, Tatsuya Shimizu, 
Teruo Okano, Satoshi Ogawa, Keio University, School of Medicine, Tokyo, Japan, 
Tokyo Women’s Medical University, Institute of Advanced Biomedical Engineering and 
Science, Tokyo, Japan
Background: Regenerated cardiomyocytes can be derived from stem cell in vitro. Lately 
novel technology has enabled to make transplantable cell-sheet grafts from cultured 
cardiomyocytes in ﬁbrin polymer dishes. We have already shown electrical communication 
from this graft to host-ventricle. Therefore, we implanted the graft as an artiﬁcial accessory 
pathway in rats with complete atrio-ventricular block (CAVB) to treat bradycardia.
Methods: Subjects were 7 nude rats. After making CAVB by ethanol injection, grafts were 
implanted and bridged over Rt. AV groove. Seven days after that, surface ECG was recorded 
and electrical conduction was studied on 6 perfused hearts by optical mapping system.
Results: Whereas 2 rats died due to severe bradycardia and AV-node conduction was 
recovered in 2 rats, CAVB was maintained in 3 rats with wide-QRS waves of inferior 
axis, LBBB and slurred beginning. The wide-QRS wave followed P-wave intermittently in 
1 rat and appeared during slow rate of escape beats with different morphology in 2 rats. 
Optical mapping system revealed that ventricle activation was spread from the ridge of 
Rt. atrial appendage during A pacing in 2 rats and atrial activation was propagated from 
there during V pacing in 1 rat.
Conclusions: In a rat model of CAVB with artiﬁcial accessory pathway, ventricle can be 
driven with speciﬁc wide-QRS waves. Activation pulse may be propagated over AV groove 
through implanted graft. This may suggests a therapeutic potential of cell-sheet graft for 
CAVB.
4:45 p.m.
826-6 A Common Polymorphism H558R in SCN5A is 
Associated with Lone Atrial Fibrillation
Lin Y. Chen, Jeffrey D. Ballew, Kathleen J. Herron, Timothy M. Olson, Mayo Clinic 
College of Medicine, Rochester, MN
Background We have shown that mutations in the cardiac sodium channel gene (SCN5A), 
predicted to reduce sodium current, can cause a syndrome of dilated cardiomyopathy 
(DCM) and atrial ﬁbrillation (AF). The minor allele of the common polymorphism H558R in 
SCN5A is associated with reduced sodium current. We hypothesized that either SCN5A 
mutations or presence of the minor R558 allele may increase susceptibility to lone AF.
Methods We recruited 157 unrelated probands with lone AF for genetic analysis. The 28 
translated exons of SCN5A were scanned for DNA sequence variation using D-HPLC 
heteroduplex analysis. Samples that formed heteroduplexes were analyzed further by 
sequencing. H558R was genotyped by restriction fragment length polymorphism analysis. 
We compared the allele frequencies in the AF cohort with 314 age and gender matched 
normal Caucasian controls. Categorical and continuous variables were tested using the 
�2 test and rank-sum test, respectively.
Results Our AF cohort was 100% Caucasian (77% males, mean age at diagnosis 44 
± 10 yrs). DNA scanning and sequence analyses did not identify mutations that altered 
splice junctions or protein sequence. The genotype frequencies in the AF cohort vs. 
normal controls were: HH, 50% vs. 63%; HR, 40% vs. 33%; and RR, 10% vs. 4%; p=0.008. 
The R558 allele was more common in our cohort than in controls (30% vs. 21%, p=0.002) 
and compared with the H558 allele, conferred an odds ratio for AF of 1.6 (95% CI 1.2 
- 2.2). The mean age at diagnosis in AF males with HR or RR genotype was earlier than 
HH homozygotes (42 vs 46 yrs, p=0.03). In AF males, RR homozygotes had longer QRS 
duration (msec) (median, interquartile range: 108, 102 - 118) than HH (98, 90 - 108) or 
HR (96, 88 - 106) (p=0.02).
Conclusions Mutations in SCN5A can cause a syndrome of DCM and AF, but are not a 
common cause for lone AF. However, there was an increased frequency of the R558 allele 
among lone AF patients compared with normal controls. The R558 allele was associated 
with younger age at diagnosis in males. RR homozygote males had a prolonged QRS 
duration that may suggest reduced sodium current. We conclude that the R558 allele, 
associated with reduced sodium current, may confer susceptibility to lone AF.
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POSTER SESSION
992 
Noninvasive Risk Stratiﬁcation
Tuesday, March 14, 2006, 8:30 a.m.-Noon
Georgia World Congress Center, Hall B1
Presentation Hour: 11:00 a.m.-Noon
992-123 Do ECG Abnormalities Pose the Same Risk for Women 
and Men?
Kavita V. Ernst, Swee Y. Tan, Marcus Sandri, Gregory Engel, Jonathan Myers, Victor F. 
Froelicher, Stanford University School of Medicine, Stanford, CA, VA Palo Alto Health 
Care System, Palo Alto, CA
Background: There is controversy regarding the relative prognostic value of the resting 
ECG in women vs men.
Objectives: To compare the diagnostic criteria of computerized ECG measurements in 
men and women in a large Veteran outpatient with follow up for cardiovascular death.
Methods: Since 1987, digitized ECGs were recorded and analyzed using the GE/Marquette 
computerized ECG system. ECGs were ordered at physician discretion for usual clinical 
indications. Through 2000, 45,855 resting ECGs were available for consideration. After 
removal of inpatients and those with pacemakers and WPW, 33,312 patients (29,320 men 
and 3,992 women) remained. Limited demographics were available (age, gender, race, 
weight, height, recording location) and the population was followed until 2002 as to cause 
of death using the California death index. ECG criteria considered included bundle branch 
block, left ventricular hypertrophy (LVH), atrial ﬁbrillation (AF), ST depression, diagnostic 
Q waves, left atrial abnormality (LAA) and QT prolongation. Kaplan Meyer survival curves 
were plotted and age and heart rate adjusted Cox Hazard analyses performed.
Results: The mean age and BMI were (55.9+/-0.1) years and (27.5+/-0.1) for males 
and (56.9+/-0.1) years and (26.2+/-0.1) for females (p<0.001). With the exception of left 
bundle branch block (LBBB), right ventricular hypertrophy, QT prolongation and left atrial 
abnormality, all ECG abnormalities were at least twice as prevalent in males compared 
to females. After a mean follow up of 7.5 years, the annual mortality was 1.1% for males 
and 0.6% for females (P< 0.001). All ECG abnormalities had signiﬁcant hazard ratios 
(HR) in men. The HRs were greater than 2 or more in all except right bundle branch block, 
AF and left axis deviation. In females, only LVH and ST depression were associated with 
signiﬁcant HR of 2 while LBBB demonstrated a HR of 1.2.
Conclusion: In this veteran population, there were signiﬁcant differences between men 
and women in the prevalence and prognostic value of classic ECG criteria. While LVH was 
associated with a similarly high HR (2 to 3 fold increase), LBBB, RVH and prolonged QT 
only had a signiﬁcant HR (greater than 2) in men.
992-124 QTc Variability in Patients With Long QT Syndrome: The 
Importance of the Maximum QTc Value From Follow-Up 
Electrocardiograms in Predicting Cardiac Events
Jehu Mathew, Ilan Goldenberg, Arthur J. Moss, Wojciech Zareba, Derick R. Peterson, 
Scott McNitt, Mark L. Andrews, Brian Morray, Jesaia Benhorin, International Long 
QT Syndrome Registry, University of Rochester School of Medicine and Dentistry, 
Rochester, NY
Background: A baseline corrected QT interval (QTc) value >500 msec has been shown 
to be associated with an increased risk of subsequent cardiac events among Long QT 
Syndrome (LQTS) patients. However, the value of follow-up electrocardiograms (ECGs) 
in risk assessment has not been determined.
Methods: A multivariate Cox survivorship model was used to assess the probability of a 
cardiac event (syncope, aborted cardiac arrest, or LQTS-related sudden cardiac death) 
between the ages of 10-20 years in 375 patients enrolled in the International LQTS 
Registry in whom two or more ECGs were recorded before the age of 10.
Results: The mean ± SD difference between the maximum and minimum mean values 
of the QTc measures was 47 ± 40 msec. Multivariate analysis demonstrated that the 
maximum QTc interval recorded before the age of 10 was associated with the highest risk 
of cardiac events (HR=4.09, p=0.002) during adolescence, whereas other follow-up QTc 
parameters, including the most recent QTc (HR =2.81, p=0.01), the mean QTc (HR=2.80, 
p=0.02), and the baseline QTc (HR=1.72, p=0.20) were associated with a lower risk of 
cardiac events. When the baseline QTc and the maximum QTc during follow-up were 
entered into the same model, a baseline QTc ≥500 msec was no longer predictive of 
cardiac events (HR= 0.82; p=0.72).
Conclusions: In LQTS patients, there is considerable variability in QTc measures on 
follow-up ECGs. The maximum QTc interval provides incremental prognostic information 
over a baseline measurement. We suggest that risk stratiﬁcation in LQTS patients should 
include follow-up ECG data.
992-125 Repolarization Complexity is Increased in Left 
Ventricular Hypertrophy: The Strong Heart Study
Peter M. Okin, Marek Malik, Katerina Hnatkova, Elisa T. Lee, James Galloway, Lyle 
G. Best, Barbara V. Howard, Richard B. Devereux, Cornell Medical Center, New York, NY
Background:ECG measures of ventricular repolarization complexity and heterogeneity 
have been shown to predict cardiovascular (CV) and all-cause mortality. Left ventricular 
hypertrophy (LVH) has been associated with an increased risk of ventricular arrhythmias 
and with arrhythmic, CV and total mortality. However, whether these T-wave descriptors 
are independently related to ECG LVH has not been examined.
Methods:The relationship of QTc and novel ECG variables characterizing the T-wave 
loop to ECG LVH was assessed in 2113 American Indian participants in the ﬁrst Strong 
Heart Study exam. T-loop morphology was quantiﬁed by the ratio of the second to 
ﬁrst eigenvalues of the T-wave vector (PCA ratio), total cosine R to T (TCRT), T-wave 
morphology dispersion (TMD) and by the sum of the squares of the 4th to 8th eigenvalues, 
the T-wave residuum (TWR). ECG LVH was measured using gender-adjusted Cornell 
product (CP) criteria: (RaVL+SV3 [+6 mm in women])*QRS duration >2440 mm•msec, 
and was present in 307 (14.5%).
Results:CP LVH was associated with a prolonged QTc (445±28 vs 430±24 ms/sec1/2), 
higher PCA ratio (22.3±12.5 vs 18.3±11.3%), greater TMD (31.3±24.6 vs 17.7±15.5 
degrees) and TWR (67.1±128.1 vs 37.9±53.2 technical units x 10-3), and with a lower 
TCRT (-0.13±0.56 vs 0.40±0.51, all p<0.001). In a step-wise linear regression analysis 
that included age, sex, blood pressure, and all ECG variables, TCRT, sex, systolic 
pressure, QTc, TMD, the PCA ratio and TWR all signiﬁcantly correlated with the magnitude 
of CP LVH. In a step-wise multivariate logistic regression model that included the same 
variables, TCRT, TMD, TWR, QTc, systolic pressure and female gender all remained 
signiﬁcant predictors of the presence of LVH by CP criteria, with lower TCRT being the 
strongest predictor (odds ratio 2.42 [per 1 SD of mean decrease in TCRT], 95% CI 2.05-
2.87, chi-square=105.2, p<0.001).
Conclusions:ECG measures of repolarization complexity are increased in CP LVH and 
independently associated with the presence and severity of LVH by CP. These ﬁndings 
suggest that abnormalities of ventricular repolarization may contribute to the increased 
mortality associated with LVH.
992-126 Heart Rate Turbulence Onset After Atrial Premature 
Complexes Does Not Reﬂect Cardiac Autonomic 
Regulations in Postinfarction Patients
Dan Wichterle, Maria T. La Rovere, Peter J. Schwartz, Marek Malik, First Medical 
School, Charles University, Prague, Czech Republic, St. George’s Hospital Medical 
School, London, United Kingdom
Background: The purpose of the study was to assess the relationship between 
Turbulence Onset after atrial premature complexes (APCs) and other indices of cardiac 
autonomic modulation.
Methods: Analysis was performed in Holter recordings (n = 1085) of ATRAMI (The 
Autonomic Tone and Reﬂexes After Myocardial Infarction) population. Heart rate 
turbulence described by Turbulence Onset and Turbulence Slope after ventricular 
premature complexes (VPCs) and after APCs was correlated with low- and high-frequency 
spectral indices of heart rate variability (HRV) and baroreﬂex sensitivity assessed by the 
phenylephrine method.
Results: All heart rate turbulence indices except Turbulence Onset after APCs signiﬁcantly 
correlated (Spearman rank correlation) with spectral HRV and baroreﬂex sensitivity. 
Turbulence Onset 
after VPCs
Turbulence Slope 
after VPCs
Turbulence Onset 
after APCs
Turbulence Slope 
after APCs
Baroreﬂex 
sensitivity -0.32 0.49 -0.08 0.39
Low-
frequency 
HRV
-0.44 0.65 -0.07 0.59
High 
frequency 
HRV
-0.37 0.58 -0.02 0.55
Conclusions: Unlike other descriptors of heart rate turbulence, Turbulence Onset after 
APCs does not reﬂect cardiac autonomic regulations. It was previously demonstrated that 
early RR interval dynamics after APCs is substantially modiﬁed by the suppression of 
sinus nodal automaticity due to direct effect of APC. Consequently, Turbulence Onset after 
APCs reﬂects the sinus node dysfunction rather than vagal modulation.
992-127 Heart Rate Turbulence as a Marker of Severity of 
Congestive Heart Failure
Iwona Cygankiewicz, Wojciech Zareba, Montserrat Vallverdu, Rafael Vazquez, Jesus 
Almendral, Miguel Fiol, Juan Cino, Pere Caminal, Antoni Bayes de Luna, on behalf of 
MUSIC Trial Investigators, Hospital St Pau, Barcelona, Spain, University of Rochester, 
Rochester, NY
Background: The aim of our study was to to determine whether heart rate turbulence 
(HRT) could be considered as a marker of congestive heart failure (CHF) advancement 
and progression giving insight into hemodynamic changes as well as changes of the 
autonomic nervous system.
Methods: Clinical evaluation, 12-lead ECG, echocardiography, chest X-ray, series of 
laboratory tests (electrolytes, creatinine, troponine, and proBNP) and 24-hour Holter 
monitoring with HRT (turbulence slope -TS and turbulence onset- TO) and HRV 
parameters analyses were performed in consecutive CHF patients (pts) with NYHA class 
II and III and sinus rhythm.
Results: The study population consisted of 589 pts (425 men) with mean age 65 yrs, 
mean LVEF of 37±14%, with majority of pts (82%) in NYHA class II. Abnormal HRT 
parameters (HRT1 or HRT2) were found in 64% of studied pts. Both HRT parameters, 
but especially TS signiﬁcantly correlated with clinical indices of heart failure as the third 
tone, peripheral oedemas, jugular distension and pulmonary congestion (on chest X-
ray). Patients with NYHA class III has signiﬁcantly lower TS and higher TO values than 
those in class II (TS 1.59 vs 3.09 ms/RR, p<0.001). Signiﬁcant correlations were found 
between HRT parameters and LVEF (r=0.27, p<0.001 for TS) as well as with left ventricle 
diameters and mitral regurgitation degree. Increased levels of blood markers of advanced 
CHF stage (proBNP, creatinine, troponine) were associated with more abnormal HRT 
measures. Pts with more abnormal HRT indices had more advanced abnormalities of 
autonomic nervous system assesses as reduced HRV parameters. Multivariate analyses 
testing the association between abnormal HRT and NYHA class and low ejection fraction 
(<40%) showed that abnormal HRT parameters: HRT2, HRT1, abnormal TS, abnormal 
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TO are independent predictors of NYHA class III or LVEF<40%.
Conclusions: Our ﬁndings indicate that in CHF patients HRT reﬂects well the severity of 
heart failure and associated left ventricular dysfunction, which were veriﬁed in this study 
by a series of established clinical, echocardiographic and biochemical parameters.
992-128 Evolution of the Paced and Nonpaced QRS Duration 
With Chronic Right Ventricular Pacing in Pediatric 
Patients With and Without Structural Heart Disease
Tchavdar N. Shalganov, Dora Paprika, Laszlo Kornyei, Zsolt Prodan, Gabor Bodor, 
Radu Vatasescu, Andras Szatmari, Tamas Szili-Torok, Gottsegen Gyorgy Hungarian 
Institute of Cardiology, Budapest, Hungary
Background: Currently QRS duration is a selection parameter for cardiac 
resynchronization therapy (CRT) in adults. Criteria for CRT in pediatric patients are not 
yet implemented.
Aim: Right ventricular (RV) pacing creates artiﬁcial left ventricular dyssynchrony and 
thus can be used as a surrogate for left bundle branch block. Our aim was to assess 
the evolution of the QRS width in chronically paced pediatric patients with and without 
structural heart disease (HD) and to compare the data to the cut-off value for cardiac 
resynchronization in adults.
Methods: A group of 99 pediatric patients (56 males) with a previously implanted 
pacemaker was studied retrospectively. Forty-three patients had isolated AV block (IAVB), 
24 patients had complex congenital malformations and the remaining 32 had isolated 
congenital HD. Patients were followed up for an average of 50.6±41.3 months. QRS width 
was measured in lead V5 or II on ECG recordings with paper speed of 50 or 25 mm/sec. 
Data on QRS width were analyzed in six age groups (group I: <1 yr, group II: 1-2 yrs, 
group III: 3-4 yrs, group IV: 5-7 yrs, group V: 8-11 yrs, group VI: 12-15 yrs).
Results: Paced QRS duration showed progressive widening during the follow-up (group 
I: 109.3±23.4 ms, group VI: 152.8±25.7 ms, p<0.05). Similar increase in non-paced QRS 
duration was observed (group I: 58.8±16.7 ms, group VI: 95.5±30.2 ms, p<0.05). Patients 
with structural HD reached the widest paced QRS (age group VI - complex congenital HD: 
160±21.9 ms, isolated structural HD: 154.3±32.5 ms, IAVB: 147.5±18.1 ms).
Conclusions: 1) Chronic RV pacing in pediatric patients with or without structural HD 
does not cause widening of the QRS complex over 120 ms until the age of 2 years. 2) 
Current adult cut-off value of 130 ms for CRT is not reached until the age of 4 years and 
cannot be used within this age frame as a parameter for selecting the optimal pediatric 
patients for CRT. 3) Paced QRS width of 150 ms, beyond which ECG identiﬁes more 
reliably left ventricular dyssynchrony, is not reached until the age of 12-15 years. 4) The 
presence of an either isolated or complex congenital HD results in a wider paced QRS 
complex.
992-129 Noninvasive Electrophysiological Study of Ivabradine 
(NESI) in Patients With Dual Chamber Pacemakers: 
Effects on Ventricular Repolarization
Irina Savelieva, Sue Jones, Kate Dougal, Marek Malik, John Camm, St George’s 
University of London, London, United Kingdom
Ivabradine (IVA) is a selective inhibitor of the If current with potential antiarrhythmic 
actions. IVA-induced heart rate (HR) reduction is associated with QT prolongation; no 
changes were observed when QT was corrected for HR. The aim of this study was to 
investigate if QT prolongation is entirely due to bradycardia or to a direct effect of IVA on 
ventricular repolarization (VR). Methods: To avoid limitations of invasive EP testing, we 
studied 25 pts (63±10 yrs; M/F 16/9; sinus node disease [SND], 14; 1o-2o AV block [AVB], 
11, incl. AVB+bundle branch block [BBB], 5) with DDD pacemakers with non-invasive 
programmed stimulation (NIPS) in the prospective randomized, double blind, placebo 
controlled study of oral IVA 5 (n=8) or 10 (n=8) mg bd. Atrial pacing (AP) at 80, 90, 100, 
110 bpm and ventricular ERP (VERP) measurements were performed before and after 
3½ days of treatment. AP at ﬁxed rates allows for direct QT comparisons at the same 
HR, with no need for HR correction. A continuous 12-lead digital Holter recording was 
used for QT analysis. Results: IVA did not prolong QT during AP compared with placebo 
(Figure). The subgroup analysis in SND and AVB±BBB showed identical results. IVA 10 
mg bd slightly increased VERP vs baseline (274±21 vs 264±20 ms; p=0.033; IVA 5 mg bd: 
271±16 vs 267±17 ms; p=0.36; placebo: 266±36 vs 258±36 ms; p=0.055). Conclusions: 
The study demonstrated the feasibility of NIPS for assessing the EP effects of oral agents. 
Direct QT comparisons during AP showed no direct pharmacologic effect of IVA on VR.
 
992-130 Determination of Atrial Flutter Type Using Interactive 
ECG Analysis
Carl W. Musser, Jr., Stephen C. Hammill, Mayo Clinic College of Medicine, Rochester, MN
Background: The morphology of the 12-lead electrocardiogram (ECG) can give important 
insights into atrial ﬂutter activation patterns. Commonly used criteria to distinguish 
between cavotricuspid isthmus (CTI) dependent and non-CTI dependent atrial ﬂutter 
are often insufﬁcient. An interactive ECG interpretative process may identify ﬂutter wave 
characteristics that improve the ability to make this distinction.
Methods: A custom software application was developed for computer-assisted ECG 
interpretation that functioned interactively with a user that directed the interpretive process. 
The software displayed digital 12-lead ECG data followed by user identiﬁcation of ﬂutter wave 
onset and offset in a single lead. The software then calculated simultaneous characteristics 
in all leads including ﬂutter wave amplitude and cycle length. The study population 
consisted of 28 patients with documented atrial ﬂutter referred for ablation. An ECG tracing 
demonstrating atrial ﬂutter was analyzed for each patient prior to electrophysiologic study. 
Flutter wave activation sequence was conﬁrmed by intracardiac mapping.
Results: In CTI-dependent (typical) atrial ﬂutter (20 patients), 19 tracings (95%) 
demonstrated ﬂutter wave polarity transition in lead I. The maximum limb and precordial 
lead ﬂutter wave amplitudes occurred most often in lead II and V4, respectively. In non-
CTI-dependent (atypical) atrial ﬂutter (8 patients), only one tracing (12%) showed ﬂutter 
wave polarity transition in lead I. The maximum limb and precordial lead peak-to-peak 
voltages occurred most often in lead III and V1, respectively. The mean ﬂutter waveform 
cycle length was signiﬁcantly longer and the mean waveform amplitudes signiﬁcantly 
were larger for typical ﬂutter as compared to atypical ﬂutter.
Conclusions: Computer-assisted ECG analysis that allows a user to direct the 
interpretive process identiﬁed previously unrecognized differences between CTI and non-
CTI dependent atrial ﬂutter.
992-131 ST-Elevation in Lead aVR During Exercise Testing 
Should Not Be Ignored
Johanne Neill, Amanda Morton, Joanne Shannon, Alison Muir, Mark Harbinson, 
Jennifer A. Adgey, Royal Victoria Hospital, Belfast, United Kingdom
Background: The diagnostic signiﬁcance of ST elevation (STE) in lead aVR during 
exercise is controversial. Lead aVR is directed towards the left ventricular (LV) cavity and 
so changes may indicate LV dysfunction on exercise. We aimed to assess the diagnostic 
value of STE in aVR during exercise prior to Tc99-sestamibi scanning and its predictive 
value in identifying ischemic territory and angiographic ﬁndings.
Methods: Consecutive patients attending for Tc99-sestamibi perfusion imaging between 
April 2004 and Aug 2004 were enrolled. Patients completed a treadmill protocol. Peak 
exercise ECGs of these patients were coded by 2 blinded investigators. STE ≥ 0.5mm in 
lead aVR was considered signiﬁcant. Perfusion imaging results including gated images 
assessing LV function were recorded. A proprotion of the images were double reported 
by a blinded investigator. Findings at angiography were assessed.
Results: Of the 605 patients recruited, mean age was 62 SD 11 years. STE in lead aVR 
occurred in 23% (138) of the patients. More patients with STE in aVR had a reperfusion 
defect on imaging compared with those that had no STE in aVR (41% 56/138 vs 28% 
132/467 p=0.006). The presence of STE in aVR did not indicate a more severe reperfusion 
defect as determined by myoquant index (median 7.1 at stress compared with 6.6 in 
the non STE aVR group p=NS). Signiﬁcant coronary artery stenosis (>70%) was more 
likely when STE in aVR occurred (73% 27/37 vs 66% 62/94, p=0.011) but there was no 
association between its presence and the arteries diseased.
Logistic regression analysis demonstrates that STE in aVR (OR 1.3 p=0.244) is not an 
independent predictor of reperfusion abnormality when adjusted for ST depression (STD) 
(OR 1.6 p=0.02)
On further regression analysis with anterior wall reperfusion defect as an endpoint, STE 
in aVR (OR 1.8 p=0.049) was a predictor despite adjustment for STD (OR 1.1 p=0.7).
Conclusions: STE in aVR during exercise occurs frequently. It does not diagnose 
signiﬁcantly more reperfusion abnormalities than STD alone. However, unlike STD which 
is not predictive of a territory of ischemia, STE in aVR is associated with an anterior wall 
reperfusion defect.
992-132 Characteristics of Heart Rate Changes in Response to 
Sleep-Disordered Breathing among Cardiac Patients
Phyllis K. Stein, Eric Lundequam, William Howells, Stephen P. Duntley, Peter P. 
Domitrovich, Kenneth E. Freedland, Robert M. Carney, Washington University School of 
Medicine, St. Louis, MO
Background: Repeated HR arousals (HRAs) occur due to obstructive apneas (OA) and 
hypopneas (H) during sleep.
Method: To explore characteristics of HRAs and factors inﬂuencing their magnitude among 
cardiac patients, data were analyzed from N=123 patients with known cardiovascular 
disease (age 58±10 yrs, 76M, 47F, 55% post-MI, 55% on beta-blockers) recruited for a 
study of depression and sleep apnea. ECGs from the 2nd night of polysomnography were 
extracted and scanned on a Holter analyzer. HRAs from N=4582 OA events and N=7548 
H events were measured and integrated with sleep stages and respiratory event type. 
Regression analysis identiﬁed the determinants of HRA characteristics including: event 
type (OA, H), sleep stage (REM, non-REM), age group (=60 yrs), gender, BMI (30), Hx of 
MI, depression and beta-blocker use.
Results: Both HR increases and HRA durations were greater during REM than non-REM 
(15±10 bpm, 35±16s for REM; 14±8 bpm, 30±13s for non-REM). HRA acceleration was 
greater for OA compared to H events during both REM and non-REM, but the difference 
was greatest during REM (OA:0.98±0.05 vs. H:0.64±0.04, p<0.001). In contrast, HRA 
accelerations were less during H events in REM than in non-REM (p= 0.005). Greater 
HRA accelerations were seen in patients <60 and were most marked in REM (0.96±0.06 
for younger vs. 0.66±0.06 bpm/s for older pts) and during OA (1.08±0.06 for younger 
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vs. 0.77±0.06 bpm/s for older pts), all p< 0.001. HRA accelerations were also greater 
among overweight patients (BMI 25-30), although also higher in obese than normal 
weight patients. Females had smaller HRA accelerations during REM and greater HRA 
accelerations during non-REM, than males, but no difference in H events. There was no 
effect of Hx of MI, depression or β-blocker use.
Conclusions: Rapid, potentially dangerous HR accelerations suggesting dramatic 
changes in autonomic tone and not affected by beta-blockade, are seen, especially in 
association with obstructive apneas during REM sleep in cardiac patients, supporting 
the importance of screening for sleep-disordered breathing. Lesser accelerations seen in 
older patients suggest a loss of autonomic sensitivity with aging or possible habituation 
to sleep apnea.
992-133 Heart Rate Variability Response to Dynamic Exercise 
Testing: Implications for Interpretation of Spectral 
Analysis Parameters During Periods of Less Oscillatory 
Autonomic Function
Frederick E. Dewey, James V. Freeman, Gregory Engel, Raul Pinoviedo, Natasha 
Ahmed, Johnathan Myers, Victor F. Froelicher, Stanford University, Palo Alto, CA, Palo 
Alto VA Health Care System, Palo Alto, CA
Background: Spectral analysis parameters of heart rate variability (HRV) are thought 
to reﬂect cardiovascular (CV) response to autonomic function. At rest, the very low 
frequency (VLF) and low frequency (LF) components are thought to reﬂect CV response 
to sympathetic input while the high frequency (HF) component is believed to reﬂect CV 
response to vagal function. We evaluated spectral analysis parameters of HRV during and 
after dynamic exercise testing to characterize the HRV response to exercise.
Methods: Spectral analysis was performed on de-trended R-R interval data taken from the 
ﬁrst and last two minutes of, and ﬁrst two minutes after exercise treadmill testing of 1302 
subjects (95% male, mean age 58) at the Palo Alto Veterans Affairs Medical Center.
Results: The fractional distribution of HRV energy is shown in the ﬁgure. Relative to the 
start of exercise, the percentage of VLF and LF power signiﬁcantly decreased during the 
last two minutes of testing when sympathetic modulation of heart rate predominates. 
Relative to peak exercise, the percentage of HF power was observed to decrease 
during the ﬁrst two minutes of recovery when parasympathetic modulation of heart rate 
predominates.
Conclusions: Current models for the frequency domain components of HRV are 
inadequate to describe the changes we observed in the fractional distribution of HRV 
energy during and after dynamic exercise testing. We hypothesize that less oscillatory 
autonomic function or non-neuronal inﬂuences must be implicated.
992-134 Prognostic Value of Signal Average Electrocardiogram 
in Predicting the Occurrence of Atrial Fibrillation. A 
Meta-Analysis
Manish Undavia, Davendra Mehta, Trong Duong, J. Anthony Gomes, Mount Sinai 
Medical Center, New York, NY
Background: Prior studies evaluating the role of signal average ECG (SAECG) in 
stratifying patients at high risk for developing atrial ﬁbrillation (AF) have been limited by 
small sample size and disparate populations.
Methods: Prospective studies evaluating the role of SAECG in predicting AF published 
between January 1988 and September 2005 were retrieved. Studies were included if 
data on cut-off value of an abnormal ﬁltered P wave duration (fPWD) was available and 
the primary endpoint was occurrence of AF. The combined primary endpoint of interest 
was the ﬁrst occurrence of AF (paroxysmal, PAF) or progression of PAF to chronic AF 
(CAF). The odds ratios (OR) and the 95 % conﬁdence intervals (CI) of the individual trials 
were pooled using a random effects model. A separate sub-group meta-analysis was 
performed on patients who were post CABG surgery.
Results: A total of 973 pts from 8 studies met our pre-speciﬁed criteria (75% M, age 
range: 46-67 yrs, follow-up: 5 days to 40 months). 17% of the patients had a prior episode 
of PAF. SAECG was done to evaluate progression of PAF to CAF in 13 %; occurrence 
of AF in the post CABG setting in 51 %; in the post MI period in 23%; left ventricular 
dysfunction (EF<40%) in 8 % and post WPW syndrome ablation in 5% of the pts. An 
abnormal fPWD as deﬁned in individual studies ranged from 126 msec to 155 msec. In 
the pooled meta-analysis, an abnormal fPWD was present in 32% of the pts. 52% of pts 
with an abnormal fPWD met the primary endpoint as compared to 11% pts with normal 
fPWD (OR-9.3, CI-5.1-17.1, P-0.000). Overall, the positive and negative predictive value 
(PPV, NPV) of abnormal fPWD for development of AF was 52 % and 88% respectively. In 
the CABG subgroup, post-operative in-hospital AF occurred in 57% of the patients with 
an abnormal SAECG as compared to 16% with a normal SAECG (OR 7.75, CI 3.5-17.6, 
P-0.000; PPV-57%, NPV-84%).
Conclusion: FPWD on a SAECG has a signiﬁcant value in predicting AF across a wide 
spectrum of patients including those who have had a recent CABG surgery. The critical 
task remains in standardizing the cut-off value for deﬁning an abnormal fPWD. Further 
studies are warranted to evaluate the incremental value of SAECG over conventional 
markers for AF.
992-135 Long History and Frequent Episodes of Paroxysmal 
Atrial Fibrillation in Patients Without Structural 
Heart Disease Do Not Lead to Deterioration of Atrial 
Electrophysiology
Raija Koskinen, Heikki Väänänen, Jouni Kuusisto, Hannu Parikka, Markku Mäkijärvi, 
Lauri Toivonen, Helsinki University Hospital, Helsinki, Finland
Background: Long lasting atrial ﬁbrillation (AF) can cause electrophysiological and structural 
changes in atria. Atrial SAECG has predicted progression of paroxysmal AF to chronic.
Methods: 81 patients with paroxysmal lone AF (aged 43±12 years) and 81 matched 
controls were examined. P-on-T atrial complexes and fast atrial tachycardias, signifying 
focally-triggered AF, were demonstrated in 57 patients (69%). The length of AF history was 
9±10 years. AF episodes occurred >1/wk in 56%, 1/wk to 1/mo in 29% and <1/mo in 15% 
of patients. Atrial electromagnetic signals were averaged and high-pass ﬁltered (40 Hz) and 
atrial wave duration (Pd) and RMS amplitude of the last 40 ms were automatically analyzed. 
Pd was 109 ms in patients and 104 ms in controls (p=0.004), but RMS (75±29 fT v74±35 fT, 
p=n.s.), PR interval, QRS duration and left atrial diameter (LAd, 36±5 mm) were normal.
Results: The length of AF history did not correlate with Pd (r=0.02, p=n.s.), LAd (r=0.19, 
p=n.s., Figure), or atrial wave RMS. None of these correlated either with the frequency of 
AF episodes. Patients with focal AF had more frequent episodes (72% vs. 17% >1/wk) and 
normal atrial RMS (80±31 vs. 62±18 fT; p=0.001) compared to those without focal triggers.
Conclusions: Paroxysmal lone AF does not lead to atrial electrical of mechanical 
remodeling even over prolonged time, particularly the focal type of AF. These observations 
favor the concept that lone atrial ﬁbrillation can be cured by successful elimination of the 
local arrhythmia substrate.
992-136 Abnormal Heart Rate Variability is a Powerful 
Independent Predictor of Long-Term Cardiovascular 
Mortality in the Elderly: The Cardiovascular Health 
Study
Phyllis K. Stein, Joshua Barzilay, Peter P. Domitrovich, Paolo H M Chaves, John 
Gottdiener, Michael W. Rich, Pentti Rautaharju, Robert E. Kleiger, Richard Kronmal, 
Washington University School of Medicine, St. Louis, MO
Background: Abnormal heart rate variability (HRV) has predicted mortality in patients with 
a variety of cardiac disorders over a relatively short follow up. Less is know about HRV 
and cardiovascular (CV) mortality in the general population over a longer follow-up.
Methods: The association of 24-hr time and frequency domain HRV, non-linear HRV and 
heart rate turbulence (HRT) with CV mortality was determined in 1384 community-dwelling 
older adults in the Cardiovascular Health Study (CHS), a multi-center, population-based 
study of the epidemiology of CV disease the elderly. CV as underlying cause of death was 
adjudicated by an expert panel. Multivariate proportional hazards models, adjusted for a 
large number of previously-identiﬁed independent predictors of CV mortality in the CHS, 
determined the association of HRV parameters with CV mortality.
Results: Subjects were 71.9 ± 4.9 (65-93) yrs, 53% female. Median FU was 12.3 years. 
For time domain HRV-eligible recordings (N=1273, 190 CV deaths), after adjustment for 
covariates, decreased SDANN [(Risk ratio (RR)=0.993, 95% CI (0.989-0.998), p=0.006] 
combined with abnormal HRT [either turbulence slope (TS) abnormal [RR=1.93 (95% 
CI (1.31-2.84), p=0.001, or both TS and onset abnormal (RR=3.14, 95% CI (2.03-4.86), 
p<0.001)] strongly predicted CV mortality. Model chi-sq was 361 without and 401 with 
HRV. For frequency domain-eligible recordings (N=1198, 175 CV deaths), the combination 
of decreased ln total power [(RR=0.79, 95% CI (0.54-0.91), p=0.009] with increases in 
the non-linear measure SD12 [ratio of the axes of an ellipse ﬁtted to the Poincaré plot of 
N-N intervals, RR=12.9, 95% CI (3.6-45.6), p<0.001] and abnormal HRT [TS abnormal 
RR=2.02, 95% CI (1.34-3.05), p=0.001, both TS and onset abnormal RR=2.82, 95% CI 
(1.73-4.58), p<0.001] had the strongest association with CV mortality. Model chi-sq was 
331 without and 390 with HRV.
Conclusions: In the elderly, abnormal HRV is a powerful risk factor for long-term CV 
mortality. Instead of ﬁnding a single best HRV predictor, results show that the combination 
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of multiple HRV predictors, including traditional and non-linear HRV and heart rate 
turbulence, has the strongest association with mortality.
992-137 Validation of an Electrocardiographic Predictive 
Regression Model for the Differential Diagnosis of 
Paroxysmal Junctional Tachycardias in Patients Without 
Preexcitation
Esteban Gonzalez-Torrecilla, Angel Arenal, Felipe Atienza, Ana Sánchez, Jesús 
Almendral, Hospital General Universitario “Gregorio Marañón”, Madrid, Spain
Background: In patients (P) without preexcitation, the differential diagnosis of paroxysmal 
junctional tachycardias consists mainly of atrioventricular nodal reentry tachycardias 
(AVNRT) and orthodromic reciprocating tachycardias (ORT) through a concealed accessory 
pathway. The objective of this study was to validate the diagnostic accuracy of a multiple 
logistic regression model using classical electrocardiographic criteria in that diagnosis.
Methods: We included 360 consecutive patients (231 females; 45±18 yrs) who 
underwent an electrophysiologic (EP) study for paroxysmal, regular, narrow-QRS complex 
tachycardias without preexcitation in sinus rhythm. Atrial tachycardias were excluded. The 
ECG recordings during tachycardia were reviewed by 2 independent observers for the 
presence of the following criteria: a) pseudo r´ deﬂection in V1 and/or pseudo s waves in 
inferior leads, b) P wave separate from the QRS complex, c) QRS alternans, and d) ST 
segment depression (≥2 mm) and/or T wave inversion during tachycardia. We performed 
a cross-validation method using the ﬁrst 230 patients to develop a multiple logistic model 
to predict the tachycardia diagnosis (derivation group). The model was validated through 
the remaining 130 patients (validation group).
Results: EP study demonstrates AVNTR in 241 P and ORT in 119 P. The presence of 
pseudo r´ deﬂection in V1 and/or pseudo s waves in inferior leads (adjusted OR: 13, 95% 
CI: 4-39; p=0.0001), a P wave separate from the QRS (adjusted OR: 0.21, 95% CI: 0.11-
0.4; p=0.0001), and QRS alternans (adjusted OR: 0.32; 95% CI: 0.13-0.8; p=0.015) were 
selected by stepwise multiple logistic regression analysis as independent predictors for the 
diagnosis of AVNRT (vs. ORT) in the derivation group. The application of the obtained model 
in the validation group showed a shrinkage prediction factor of only 1% of the cases.
Conclusion: The presence of pseudo r´ deﬂection in V1 and/or pseudo s waves in 
inferior leads, a P wave separate from the QRS, and QRS alternans during tachycardia 
permit derivation of a reliable logistic model for predicting the mechanism of paroxysmal 
junctional tachycardias in patients without preexcitation during sinus rhythm.
992-138 Methodological Issues of QRS Duration Measurements 
in Candidates for Cardiac Resynchronization Therapy
Dimosthenis Avramidis, George K. Andrikopoulos, Stylianos Tzeis, Vassiliki Tsagou, 
Konstantinos Triantafyllou, Panagiotis Politis, Konstantinos Kappos, Antonis S. Manolis, 
Evangelismos Hospital, Athens, Greece
Background: Although cardiac dyssynchrony (CD) may exist despite a normal QRS 
duration, prolonged QRS duration has been extensively used as a surrogate marker of 
CD. However, there is limited information on interobserver variability of QRS duration 
measurements, which may delineate its role in the selection of candidates for cardiac 
resynchronization therapy (CRT).
Methods: We studied 52 consecutive patients (mean age 66±11 years, 83% males, 56% 
suffering from ischemic cardiomyopathy, and 64% in NYHA stage III-IV) admitted due 
to worsened heart failure. Maximum QRS duration was measured by four experienced 
cardiologists using : a) conventionally measured paper 12-lead ECGs, b) on screen 
measurements of computerised ECGs, and c) measurements of the ﬁltered QRS duration 
of the signal-averaged ECGs (CS 200, Schiller, CH).
Results: The average value of the maximum QRS duration differed signiﬁcantly with the 
three methods (145±33, 144±35 and 131±32 ms respectively, P<0.001). Interventricular 
electromechanical delay was correlated better to the ﬁltered QRS duration obtained from 
SAECG (R=0.460, P<0.001) compared to the values obtained from conventional (R=0.359, 
P=0.010) or from the computerised ECGs (R=0.311, P=0.026). QRS duration measured 
conventionally differed substantially between the four observers (137±35, 143±33, 
155±34 and 142±34 ms respectively, P<0.001). Consequently, signiﬁcant discrepancies 
were observed when the studied patients were classiﬁed in two groups using the cut-off 
value of 130 ms. Thus, 28(54%), 33(64%), 33(64%) and 26(50%) patients were classiﬁed 
as having prolonged (≥130 ms) QRS duration by the four observers, respectively.
Conclusions:In a cohort of unselected patients, candidates for CRT, the ﬁltered QRS 
duration measurements were more reproducible and better correlated to interventricular 
delay compared to both the conventionally measured QRS duration or to onscreen 
measurements using computerised methods. Interobserver variability in QRS duration 
measurements may partly explain inappropriate identiﬁcation of patients as candidates for 
CRT in studies of biventricular pacing using QRS duration as the main inclusion criterion.
992-139 Open Irrigated-tip Technology Versus Intracardiac Echo 
Guided Energy Delivery Using an 8 Mm Tip Catheter 
For Pulmonary Vein Isolation in Patients With Atrial 
Fibrillation: A Randomized Comparison
Jens Guenther, Georg Noelke, Klaus Gutleben, Johannes Brachmann, Nassir F. 
Marrouche, Klinikum Coburg, Coburg, Germany
Background: Radiofrequency energy (RF) delivery for pulmonary vein isolation (PVI) 
utilizing both irrigated tip and an 8 mm tip catheter under intracardiac echo (ICE) guidance 
have been proven to be safe and efﬁcient. This study was initiated to prospectively 
compare the 2 ablation modalities.
Methods and results: 56 patients (40 men; mean age 56±12 years) presenting for PVI 
for treatment of symptomatic AF were randomized to ablation using one of the following 
ablation modality: RF delivery using an open irrigated-tip catheter (Group 1); or RF 
energy delivery under ICE guidance using an 8 mm tip catheter (Group 2). In group 
1 temperature and power (with a saline pump ﬂow rate of 30 ml/min) were set at 50° 
and 45W, respectively. In group 2 patients power delivery was initiated at 25 W and was 
titrated upwards until scattered microbubbles were observed, then the power was titrated 
downwards to subside the MB formation. Only if MB formation subsided energy delivery 
was continued for 25-35 seconds. Table 1 demonstrates patients characteristics and 
outcome in both study groups. No major complications were observed at follow up in both 
groups. Conclusion: From the preliminary results of this study open irrigated tip ablation 
catheter technology is as efﬁcient as ICE guided RF energy delivery in patients presenting 
for PVI. Nevertheless, open irrigation ablation technology seems to be superior in terms of 
rapid achievement of isolation, ﬂuoroscopy exposure and procedure time.
 
Group 1 Group 2 P value
Patients 26 27 ns
Age (years) 53±8 54±8 ns
Left atrial size (cm) 4.4±0.8 4.3±0.7 ns
Duration of AF (years) 5.1±3.4 5±3.5 ns
Paroxysmal AF 16 17 ns
Persistent/permanent AF 10 10 ns
Follow-up (months) 6±2 6±4 ns
Fluoroscopy exposure (µGym2) 7560±2 12240±4 0.008
Procedure time (minutes) 164±32 204±47 0.005
Mean duration of RF energy delivery /PV antrum 
(min) 5.1±2.2 9.2±3.2 0.03
AF Recurrence 18 % 21 % ns
 
992-140 First Experience With Cryoballoon Technique and 
Long-Term Success of Pulmonary Vein Isolation With 
Cryotechnique Only
Juergen Vogt, Anja Dorszewski, Johannes Heintze, Lam Luong Thanh, Helga Buschler, 
Peter Schwartze, Dieter Horstkotte, Heart Center North Rhine-Westphalia, Ruhr 
University Bochum, Bad Oeynhausen, Germany
Background: Segmental isolation of pulmonary veins (PV) with radiofrequency ablation 
is associated with reconduction in 90% and risk of PV stenosis. A new risk of esophago-
left atrial ﬁstulas with RF technique for PV encircling and linear lesions has been reported 
worldwide. This study reports on the efﬁcacy of circumferential PV isolation using 
cryotechnique only and ﬁrst results with a new cryoballoon.
Methods: The PV isolation was performed with the max. 30-mm self-expanding Arctic 
Circler (AC) over 4 minutes (min) of 3-4 cryoimpulses (CI) down to - 85°C with N2O. Gaps 
were closed using a 6-/8-mm tip cryocatheter (Freezor xtra / -max). The last patients (P) 
were treated with a new steerable over the wire cryoballoon with 28 mm diameter.
Results: 68 P (22 female, mean age 61±9 years, 62 with paroxysmal, 6 with persistent 
AF, left atrium 43±5 mm, 37 with lone AF, 21 with hypertension, 10 with structural heart 
disease) were treated with the AC. 8% of 263 PV were segmentally isolated. 92 PV (35%) 
were isolated with the AC only, 56% (148 PV) with additional gap closing. In 21 redos, we 
observed 27% of 82 PV isolated and 73% with reconducting sleeves. All reconducting veins 
were reisolated. During a mean follow-up of 16±9 months (mo) and 1.4 procedures per 
P, 28 of 52 P (52%) had no recurrent AF, 28% a signiﬁcant reduction of AF burden. 20% 
remained unchanged. The clincial efﬁcacy was 80%, excluding persistent AF 88%! Due to 
simultaneous isolation with two AC in 31 P, the procedure time was reduced to 198±44 min 
(p<0.01) and the X-ray burden to 43±11 min (p=0.021). In 5 P with large PV (22±4 mm), 
70% of these veins including parts of the antrum could be isolated with the new balloon 
during 3 freezes over 4 to 8 min per vein. Only in P with thick muscle layers at the antrum 
due to hypertensive heart disease, additional segmental freezing was necessary.
Conclusions: The new cryotechnique to eliminate the pulmonary vein triggers only is 
highly effective during long-term course in paroxysmal AF. Recurrence of AF develops 
mainly because of reconducting veins. The risk of PV stenoses is deﬁnitiely eliminated. 
The new cryoballoon is encouraging in primarily isolating the most veins without additional 
mapping and ablation catheters.
992-141 Persistence of Iatrogenic Atrial Septal Defect after 
Pulmonary Vein Isolation with Transseptal Puncture - 
an Underestimated Risk?
Christoph Hammerstingl, Kyung-Mi Jeong, Clemens Troatz, Klaus Tiemann, Berndt 
Luederitz, Lars Lickfett, University of Bonn, Bonn, Germany, St. Marien Hospital Bonn, 
Bonn, Germany
Objective: We sought to determine the risk of persistent iatrogenic atrial septal defect 
(iASD) after pulmonary vein isolation (PVI) with transseptal puncture.
Background: The number of PVI in patients (pts) with paroxysmal atrial ﬁbrillation is 
increasing. Until now, there are inconsistent data in what percentage of pts iASD with 
interatrial shunting persists after long-term follow up (FU).
Methods: 36 pts with AF underwent PVI, thereof 27 pts with single respectively 9 pts 
with double transseptal puncture. Serial transesophageal echocardiography (TEE) was 
performed before the intervention and thereafter at long-term FU (FU-time 266.7 ± 37.9 
days). Interatrial shunt was characterized by echocardiographic parameters; right-to-left-
shunting (RLS) was quantiﬁed by contrast echocardiography.
Results: In 8 of 27 pts with single transseptal puncture iASD occurred after PVI, thereof 
6 pts with distinct RLS. We saw no iASD in 9 pts after double transseptal puncture during 
follow up, this difference was statistical signiﬁcant (p= 0,046; CI 0.89 to 0.014). In pts with 
RLS and iASD preprocedural pulmonary artery pressure (PAP) was signiﬁcant higher 
compared to pts with iASD and no RLS (23.75±0.50 vs 17.59±5.82 ; p=0.0483, CI 0.048 
to 12.27).
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Conclusion: Persistence of iatrogenic atrial septal defect with right-to-left-shunting 
after pulmonary vein isolation with single transseptal puncture is a common ﬁnding. 
The results of this study suggest that double transseptal puncture is less traumatic then 
single puncture with double access. Increasing PAP seems to be a risk-factor for the 
development of iASD with RLS. Adverse effects of interatrial shunting should be subject 
of further investigation.
992-142 Early Experience Of Pulmonary Vein Antral Isolation 
Using an Open Irrigation Ablation Catheter for the 
Treatment of Atrial Fibrillation: Immediate Short Term 
Results of a Randomized Study
Mohamed H. Kanj, Oussama M. Wazni, Mauricio Arruda, Dhanunjaya Lakkireddy, Sergio 
Thal, Walid Saliba, Robert Schweikert, David Burkhardt, David O. Martin, Gemma 
Pelargonio, Antonio Dello Russo, Pietro Santarelli, Domenico Potenza, Raffaele Fanelli, 
Raimondo Massaro, Giovanni Forleo, Andrea Natale, Cleveland Clinic Foundation, 
Cleveland, OH, Casa Sollievo Della Sofferenza, San Giovanni, Rotondo, Italy
Background: An open irrigation catheter allows radiofrequency current delivery at a higher 
power while maintaining the tip electrode-tissue interface at lower temperatures resulting 
in larger RF lesions and importantly avoiding coagulum formation. We investigated the 
efﬁcacy and safety of irrigated-tip catheters in a consecutive series of patients with atrial 
ﬁbrillation presenting for pulmonary vein antrum isolation (PVI).We hypothesized that this 
approach is safe and may shorten the left atrial instrumentation and ﬂuoroscopy times.
Methods: Patients were randomized to either Celsius™ (8mm Tip) or Celsius™ 
ThermoCool® diagnostic/ablation deﬂectable tip catheters (Biosense Webster, Diamond 
Bar, CA). The procedure endpoint was isolation of all the pulmonary vein antra. A circular 
Lasso shaped catheter was used for mapping. Study endpoints were: 1) procedural 
success, 2) cardiac or thromboembolic complication, and 3) ﬂuoroscopy time and left 
atrial instrumentation time. The latter was deﬁned as the total clock time where catheters 
are present in the left atrium.
Results: A total of 62 patients were randomized to this study (32 using Celsius™ 
ThermoCool® catheter and 30 using Celsius™ 8mm tip catheter). Pulmonary vein 
antral isolation was achieved in all of the patients at the end of the procedure. The mean 
ﬂuoroscopy time needed for PVI was signiﬁcantly lower in the Celsius™ ThermoCool® 
compared to the Celsius™ catheter (26 +/- 2 minutes vs 39+/- 2 minutes, p< 0.01). 
Additionally, the mean left atrial instrumentation time was signiﬁcantly lower in the 
Celsius™ ThermoCool® compared to the Celsius™ catheter (60+/- 3 minutes vs 86 +/- 6 
minutes, p<0.01) time. There were no cases of cardiac perforation, esophageal injury or 
thromboembolic complications in either group.
Conclusion: Open-irrigation catheters can safely be used for PVI procedures. It minimizes 
radiation exposure and LA instrumentation time. Avoidance of impedance rise (commonly 
associate with coagulum formation) is possible without compromising power delivery. This 
may result in more effective lesions thus improving long term success rates.
ORAL CONTRIBUTIONS
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838-3 Circumferential Pulmonary Vein Ablation. Early 
Experience on Remote Magnetic Navigation Versus 
Standard Technique
Carlo Pappone, Gabriele Vicedomini, Nicoleta Sora, Simone Sala, Maria Avitabile, 
Enrico Frigoli, Cristiano Ciaccio, Laura Livolsi, Giuseppe Augello, Stefania Sacchi, 
Alessandra Marzi, Vincenzo Santinelli, San Raffaele University Hospital, milan, Italy
Background: Continuous stability of ablation catheters may be obtained by the 
combination of the external magnetic ﬁeld and ﬂexibility of magnetic soft catheters.
Methods: We evaluated the safety and feasibility of remote catheter guidance using the 
NIOBE II system (Stereotaxis, Inc) in 40 patients undergoing circumferential pulmonary 
vein ablation (CPVA) for symptomatic atrial ﬁbrillation (AF). Ablation was performed with 
a 4-mm tip, magnetic catheter (65°C, maximum 50 W, 15 seconds). The catheter tip 
was guided by a uniform magnetic ﬁeld (0.08 T), and a motor drive (Cardiodrive unit, 
Stereotaxis, Inc) advanced or retracted the catheter to the predeﬁned targets. The left 
atrium map was created using an integrated CARTO-RMT system. End point of ablation 
was voltage abatement > 90% of bipolar electrogram amplitude.
Results: Remote navigation was successful in 38/40 patients without complications. The 
overall median mapping and ablation time was 152.5 minutes (Min-Max, 90-380 minutes) 
but was much longer in the ﬁrst 12 patients (192.5 minutes versus 148 minutes; P=0.012). 
Median ablation time was 49.5 minutes (Min-Max, 17-154) but it was much shorter in the 
last 28 patients than in the ﬁrst 12 patients (49 minutes versus 70 minutes; P=0.021). 
Compared with controls, remote ablation had longer procedure times (p<0.001) with 
similar mapping time but shorter ablation time on right-sided PVs. Much more mapping 
points regardless of their location were collected remotely (p<0.001).
Conclusions: Remote magnetic navigation for AF ablation is safe and feasible with a short 
learning curve suggesting that AF ablation can be performed even by less experienced 
operators, reducing in all cases ﬂuoroscopic exposure time for the operator.
9:15 a.m.
838-4 Catheter Ablation of Atrial Fibrillation or Left Atrial 
Flutter Under Uninterrupted Oral Anticoagulation
Sergio L. Pinski, Marcelo E. Helguera, Cleveland Clinic Florida, Weston, FL
Background: Embolic events are a complication of catheter ablation for atrial ﬁbrillation (AF) 
or left atrial ﬂutter (Aﬂ). The standard of practice consists of interrupting oral anticoagulation 
several days in advance of the procedure and to use heparin or enoxaparin as a bridge. It was 
our hypothesis that catheter ablation without interruption of warfarin is feasible and safe.
Methods: For the last 18 months, we routinely performed catheter ablation of AF or left Aﬂ 
without interrupting oral anticoagulation. Depending on the baseline INR, warfarin was held 
for one night or not at all, aiming at an INR between 2 and 3 the day of the procedure. A 
TEE was obtained within 24 hours of the procedure. All venous access was femoral, and 
included an 11F introducer for intracardiac echocardiography (ICE) probe. We monitored 
intraarterial blood pressure via a radial line. Transeptal puncture was performed under ICE 
guidance. For AF, we performed left atrial circumferential ablation or left pulmonary vein 
antral isolation, often combined with cavotricuspid isthmus ablation. Intravenous heparin 
was given during left atrium instrumentation to maintain the ACT between 250 and 300 
seconds. Enoxaparin was given if needed after the procedure until the INR was ≥ 2.
Results: We analyzed 63 ablation procedures (60 AF, 3 left AFl) in 55 pts (47 males, age 57 
± 9) The INR the day of the procedure was 2.3 ± 0.5 (range 1.4 to 3.6). Three procedures 
had to be rescheduled due to an unexpected INR ≥ 4. The INR had inadvertently dropped 
below 1.8 in 8 pts. ICE monitoring did not disclose formation of thrombus in the left atrial 
catheters or sheaths in any case. The INR the morning after was 2.4 ± 0.6 (range 1.2 to 
3.8). More than 1 dose of enoxaparin was required after 9 cases (14 %) . One pt (1.5 %) 
developed a large thigh hematoma that required transfusion. There were no thrombotic or 
embolic events, cardiac perforation or tamponade. The median hospital stay was 1 day.
Conclusion: Catheter ablation of AF under uninterrupted oral anticoagulation appears 
safe. It prevents lapses in anticoagulation while minimizing the need for postprocedural 
enoxaparin. A randomized comparison of this strategy against the standard of practice 
appears desirable.
9:30 a.m.
838-5 Intraoperative Cooled-tip Radiofrequency Linear Atrial 
Ablation to Treat Permanent Atrial Fibrillation
Thomas Deneke, Krishna Khargi, Peter H. Grewe, Thomas Lawo, Andreas Mügge, Axel 
Laczkovics, Bernd Lemke, Medical Clinic II , BG Kliniken Bergmannsheil, University 
Hospital Bochum, Bochum, Germany, Clinic for Cardio-Thoracic Surgery, BG Kliniken 
Bergmannsheil, Univ, Bochum, Germany
Atrial ﬁbrillation (AF) surgery has become more engaged in every-day practise of speciﬁed 
cardio-surgical centres. The cut-and-sew technique still remains the gold standard with 
superior efﬁcacy. Is an intraoperative approach using cooled-tip radiofrequency energy to 
induce linear atrial lesions (SICTRA) safe and effective in treating AF?
Methods: 180 patients (mean EUROSCORE 6.2, AF duration 7years) presenting 
with permanent AF (>1 year, 1 failed cardioversion) and the need for cardiac surgery 
were consecutively included. In addition to the cardio-surgical procedure SICTRA was 
performed. In 80 patients the ablation pattern was restricted to the left atrium alone. 
Follow-up constituted of ECG, holter-ECG and Doppler echocardiography.
Results: Concomitant cardio-surgical procedures were mitral valve surgery in 74, aortic 
valve replacement in 23, bypass surgery in 67 including 24 patients with additional 
mitral valve surgery and combined procedures in 16. During follow-up 141 patients 
(78%) converted to sinusrhythm (SR). At discharge (0.5months post operatively) 31% of 
patients, at 3 months 65%, at 6 months 78% and after 12 months 79% of patients were 
in SR. Biatrial contraction was documented in 82% of patients in SR at 6 month follow-up. 
In patients with a left atrial procedure conversion rates were not signiﬁcantly different 
compared to a biatrial approach (80% versus 78%, p=0.47). The type of cardio-surgical 
procedure did not inﬂuence 12-month conversion.
30-day-mortality was found to be 5% (9/180) mainly due to cardiac insufﬁciency (78%) 
and histopathology revealed 24% of all lesions to be histologically non-transmural. 4% 
of patients developed sustained regular atrial arrhythmia (2.8% right atrial arrhythmia) 
needing invasive therapy (catheter ablation long-term success 75%).
Conclusions: SICTRA is safe and produced stable SR in 80% of patients undergoing 
open heart surgery with permanent AF. A biatrial contraction can be restored in 80% of 
these patients. Rhythm conversion is not inﬂuenced by treatment of the right atrium or the 
performed cardio-surgical procedure. Sustained regular atrial arrhythmia with the need for 
invasive treatment strategies occur in 4%.
9:45 a.m.
838-6 Autonomic Heart Plexus Localization With Epicardial 
and Endocardial Cardioneurostimulation
Cristiano F. Pisani, Barbara D. Oliveira, Sissy Lara, Fernando A. Vidal, Francisco 
Darrieux, Ivani C. Trombetta, Denise Hachul, Carlos Eduardo Negrão, Maurício 
Scanavacca, Eduardo Sosa, Heart Institute - InCor, São Paulo, Brazil
Background: Autonomic nervous system modiﬁes eletrophysiologic properties of both 
atria, predisposing the appearance of atrial ﬁbrillation (AF). Autonomic heart innervations 
are composed of parasympathetic ganglia and sympathetic post-ganglionar ﬁbers over 
epicardial surface.
Objective: Evaluate if parasympathetic ganglia can be identiﬁed by direct eletrophysiologic 
stimulation over epicardium and endocardium, owing to radiofrequency catheter ablation 
of this structure.
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Methods: Ten patients with isolated paroxysmal AF with history suggesting vagal mechanism 
of origin were selected. Nine were male with 42.5±10.6 years old. Cardioneurostimulation 
was performed (20Hz, 100V, 4ms, 3 sec, Grass 70 stimulator) on pulmonary veins (PV) 
antrum and left atrium posterior wall (LAPW) on epicardial and endocardial surface that 
could elicit an important vagal response (pause of more than 1.5 seconds). Subxyphoid 
puncture was performed to access epicardium space. Five ﬁxed points of stimulation 
(RSPV, LSPV, RIPV, LIPV and LAPW) were selected during the procedure.
Results: No vagal response was observed in 3 patients. Epicardial response was 
observed at LSPV in 4 patients, at RSPV in 5 and at LIPV, RIPV and LAPW in 6, 5 and 
5 patients respectively. Endocardial stimulation response was observed in 2 patients at 
LSPV, RSPV, RIPV and LAWP and at LIPV vagal response was observed in 4 patients. 
Vagal response was observed in 23 of 50 points in epicardial surface and 12 of 50 points 
(p=0.021) in endocardial surface.
Conclusion: Parasympathetic ganglia mapping is possible to be done with cardioneurostimulation. 
Area of response is wider at epicardial surface stimulation.
10:00 a.m.
838-7 Clinical Signiﬁcance of Early Recurrences of Atrial 
Fibrillation or Atrial Flutter After Pulmonary Vein 
Antrum and Superior Vena Cava Isolations
Sakis Themistoclakis, Robert A. Schweikert, Walid I. Saliba, Jennifer E. Cummings, 
Aldo Bonso, Antonio Rossillo, Oussama Wazni, William A. Belden, Michelle Williams-
Andrews, Dhanumjaya Lakkireddy, Antonio Raviele, Andrea Natale, Umberto I Hospital, 
Mestre-Venice, Italy, Cleveland Clinic Foundation, Cleveland, OH
Purpose: this multicenter study evaluate the long-term outcome of a large population of 
patients (Pt) with early recurrences of atrial ﬁbrillation (ERAF) or atrial ﬂutter (ERAFL) 
after pulmonary vein antrum and superior vena cava isolations (PVAI).
Methods: ERAF and ERAFL that occur within 3 months after PVAI were observed in 
489 of 1495 (33%) consecutive pts (male 386, mean age 57±11 years) with symptomatic 
drug refractory paroxysmal-persistent (58%) and permanent (42%) atrial ﬁbrillations (AF). 
ERAF and ERAFL were observed in 444 (30%) and 45 (3%) pts respectively. The mean 
duration of AF was 89±77 months, structural heart disease were present in 105 pt (46%) 
(mean left ventricular ejection fraction 55±9%, mean left atrium diameter 45±6 mm). The 
PVAI was guided by intracardiac echocardiography and the end point of the procedure 
was deﬁned as the abolition of all PV potentials on the circular mapping catheter at the 
antrum of all PVs. All pts were followed with history, ecg and Holter recordings at 1, 3, 
6 and than every 6 month follow up (FU). An event recorder was given to 1364 pts for 
the ﬁrst two months after PVAI and repeated at the third month and forth month FU. In 
case of symptom recurrences ECG and Holter recordings were also performed. Complete 
success was deﬁned as the persistence of sinus rhythm in the FU without antiarrhythmic 
drugs (AAD). Only single procedures were considered.
Results: the end point of the procedure was achieved in all pts. After a mean follow up of 
22±9,8 months sinus rhythm was maintained in 222 (50%) pts with ERAF and 22 (49%) 
pts with ERAFL without AAD.
Conclusions: approximately half of pts with ERAF and ERAFL have no further arrhythmic 
recurrences in a long term follow up. Therefore early repeat ablation should not be 
considered in pts with early recurrence of AF or AFL.
10:15 a.m.
838-8 Three-Dimensional Electroanatomical Image Integration 
Versus Phased Array Intracardiac Echocardiography 
for Left Atrial Mapping Procedure: Operator Blinded 
Accuracy Study
Jens Guenther, Georg Noelke, Klaus Gutleben, Johannes Brachmann, Nassir F. 
Marrouche, Klinikum Coburg, Coburg, Germany
We performed a prospective study to assess the mapping accuracy of the 3D image 
integration mapping system (CARTOMERGE (CM)) when compared to intracardiac 
echocardiography (ICE) as a real-time imaging modality.
In 14 patients (9 men, mean age 57±9 years) presenting for pulmonary vein isolation 
(PVI) for treatment of atrial ﬁbrillation (AF) the CM system was utilized, and registration of 
the left atrial CT-scan image with the electroanatomical map was performed without ICE 
guidance. The operator was asked to position the mapping catheter at 5 left atrial pre-
deﬁned sites after the CM map (CMM) was completed: right upper PV ostium (RUPO), 
right lower PV ostium (RLPO), left upper PV ostium (LUPO), left lower PV ostium (LLPO), 
and left atrial appendage (LAA)- left PVs carina (LC). The operator, blinded to the CMM, 
ﬁrst targeted the 5 sites under ICE guidance. The corresponding CMM points were 
tagged (TS) and the difference between the PS and TS (∆ cm) was measured. Then, the 
operator was asked to target the 5 sites using the CMM (TS2), blinded to ICE, and the 
corresponding ICE points (PS2) were marked on CMM. The difference between PS2 and 
TS2 (∆2 cm) was measured. Results of ∆ and ∆2 are listed in table 1. Conclusion: From 
the preliminary results of this study integration of 3D CT images with electroanatomical 
mapping to guide left atrial mapping seems to be lacking accuracy when compared with 
ICE. Integrating a real-time imaging modality to the image integration process might 
improve the mapping accuracy of this system. 
∆ ∆2
RUPV 0.5±0.2 cm 0.5±0.2 cm
RLPV 0.5±0.4 cm 0.4±0.3 cm
LUPV 0.6±0.3 cm 0.5±0.3 cm
LLPV 0.4±0.4 cm 0.6±0.3 cm
Carina-LAA/LPV 0.9±0.5 cm 0.9±0.6 cm
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1015-123 Cardiac Resynchronization Therapy (CRT) In Patients 
With Left Ventricular Dysfunction and Narrow QRS 
Complex: Sequential Echocardiographic Dyssynchrony 
Analysis and Correlation with Improvements in Heart 
Failure Symptoms
Bischan Hassunizadeh, Denise Cunningham, Christian Machado, Providence Hospital 
and Medical Center, Southﬁeld, MI
Background: Current guidelines recommend CRT for patients with left ventricular EF < 
35 %, refractory, severe heart failure despite optimal medical therapy, and QRS duration 
> 120 ms. Mechanical dyssynchrony has shown to be a better predictor of response to 
CRT than QRS prolongation on the electrocardiogram.
Methods: CRT was performed in 14 patients with severe LV dysfunction (EF < 35%) 
and normal QRS duration < 120 ms. Echocardiographic dyssynchrony analysis was 
performed before CRT and after a mean of 217 ± 24 days including right ventricular 
electromechanical delay (EMD) and LV EMD as assessed by Pulsed Wave Doppler to 
calculate interventricular dyssynchrony (IVD, difference between right and left ventricular 
EMD) and septal wall EMD, lateral wall EMD, anterior wall EMD and inferior wall EMD 
assessed by Tissue Doppler Imaging to determine intraventricular dyssynchrony (maximal 
difference of EMDs of the four myocardial walls). Additionally, Minnesota Living with Heart 
Failure Questionnaire Score (MHFQ-S) and LV EF were assessed at both time points.
Results: Mean age of patients was 57 ± 11 years. Mean QRS duration was signiﬁcantly 
longer at follow-up compared to before CRT (150 ± 26 ms vs. 102 ± 16 ms, p<0.005). 
IVD was signiﬁcantly shorter at follow-up compared to before CRT (40 ± 29 ms vs. 20 
± 11 ms, p=0.04). Signiﬁcant reduction in MHFQ-S (43 ± 24 points vs. 64 ± 27 points, 
p=0.003) was noted at follow-up and also improvement in LV EF compared to before CRT 
(26 ± 12 vs. 18 ± 8,p=0.01). Additionally, the reduction in IVD signiﬁcantly correlated with 
improvements in MHFQ-S by Pearson correlation (p=0.008). Intraventricular delay times 
were similar before CRT and at follow-up (93 ± 76 ms vs. 69 ± 25 ms, p=0.346).
Conclusions: 1)Patients with reduced LV EF (< 35%) and narrow QRS show signiﬁcant 
clinical improvement (MHFQ-S and LV EF) after CRT. 2) IVD but not intraventricular delay 
time is signiﬁcantly decreased after CRT in this patient cohort. 3) The improvements 
in IVD correlate signiﬁcantly with reduction of MHFQ-S. Parameters of interventricular 
dyssynchrony may be better predictors of response to CRT than parameters of 
intraventricular dyssychrony in patients with LV dysfunction and narrow QRS complex.
1015-124 An Evaluation of Optimal AV Delays During Exercise 
in Heart Failure Patients Receiving Cardiac 
Resynchronization Therapy
Jing Ping Sun, Edward Chinchoy, George Perlic, Deborah Agler, Zouying Hu, James 
D. Thomas, Bruce L. Wilkoff, Richard A. Grimm, The Cleveland Clinic Foundation, 
Cleveland, OH
Background: Cardiac Resynchronization Therapy (CRT) procedures are currently 
performed with patients (pts) at rest. Because of improved exercise tolerance following 
CRT, the suitability of optimized atrio-ventricular (AV) delay at rest for an active lifestyle 
remains largely unknown. We hypothesized that exercise-induced increase in heart 
rate (HR)would necessitate different AV delay than that at rest, to maintain optimal 
left ventricular (LV) ﬁlling. Methods: Heart failure pts with CRT who were capable of 
exercising were studied. Various parameters including end-diastolic and systolic volumes, 
ejection fraction (EF), pulsed and color Doppler were recorded at rest and during exercise 
in supine position.. After recording baseline Echo, pts were then exercised to target HR 
of 20 and 40 beats/minute above their intrinsic rates, and the AV interval optimization 
procedures repeated at each of the elevated HR. Results: Fifteen pts (6 male, 9 female, 
57±16 years; 12 NYHA II, 3 NYHA III; mean QRS of 151±20 msec) with an average LV EF 
of 37±15 % (pacing off) and 43±14 % (pacing on) were studied. The correlation between 
optimal AV delay and heart rate was shown in ﬁgure.
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Conclusion: This study indicated that CRT pts required a shorter AV delay that is 
proportionate to HR during exercise, to maintain an optimal LV ﬁlling duration. Further 
analysis and understanding of the relationship between LV ﬁlling and increased HR 
during CRT would allow rate related algorhythms to be implemented in these devices 
more routinely.
1015-125 Comparison of Reverse Ventricular Remodeling 
Between Surgical Direct Epicardial and Tranvenous 
Coronary Sinus Lead Placement for Cardiac 
Resynchronization Therapy
Sandeep Joshi, Joseph J. DeRose, Jr., Devi S. Gopinath, Ajay Shah, Jonathan S. 
Steinberg, St. Luke’s-Roosevelt Hospital Center, New York, NY
Introduction: Cardiac resynchronization therapy (CRT) has been shown to promote 
reverse ventricular remodeling in patients with heart failure, however inconsistent venous 
anatomy has limited this. Robotic surgical CRT implants the lead on the left ventricle 
(LV) epicardial surface with no limitations on lead positioning. A comparison of reverse 
remodeling between surgical and transvenous CRT hasn’t been studied.
Methods: A retrospective case-control comparison was performed with patients matched 
for age, gender, medications, heart failure etiology, New York Heart Association Class 
(NYHA) and LV ejection fraction. 16 patients underwent robotically-assisted epicardial 
LV lead implantation and 16 underwent transvenous CRT. Reverse remodeling was 
assessed at a follow-up echocardiogram 6-12 months post-implant.
Results: The 32 patients (68 + 8 yrs, 22 males, 50% ischemic cardiomyopathy, LV ejection 
fraction 0.22 + 9, NYHA 3.3 + 0.5) were well matched in all variables between groups. 
Following a mean 9 + 2 months, the surgical group demonstrated signiﬁcant reductions in 
LV internal dimension index, systolic (LVIDI(s)[-9%, P=0.04] and diastolic(d)[-7%, P=0.04] 
vs. lesser nonsigniﬁcant changes (LVIDI(s)-5% P=NS, LVIDI(d)-3% P=NS) (see ﬁgure) in 
tranvenous CRT.
Conclusions: Robotic surgical CRT was more effective in promoting reverse remodeling 
than transvenous CRT. Given these results, direct epicardial surgical lead placement 
warrants further analysis as the initial approach for CRT.
 
1015-126 Biventricular Pacing Reduces Incidence of Microvolt T 
Wave Alternans in Patients With Congestive Heart Failure
Safwat A. Gassis, Fernando Mera, David B. DeLurgio, Paul F. Walter, Jonathan J. 
Langberg, Angel R. Leon, Carlyle Fraser Heart Center, Emory University, Atlanta, GA
Background: Microvolt T-Wave alternans (MTWA) is a useful non-invasive tool to 
asses risk for malignant ventricular arrhythmias. Cardiac resynchronization (CRT) with 
biventricular pacing (BiV) has been shown to improve hemodynamics and may reduce 
the risk of sudden cardiac death. The purpose of the current study was to determine the 
effect of CRT on MTWA.
Methods: Twenty two patients underwent implantation of a CRT device (9 ischemic, mean 
ejection fraction 18 +/- 7%). MTWA was measured during atrial pacing, DDD pacing with 
only right ventricular (RV) activation, and during DDD pacing with biventricular pacing in 
an integrated bipolar conﬁguration.
Results: MTWA during atrial pacing was positive in 55%, negative in 27% and 
indeterminate in 18% of patients. MTWA results were dichotomized into negative and 
non-negative categories. BiV pacing increased the incidence of negative MTWA from 
27% with atrial pacing to 64%. Overall MTWA concordance between atrial and BiV pacing 
was 55% whereas concordance between atrial and RV pacing was 73%. Concordance of 
atrial or RV pacing with BiV pacing was 44% for positive or indeterminate tests compared 
to 83% for negative MTWA tests.
Conclusion: MTWA measurement during BiV pacing is feasible and reduces the 
proportion of positive or indeterminate results whereas atrial and RV pacing is more 
likely to lead to non-negative results. Whether the shift to a negative MTWA test during 
BiV pacing truly represents a decrease in risk for ventricular arrhythmia remains to be 
determined.
1015-127 Attenuation of Cardiac Remodeling After Recent 
Myocardial Infarction Through Biventricular Pacing
Eugene S. Chung, Santosh Menon, Raul Weiss, Edward Schloss, Theodore Chow, 
Dean Kereiakes, Joseph Pastore, Christ Hospital, Cincinnati, OH, Riverside Hospital, 
Columbus, OH
Background: Dilation of the left ventricle (LV) after a myocardial infarction (MI) is 
associated with poor clinical outcomes. Furthermore, treatments that attenuate LV 
remodeling typically improve outcomes. One possible mechanism for LV remodeling after 
MI is increased LV stress resulting from an area of delayed activation. We present the 
results of a randomized feasibility study to test the hypothesis that chronic biventricular 
pacing with leads placed near the MI location can attenuate LV remodeling.
Methods: 16 patients with recent (within 30-45 days) MI, LV ejection fraction (EF) < 
30%, narrow QRS (<120 ms), and heart failure were enrolled in the Ohio Pacing post-
Infarction Study (OPIS) and randomized to receive an implantable deﬁbrillator (ICD) or 
atrially-synchronized biventricular pacing with deﬁbrillator (BIV) between day 30-60 post 
MI. Clinical evaluation, laboratory studies, and echocardiogram (ECHO) were obtained at 
enrollment, 6 months, and 12 months. ECHO’s were analyzed for LV volumes.
Results: 8 patients in the BIV arm (V-paced>95%) were compared with 7 patients in 
the ICD (0 % V-pacing) arm. At 12 months, all patients in both groups were alive and 
none had received shock therapy for ventricular arrhythmia. There were no unanticipated 
adverse events in either group.
At baseline, the two groups were similar with regard to major demographics (age, sex, 
medication use), cardiac structure (LV volumes, EF, sphericity index) and clinical status 
(NYHA, quality of life, 6 minute walk). At 1, 6, and 12 months, there were no signiﬁcant 
differences in NYHA, QOL, 6 minute walk between two groups. Sphericity index rose from 
0.38 at baseline to 0.53 at 12 months in the ICD group but remained stable in the BIV 
group (0.45 at baseline and at 12 months). At 12 months, LV end-diastolic volume and LV 
end systolic volume increased in the ICD group (24±21% and 20±24%, respectively), but 
remained largely unchanged in the BIV group (1±17% and -6±18%, respectively). LVEF 
was not different between the two groups.
Conclusions: Chronic application of BIV pacing appears to be feasible in patients with 
recent MI . Trends in these pilot data suggest that BIV pacing may attenuate post-MI 
remodeling.
1015-128 Effects of Differents Pacing Modes on Right Ventricular 
Function in Cardiac Resynchronization Patients
Erwan Donal, Sr., Noelle Vignat, Sr., Christian de Place, Sr., Christophe Crocq, Sr., 
Philippe Mabo, Sr., Claude Daubert, Sr., Christophe Leclercq, Sr., University Hospital, 
Rennes, France
Cardiac resynchronization therapy (CRT) is a recognized treatment in advanced heart 
failure patients (pts) with left ventricular (LV) dysfunction and wide QRS. The impact of 
CRT in right ventricular (RV) function, remains non established. The aim of the study was 
to evaluate the acute effects of differents pacing modes in CRT pts on RV function.
Methods : 15 pts (age 67 years) implanted with a CRT device underwent an 
echocardiographic evaluation 6 months after device implantation in sinus rhythm (SR), 
RV,LV, and biventricular (BiV) pacing modes (in random order) to assess RV systolic and 
diastolic functional parameters (tricuspid annulus peak velocity (Sa); tricuspid annulus 
plan systolic excursion (TASPE), right myocardial performance index (MPI), pulmonary 
output and tricuspid ﬂow).
Results : The median LV ejection fraction was 20% with a median LV end-diastolic 
diameter of 78mm. RV function was impaired as with a fractional shortening of RV 
surfaces of 36%.
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With BiV, Sa was signiﬁcantly improved as compared to SR, RV and LV pacing modes 
(table 1). There was a trend to an improvement in TASPE and right MPI with biventricular 
pacing as compared to the other modes (Table 1). No signiﬁcant difference was observed 
between the different pacing modes for pulmonary arterial pressures, indices of right 
diastolic parameters and pulmonary output.
Conclusion : This acute study showed that right systolic function was signiﬁcantly improved 
with biventricular pacing as compared to SR, RV or LV pacing modes in CRTpts.
Results (* = p<0.01)
AAI RV LV BiV
Tricuspid Sa (cm/s) 9.9 10 11.7 12.6*
TASPE (cm/s) 17.2 17.6 18 18.6
IMP 0.49 0.44 0.56 0.38
Pulmonary output (l.min) 4.1 4.2 4.2 4.6
1015-129 Impact of Pulmonary Hypertension on Left Ventricular 
Reverse Remodeling and Long-term Outcome in 
Patients with Cardiac Resynchronization Therapy
Joshua D. Stern, Lorne Murray, Jeffrey Chung, Michael H. Picard, Marc J. Semigran, 
Jeremy N. Ruskin, Jagmeet P. Singh, Massachusetts General Hospital, Boston, MA
Background: Many patients with heart failure remain non-responsive to Cardiac 
resynchronization therapy (CRT). There is a paucity of information on the impact of 
baseline pulmonary hypertension (PH) on clinical outcome and on left ventricular reverse 
remodeling (LV-RR) after CRT.
Methods: 59 subjects with standard indications for CRT were followed for a 12-month 
period. Subjects were stratiﬁed into 2 groups based on the echocardiographic estimation 
of right ventricular systolic pressure (RVSP) i.e. RVSP>50 mm Hg (n=24) and RVSP 
< 50 mm Hg (n=35). Long-term response was measured as a combined endpoint of 
heart failure hospitalizations and all cause mortality at 12 months (see Figure). Follow up 
echocardiograms to assess for LV-RR were available in 41 subjects (mean duration 6.7 
months). LV-RR was deﬁned as any improvement in global systolic function and reduction 
in left ventricular internal diameter.
Results: The study population was comprised of 15 women and 44 men; (age, mean + 
SD; 70+11 years), with a decreased left ventricular ejection fraction (24+ 8 %) and a wide 
QRS (174+57 ms). There were no signiﬁcant differences in the clinical features between 
the high and low RVSP group. Baseline RVSP was not predictive of LV-RR (p=0.32). 
Subjects with RVSP> 50, had a signiﬁcantly worse outcome (Hazard ratio ( 95% CI), 2.9 
(1.2-7.7), p=0.02).
Conclusion: In patients receiving CRT, although PH (RVSP> 50 mm Hg) does not 
signiﬁcantly impact LV reverse remodeling, it is associated with an adverse long-term 
outcome.
1015-130 Blacks Are Less Susceptible to Atrial Fibrillation 
Despite an Adverse Risk Proﬁle: A Meta-Analysis
Gian M. Novaro, Craig R. Asher, Sergio L. Pinski, Deepak L. Bhatt, Cleveland Clinic 
Florida, Weston, FL, Cleveland Clinic Foundation, Cleveland, OH
Background: Development of atrial ﬁbrillation (AF) in cardiac patients (pts) is 
multifactorial, including not well deﬁned genetic factors. We sought to determine if race 
was associated with the development of AF in pts with coronary disease.
Methods: We conducted a meta-analysis of 7 prospective randomized clinical trials 
coordinated by the Cleveland Clinic Clinical Coordinating Center that prospectively 
collected data on the development of AF: 4 trials in patients with acute myocardial 
infarction (GUSTO I, IIb, III, V), and 3 trials in pts with acute coronary syndromes 
(PURSUIT, IMPACT II, PARAGON A). Follow-up periods ranged from 6-12 months.
Results: A total of 95,787 pts were identiﬁed (93,050 white, 2737 black). At baseline, black 
pts were younger, had greater body mass index, and a greater prevalence of hypertension, 
diabetes, tobacco use, and prior infarction compared to white pts. Development of AF was 
lower in black than in white pts (4.3 % vs. 7.6%; OR 0.52; 95% CI 0.43-0.63; p<0.001), 
while rates of ventricular tachycardia and ﬁbrillation were similar in both groups. There 
was no signiﬁcant heterogeneity in the effect among the individual trials (p=0.46; Breslow-
Day test). In multivariate logistic analysis, white race was associated with signiﬁcantly 
higher rates of AF (OR 1.55; 95% CI 1.39-1.74; p<0.001) compared to black race.
Conclusions: Despite an adverse risk proﬁle, black race appears to be protective against 
the development of AF. Further study is needed to investigate the mechanisms and 
potential genetic underpinning behind this association.
1015-131 Does Hormone Therapy Impact Stroke Risk Among 
Women With Atrial Fibrillation?Results from the 
AFFRIM trial
Suma H. Konety, Mitchell Barnett, Brian Olshansky, University of Iowa Hospitals and 
Clinics, Iowa City, IA
Background: Atrial ﬁbrillation (AF) is a well established risk factor for stroke. It is unclear 
if there is any impact of hormone therapy (HT) on the risk of ischemic stroke among 
women with AF.
Methods: Risk of ischemic stroke was evaluated in 1594 women enrolled in the AFFIRM 
trial, 98% of whom had HT data (estrogen or estrogen+progesterone). An actuarial 
analysis of time to ﬁrst ischemic stroke by HT use was adjusted for age, heart failure, 
diabetes, hypertension, prior stroke, randomization group (rate-control vs. rhythm-control) 
and international normalized ratio (INR) level at last follow-up visit.
Results: Women taking HT (n=350) were younger but otherwise, had similar baseline 
characteristics compared to women not taking HT (n=1213) [Table 1]. The unadjusted 
risk for ischemic stroke was signiﬁcantly lower in women taking HT compared to those 
not taking HT (Hazard Ratio [HR] =0.38; 95% conﬁdence interval [CI]= 0.18, 0.79). The 
interaction between age and HT was not signiﬁcant (p=0.98). After adjusting for potential 
confounding variables and INR levels, the stroke rate in women taking HT remained lower 
compared to women not taking HT (HR=0.45; 95% CI= 0.21, 0.96).
Conclusions: In the AFFIRM Trial, women with AF taking HT were at lower risk for 
ischemic stroke compared to women with AF who were not taking HT even after adjusting 
for age, INR levels and other stroke-risk variables. These data highlight the need to 
consider the impact of HT in similar populations of women with AF.
Baseline Characteristics of Women According to Hormone Therapy
Patient characteristics Women on HT Women not on HT p value
Age, y* 69 + 7 72 + 7 <0.01
BMI* 28 + 6 29 + 7 0.05
Congestive heart failure, % 19 23 0.16
Hypertension, % 73 73 0.99
Diabetes, % 17 20 0.20
Coronary artery disease, % 30 29 0.78
Prior Stroke, % 15 13 0.45
Time to stroke, y* 2.2 + 1.4 2.1 + 1.4 0.84
* = mean + standard deviation; y = years
 
1015-132 Typical Atrial Flutter is Associated with Obstructive 
Sleep Apnea
Dai Yumino, Katsuya Kajimoto, Koichi Takeuchi, Eriko Ushikubo, Tetsuyuki Manaka, 
Koichiro Ejima, Kohei Tanizaki, Atsushi Takagi, Yukio Tsurumi, Morio Shoda, Nobuhisa 
Hagiwara, Tokyo Women’s Medical university, Tokyo, Japan
Background Recently, it is suggested that a strong association exists between arrhythmias 
and obstructive sleep apnea (OSA). Furthermore, OSA inﬂuences right heart morphology 
and function, and then may contribute to arrhythmogenesis. Therefore, we tested the 
hypothesized that the prevalence of typical atrial ﬂutter (AFL), a macro-reentrant rhythm 
in right atrium, is associated with OSA.
Methods and Results:  We prospectively studied consecutive patients who underwent 
the cavotricuspid isthmus ablation for typical AFL (n=52, except for congenital heart 
disease) and consecutive cardiovascular disease patients without past or current AFL 
referred to a general cardiology practice (n=198). Pts with an apnea hypopnea index 
>10/hr by polysomnography was considered as OSA.
The proportion of pts with OSA in the AFL group was signiﬁcantly higher than that of the 
general cardiology group (79% versus 36%, P<0.001). By multivariate analysis, AFL, in 
addition to body mass index, hypertension, and diabetes mellitus remained signiﬁcantly 
associated with OSA, showing largest OR for AFL (OR 9.07, P<0.001; Figure). However, 
there was no signiﬁcant relationship between OSA and atrial ﬁbrillation (OR 0.90, P=0.754).
Conclusions: This study suggests that there is a strong association between OSA and 
the prevalence of AFL arising from the right atrium. Interestingly, we did not ﬁnd signiﬁcant 
relationship between OSA and prevalence of atrial ﬁbrillation in our population.
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1015-133 Do Endurance Exercise-Induced Sinus Node 
Dysfunction and Arrhythmias Persist? A Case-Matched 
Long-Term Follow-Up Study of 62 Former Professional 
Cyclists
Sylvette Baldesberger, Christine H. Attenhofer Jost, Reto Candinas, Burkhardt Seifert, 
Michel Zuber, Manfred Ritter, Erwin Oechslin, Pia Luethi, Christoph Scharf, Urs 
Bauersfeld, HerzGefaessZentrum Zurich, Zurich, Switzerland
Background: Signiﬁcant brady- and tachyarrhythmias may occur in active endurance 
athletes. It is controversial whether these arrhythmias persist after cessation of competitive 
endurance training.
Methods: 62 (46 %) of all 134 former Swiss professional cyclists (PC) participating ≥1x 
in the professional bicycle race Tour de Suisse in 1955-1975 could be recruited for a 
prospective study. The PC were screened with history, clinical exam, ECG, 24 hour ECG 
and echocardiography. The control group consisted of 62 golfers matched for age, gender, 
weight, hypertension and cardiac medication.
Results: Mean time since the last bicycle race as a PC was 38±6 years. Mean age at 
exam was 66±6 years in controls and 66±7 in PC (p=0.77). There was no difference 
in coronary risk factors; only smoking was more prevalent in controls (p<0.0001). The 
percentage of study participants with more than 4 hours sports activity per week was 
identical. Left ventricular ejection fraction was higher in controls (65±8 %) than PC (62±8 
%, p=0.02), left ventricular muscle mass index tended to be higher in PC than controls 
(110± 34g/m2 versus 100±18g/m2, p=0.07).
QRS duration (101 ± 20 versus 95 ± 13 ms, p=0.03) was longer in PC. There was no 
difference in the number of atrial or ventricular premature complexes, or supraventricular 
tachycardias in the 24 hour ECG. Average heart rate was lower in PC with 66 ± 9 versus 
70 ±8 beats per minute (bpm), p=0.01. Minimal heart rate was 49 ± 8 in PC versus 51 
± 6 bpm in controls (p=0.08). Ventricular tachycardias tended to occur more often in PC 
than in controls (13 % versus 3 %, p=0.10). There was no difference in atrioventricular 
blockage (p>0.99).
Signs of sinus node dysfunction (SNC) with bradycardia of <40 bpm/min (10 % versus 
2 %), atrial ﬂutter (5 % versus 0 %), pacemaker for bradyarrhythmias (3 % versus 0 %) 
and/or maximal RR interval of >2.5 sec (6 % versus 0 %) were more common in PC (18 
%) than controls (2 %, p= 0.004).
Conclusions. Among former PC, SND occurs signiﬁcantly more often compared to 
matched controls. There is a trend towards more frequent ventricular tachycardias in 
former PC. Further studies have to evaluate the impact on follow-up and management of 
arrhythmias in former competitive endurance athletes.
1015-134 Do Symptoms Predict Atrial Fibrillation Episodes in 
Patients With Paroxysmal Atrial Fibrillation?
Rick A. Veasey, John Silberbauer, John Vrahimides, Wasing Taggu, Vince Paul, Neil 
Sulke, Eastbourne District General Hospital, Eastbourne, United Kingdom
Background: Using diary cards in conjunction with beat to beat pacemaker Holters, 
correlation between symptoms and atrial ﬁbrillation (AF) episodes and duration is 
possible.
Methods: 87 symptomatic paroxysmal atrial ﬁbrillation (PAF) patients with AF burden of 
1 to 50% were assessed. 46 pts were excluded due to incomplete diary cards or sensing 
aberrancy. Holters and corresponding symptom diary cards were analysed from the 41 
remaining patients (age 71 +/-9, 58.5% male). Patients accurately documented time 
and duration of their symptoms and this was correlated with device Holter AF episodes. 
Symptoms without corresponding AF, asymptomatic AF, and symptomatic AF could then 
be described.
Results: 1,960 days (5.4 years) of corresponding Holter and symptom diaries were 
analysed. 194 symptom episodes without AF, 333 symptom episodes with AF, and 4,274 
episodes of asymptomatic AF were recorded. 92.8% of AF was asymptomatic. 36.8% 
of reported symptoms were not AF related. 63.2% of symptoms exactly correlated with 
episodes of AF (see ﬁgure).
Conclusions: In highly symptomatic PAF patients the majority of symptoms are due to 
AF episodes. However, the majority of AF detected by the devices was asymptomatic. 
Thus trials suggesting therapeutic efﬁcacy of drugs and other interventions must be 
interpreted with caution, without complete beat to beat information.
1015-135 Do Implantable Cardioverter-Deﬁbrillator Patients Have 
Adequate Rate Control During Atrial Tachyarrhythmias? 
Results From a New Continuous Long-Term Monitoring 
System
Kevin T. Ousdigian, Daniel Weiss, Charles J. Lanzarotti, Jodi Koehler, Bruce L. Wilkoff, 
Medtronic, Inc., Minneapolis, MN
Background: Poor ventricular (V.) rate control during atrial tachyarrhythmias (AT/AF) has 
been associated with worse clinical outcomes, including cardiovascular hospitalizations. 
Implantable cardioverter-deﬁbrillators (ICDs) shocks have been associated with 
diminished quality of life. Some newer ICDs have a feature (Cardiac CompassTM) which 
records the daily time in AT/AF and the daily mean V. rate during AT/AF for up to 425 days. 
The objective of this study was to characterize the long-term AT/AF burden and V. rate 
control in ICD patients (pts) and determine if poor rate control was associated with shocks 
for supra-ventricular tachycardias (SVTs).
Methods: A retrospective analysis was conducted on pts enrolled in the large, worldwide 
EMPIRIC trial. Pts were included if they had >=30 trend days. A pt was considered to have 
poor rate control if they had at least one day with >=6 hours AT/AF duration and a mean 
V. rate >100 bpm during the AT/AF. All episodes with electrograms were adjudicated by 
at least two reviewers. The proportion of pts with poor rate control and SVT shocks were 
computed. Fisher’s exact test was used to determine signiﬁcance.
Results: A total of 900 pts received a dual chamber ICD (Marquis DR Model 7274) and 
were enrolled in the EMPIRIC trial. Of these, 845 pts had >= 30 trend days with a mean 
of 340+-76 days. The mean age was 64.7+-12.5, EF = 32.3+-12.7%, and 25.2% of pts 
had a history (hx) of AT/AF. There were 142 pts (17%) with >= 6 hrs AT/AF on at least 
one day, including 41% (88/213) of pts with a hx of AT/AF and 9% (54/632) of pts without 
a hx of AT/AF. Of the 142 pts with >= 6 hours AT/AF, 52% had poor rate control (mean V. 
rate >100 bpm during the >=6 hrs AT/AF) on at least one day. The proportion of pts with 
inappropriate SVT shocks increased from 12% (8/68) in pts with adequate rate control to 
28% (21/74) in pts with poor rate control (p=0.02).
Conclusions: About half (52%) of ICD patients with longer duration AT/AF have poor V. 
rate control. Poor rate control in these pts is associated with an increased probability of 
receiving an inappropriate SVT shock. The long-term trends of AT/AF burden and V. rate 
during AT/AF may help identify pts who require more vigilant monitoring or interventions
1015-136 Prognostic Signiﬁcance of Interleukin-2 for the 
Pharmacological Cardioversion of Recent Onset Atrial 
Fibrillation
Spiros Dragomanovitch, Ioannis Rizos, Sotirios Papathanasiou, Angelos Rigopoulos, 
Andreas Kalogeropoulos, Androkles Andreadis, Hariton Antonakoudis, Dimitrios 
Kremastinos, Attikon General Hospital, University of Athens, Athens, Greece, 
Asklepeion General Hospital, Athens, Greece
Background: Several recent studies have provided clues of a relation between atrial 
ﬁbrillation (AF) and inﬂammation. This relation is not fully understood in terms of cause 
and effect. IL-2, IL-6 and hs-CRP are inﬂammatory mediators released in serum 
at various stages of the inﬂammatory cascade. Aim of this study is to investigate the 
signiﬁcance of these serum markers for the success of pharmacological cardioversion 
of recent onset AF. Methods: We studied 65 patients with recent onset AF(<24 hrs, 
mean 6±4 hrs) who were admitted for cardioversion with amiodarone. Exclusion criteria 
were: active inﬂammatory disease, recent trauma or surgery, acute coronary syndromes, 
pulmonary embolism, heart failure NYHA>II, chronic airway disease, hepatic or renal 
failure, hyperthyroidism, recent use of corticosteroids or antiiﬂammatory drugs. Patients 
underwent thorough physical examination, ECG, routine laboratory evaluation, thyroid 
hormone measurement, echocardiography and measurement of IL-2, IL-6 and hs-CRP on 
admission and at 48 hrs. Anticoagulation was given according to guidelines. Amiodarone 
was given (5mg/kg iv bolus in 20 mins and then 500-900 mg iv in 12 hrs) and the ECG 
was monitored for 48 hours.
Results: Within 48 hrs 55/65 patients (84.6%) had successful cardioversion to sinus 
rhythm (responders), whereas 10/65 (15.4%) remained in AF (nonresponders). IL-2 
on admission was signiﬁcantly higher in nonresponders than in responders (1.2±1.3 vs 
0.45±0.55 U/ml respectively, p=0.004). On the contrary the difference of the two groups 
for IL-6 (5.23±4.25 vs 6.62±13.6 pg/ml p=0.75) and hs-CRP (5.39±3.6 vs 8.81±21.3mg/lt 
p=0.6) on admission, was nonsigniﬁcant. At 48 hrs nonresponders had a signiﬁcant rise in 
both IL-6 (5.23±4.2 vs 36±37 pg/ml, p=0.026) and hs-CRP (5.39±3.6 vs 25.21±13.75mg/
lt p=0.001) and a decline in IL-2 (1.184±1.3 vs 0.306±0.29 U/ml p=0.04). Responders at 
48 hrs showed nonsigniﬁcant changes of the measured parameters.
Conclusion: In patients with recent onset of AF IL-2 is increased in non-responders to 
pharmacological cardioversion, whereas it remains normal in responders. These ﬁndings 
emphasize the crucial role of inﬂammation and in particular IL-2 in AF.
1015-137 Biochemical Markers of Collagen Turnover in Atrial 
Fibrillation
Yoshioki Nishimura, Keiji Yamamoto, Masaru Ichida, Yukihiro Hojo, Yuji Umeda, Hideyuki 
Fujikawa, Kazuyuki Shimada, Jichi Medical School, Tochigi, Japan
Background: Fibrosis of atrium is associated with the initiation or perpetuation of 
atrial ﬁbrillation (AF). Serum concentration of collagen marker is related to myocardial 
ﬁbrosis in hypertensive patients. Methods: We determined levels of pyridinoline cross-
linked carboxyterminal telopeptide of type I collagen (ICTP), a marker of collagen type 
I degradation, and procollagen type III aminoterminal peptide (PIIINP), a marker of 
collagen type III synthesis, in 21 control subjects, 12 paroxysmal AF patients and 12 
chronic AF patients, and we also measured ANP and BNP levels. We determined left 
ventricular mass index (LVMI) and left atrial volume (LAV) /body surface area (BSA) by 
echocardiography, and investigated the relationship between serological markers (BNP, 
ANP, ICTP, PIIINP) and echocardiographic parameters. Results: ICTP level in chronic 
AF was signiﬁcantly higher than that in control group (p<0.05). Moreover, ICTP level 
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in AF was correlated with BNP (r=0.68, p<0.001), ANP (r=0.42, p<0.05) and LAV/BSA 
(r=0.45, p<0.05), but not with LVMI. ANP was correlated with LAV/BSA (r=0.55, p<0.01). 
Conclusions: The present study demonstrated that collagen turnover was accelerated 
in chronic AF, suggesting that the maintenance of AF is associated with atrial ﬁbrosis. 
In addition, ICTP level in AF reﬂected LA remodeling independently of left ventricular 
hypertrophy in AF. Collagen markers have a possibility to indicate the atrial ﬁbrosis as 
well as the atrial remodeling in AF.
Correlations
PIIINP ANP BNP LAV/BSA LVMI
ICTP rp
0.524
0.001
0.415
0.049
0.676
0.001
0.449
0.028
0.255
0.229
PIIINP rp
0.311
0.149
0.320
0.028
0.203
0.340
0.136
0.527
ANP rp
0.681
0.001
0.550
0.007
0.088
0.688
BNP rp
0.571
0.004
0.238
0.262
LAV/BSA rp
0.253
0.233
 
1015-138 Anatomical Remodeling of Left Atria in Subjects with 
Chronic and Paroxysmal Atrial Fibrillation Evaluated by 
Multislice Computed Tomography
Nobusada Funabashi, Miki Asano, Marehiko Ueda, Issei Komuro, Chiba University 
Graduate School of Medicine, Chiba, Japan
Background: We used ECG-gated enhance multislice computed tomography (MSCT) 
to evaluate and compare anatomical change to left atria (LA) including left atrial 
appendage (LAA) in subjects with chronic and paroxysmal atrial ﬁbrillation (CAF and PAF, 
respectively). Methods: Retrospective ECG-gated MSCT (Light Speed Ultra 16, General 
Electric) was performed in 16 subjects with CAF (10 male, median age 68/period of CAF 
6 years, 3 severe or moderate mitral stenosis (MS), 3 mitral regurgitation (MR)) and 17 
with PAF (11 male, median age 62/period of PAF 3 years, one MS, one MR) 30 seconds 
and 8 minutes after injection of contrast. We evaluated: qualiﬁed observed morphology 
of pectinate muscles (PM) in LAA (well/poorly/non- developed); absolute thickness of LA 
anterior wall; presence of abnormal late enhancement (LE) of LA wall suggesting ﬁbrotic 
changes; defect of contrast in LAA only in early phase and LAA enlargement; comparison 
of LA diameter evaluated by 4-chamber view obtained by transthoracic echocardiogram. 
Results: CAF group: well-developed PM (19% subjects), poor PM (44%), no PM (38%). 
PAF group: well-developed PM (41%), poor PM (47%), no PM (12%). Incidences of well- 
and non-developed PM were signiﬁcantly less and more in CAF group, respectively. CAF 
subjects with no PM had longer periods of CAF and larger LA diameter than those with 
developed PM (P<0.01). By contrast, there was no relation between PM morphology and 
PAF periods or LA diameter. Incidence and mean thickness of abnormal LE of LA wall was 
similar in both groups (2.6mm): 25% (CAF); 24% (PAF). There was a negative correlation 
in the CAF group between thickness of LA wall and LA diameter (R2=0.19), but not in 
the PAF group. Contrast defect in LAA only in early phase and enlargement of LAA were 
observed in 56%, 88% (CAF) and 24%, 41% (PAF); ratios were signiﬁcantly higher in 
CAF group (p<0.01). Conclusions: There were anatomical differences between CAF 
and PAF groups in MSCT. In CAF group, depending on the period of CAF or degree of 
LA diameter enlargement, anatomical remodeling (e.g. recession of PM, thinning of LA 
wall, enlargement of LAA) may appear, which may cause blood ﬂow stagnation, seen as 
contrast defect in LAA in early phase.
1015-139 Effect of Left Atrial Decompression by Percutaneous 
Mitral Commissurotomy on Atrial Electrophysiologic 
Properties
Hyong Jun Kim, Dong-Gu Shin, Jang-Won Sohn, Hyeun-Su Cho, Gue-Ru Hong, Jung-Sun 
Park, Yong-Jo Kim, Bong-Sub Shim, Yeungnam University Hospital, Daegu, South Korea
Background and objective : Atrial dilatation contributes to the inducibility of atrial 
ﬁbrillation(AF) by changing atrial electrophysiological properties. None of the data 
was collected from the left atrium(LA), where the most signiﬁcant electrophysiological 
impact might be expected to occur in case of mitral stenosis(MS). We investigated 
electrophysiological chages after reduction of LA pressure in patients undergoing 
percutaneous balloon mitral commissurotomy (PBMC).
Methods : Twenty-six patients(21 women, 50±12 years) with MS including seven sinus 
rhythm(SR) patients were studied. Effective refractory period (ERP), monophasic action 
potential duration (MAPD90), and conduction time (CT) were determined simultaneously 
in both atrium at 600, 500, 400, and 300 ms of drive cycle length (DCL). Restitution 
slope(RS) was also calculated by S1S2 method. Atrial ﬁbrillation cycle length (AFCL)and 
dominant Frequency (DF) in case of AF were calculated and all measurements were 
repeated after PBMC.
Results : Mean LA pressure was signiﬁcantly reduced after PBMC in both AF and SR 
patients (17.0±5.5 mmHg vs 10.4±4.0mmHg, P <0.01; 17.6±7.1mmHg vs 9.0±2.8mmHg, 
P <0.01). A signiﬁcant increases of ERP was observed in the LA ( 212±32ms vs 
241±41ms;P=0.1) after PBMC, but not in the right atrium(RA). The increase of MAPD90 
after PBMC was signiﬁcant in the LA at all tested DCL, but not in the RA. The CT also 
decreased signiﬁcantly at all the tested DCLs after PBMC. RS in the LA decreased from 
1.71±0.82 to 0.76±0.33 after PBMC.(P=0.028) AF induced in 3 of 7 SR patients by single 
atrial stimulation, which was abolished after PBMC. However, no signiﬁcant change of 
AFCL, DF and RS after PBMC were observed in AF group.
Conclusion : Chronic atrial stretch altered atrial electrophysiological milieu, especially of 
the LA, which was partially reversible in SR patients . This result support the theoretical 
basis for early intervention to reduce atrial pressure overload
1015-140 Risk of Ischemic Stroke in Atrial Fibrillation: Is There an 
Ethnic Difference in Its Incidence and in the Efﬁcacy of 
Warfarin?
Albert Y-J Shen, Janis F. Yao, Wansu Chen, Michael B. Jorgensen, Somjot S. Brar, 
Kaiser Permanente Medical Center, Los Angeles, CA
Background Studies showing that warfarin reduces atrial ﬁbrillation (AF) related strokes 
have included predominantly Caucasians and African Americans (AA). We sought to 
assess whether there is an ethnic difference in stroke incidence and warfarin efﬁcacy 
in reducing stroke.
Methods We identiﬁed all ﬁrst time hospitalizations for non-rheumatic AF in patients 
without prior or acute stroke from 1995 to 2000 for all 2 million plus Southern California 
Kaiser adult members. Average follow-up was 3.5 years. Warfarin use was obtained 
from pharmacy records, while AF, type of stroke, and other comorbidities were based 
on hospital discharge ICD-9 codes. We recorded the event rate of each ethnicity while 
on or not on warfarin.
Results We identiﬁed 20,835 AF hospitalizations, of which 15,860 (76%) were 
Caucasian, 1,650 (8%) were AA, 1,952 (9.4%) were Hispanics and 786 (3.8%) were 
Asians. There were 1448 ischemic stroke events. Treatment with warfarin reduced stroke 
rate by over half in all ethnicities except AA. After adjusting for age, gender, warfarin 
use, hypertension, diabetes, and heart failure, the hazard ratio for ischemic stroke with 
Caucasians as referent is shown. 
On warfarin Not on warfarin
# of Ischemic Strokes /Total 
Person-Years 176 / 16039 1272 / 56725
Ischemic Stroke/100 Person-Years Rate Ratio (95% CI)
All 1.10 2.24 0.49 (0.42 - 0.57)
Caucasian 0.99 2.21 0.45 (0.37 - 0.54)
AA 2.33 3.03 0.77 (0.52 - 1.14)
Hispanic 1.09 2.34 0.47 (0.28 - 0.78)
Asian 0.88 2.07 0.42 (0.17 - 1.06)
Adjusted Hazard 
Ratio 95% CI
Caucasian 1
AA 1.61 1.40 - 1.90
Hispanic 1.33 1.12 - 1.59
Asian 1.16 0.88 - 1.53
Conclusions In a large, multiethnic cohort of AF patients, the risk reduction for ischemic 
stroke with warfarin was statistically signiﬁcant for Caucasians and Hispanics, but not 
signiﬁcant for AA and Asians. After adjustment for risk factors and warfarin use, AA and 
Hispanics were at signiﬁcantly greater stroke risk than Caucasians.
1015-141 Nadroparin Versus Unfractionated Heparin for 
Anticoagulation of all Cause Atrial Fibrillation: Final 
Results of the NADROPAF Trial
Habib Gamra, Faouzi Addad, Mohamed Derdabi, Khaldoun Ben Hamda, Fethi Betbout, 
Sonia Hamdi, Zohra Dridi, Sabri Maaoui, Faouzi Maatouk, Hatem Bouraoui, Abdallah 
Mahdhaoui, Habib Ammar, Mohamed Ben Farhat, F Bourguiba University Hospital, 
Monastir, Tunisia, F Hached University Hospital, Sousse, Tunisia
Background: Few studies were conducted to test the safety and efﬁcacy of low molecular 
weight heparin (LWMH) as an anticoagulation modality in new onset atrial ﬁbrillation (AF) 
and most of those studies excluded high risk patients (pts) particularly those with valvular 
heart disease.
Methods:
The NADROPAF trial (Nadroparin for Atrial Fibrillation) is a prospective randomized open 
label multicenter study comparing Nadroparin versus unfractionated heparin (UH) in pts 
with all cause atrial ﬁbrillation of more than 48 hours duration. From October 2001 to June 
2005, 540 pts were included: 270 pts in each group. The demographic characteristics 
were similar between the 2 groups as shown in the table below.
LMWH UH p
Age (yrs) 60.3±12.2 60.3±12.4 NS
Sex (Female) 189 (70%) 186 (68.9%) NS
AF Etiology
Valvular Disease 59 (21.9%) 71 (26.3%) NS
Hypertension 97 (35.9%) 101 (37.4%) NS
Other 30 (11.1%) 28 (10.4%) NS
Lone 84 (31.1%) 70 (25.9%) NS
In hospital clinical events (death, hemorrhagic or ischemic events) were compared 
between the 2 groups.
Results:
There was only 1 death that occurred in the UH group. There was no major stroke in 
either group. However, transient ischemic attack was observed in 2 pts of the UH group. 
Major hemorrhagic event (gastro-intestinal bleeding) occurred in 1 pt of each group. 
Minor hemorrhage was observed in 2 pts of LMWH group and in 1 pt of UH group. The 
composite endpoint including death, embolic or hemorragic event was 1.1% in the LMWH 
group and 1.8% of UH group (p=0.65).
Conclusions:
Anticoagulation of AF from all cause including valvular heart disease can be safely and 
effectively accomplished by LMWH. These ﬁndings need to be conﬁrmed by other studies 
before recommending an outpatient management of all pts with AF.
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1015-142 Long-Term Follow-Up in Patients With Percutaneous 
Left Atrial Appendage Transcatheter Occlusion 
System (PLAATO): Risk of Thrombus Formation and 
Development of Pulmonary Venous Obstruction After 
Percutaneous Left Atrial Appendage Occlusion
Harald Schmidt, Christoph Hammerstingl, Giso von der Recke, David Hardung, Heyder 
Omran, St.-Marien-Hospital, Bonn, Germany
Background: A new interventional occlusion system for the left atrial appendage 
(PLAATO) has been introduced as an alternative treatment in patients with increased 
thromboembolic risk due to atrial ﬁbrillation (AF) and contraindications for oral 
anticoagulation (OAC). Occlusion of the left atrial appendage (LAA) may compress the 
left pulmonary vein and carries the risk of thrombus formation on the surface of the 
device. During the procedure the interatrial septum is punctured to access the left atrium. 
The aim of this prospective study was to evaluate the morphological and hemodynamical 
changes following the procedure by means of serial transthoracic and transesophageal 
echocardiographic examinations.
Methods: Since 2001 48 patients with persistent AF were included in the study (84 patient 
years) Echocardiographic examinations were performed 24 hours prior to the procedure, 
during the occlusion procedure, prior to discharge of the hospital, after 1, 3, 6, 12, 24, 
36 and 48 months. The echocardiographic analysis included the following parameters: 
morphology of the interatrial septum, peak pulmonary vein ﬂow and presence of thrombi 
on the surface of the device and in the left atrium.
Results: Small atrial septum defects are present in all patients immediately after the 
procedure and disappear within 6 months usually. ASD was still present in only 3 patients 
after 6 months. Presence of thrombi could be documented in two cases in the follow up 
period. In one patient a parietal thrombus was detected on the surface of the occluding 
device, another patient showed a thrombus at the interatrial septum. Under continued 
combined therapy of Clopidogrel and ASS for three months both thrombi disappeared. 
Peak ﬂow velocities of the pulmonary veins were not signiﬁcantly higher after positioning 
of the device (0.60 ± 0.15 prior versus 0.67 ± 0.14 m/s after the occlusion, p = ns).
Conclusion: Long term complications after percutaneous left atrial appendage occlusion 
are rare. Thrombotic appositions may occur rarely and disappear under continued 
antiplatelet therapy. The risk of remaining ASD is low.
1015-143 Stroke Prevention Technology for Patients With Non-
Valvular AF - Worldwide Experience with the New 
WATCHMAN LAA System
Peter B. Sick, Matthias Ulrich, Karl Eugen Hauptmann, Eberhard Grube, David Holmes, 
Zoltan Turi, Michael Mooney, Steven Almany, Gregory Mishkel, Steven Yakubov, Gerhard 
Schuler, University of Leipzig, Heart Center, Leipzig, Germany
Background: Multiple studies have conﬁrmed the presence of thrombus in the left atrial 
appendage (LAA) in more than 90% of patients with stroke related to atrial ﬁbrillation 
(AF).
Methods: The WATCHMAN LAA system (Atritech, Inc., Minneapolis, MN) is placed in the 
LAA via transseptal puncture to prevent the occurrence of thromboembolism. The implant 
has a 160 micron polyethylene membrane on the proximal face of a nitinol cage and 
incorporates a row of ﬁxation barbs around the mid perimeter. The WATCHMAN device is 
available in 5 sizes (from 21 to 33 mm). Since August 2002, implantation was started in 
Europe, in October 2003 also in the US. Patients were assessed at 45 days and 6 months 
with TEE and chest x-ray and annual clinical assessments thereafter. Clinical endpoint 
was rate of ischemic stroke, systemic embolism and major bleedings.
Results: In 66 patients worldwide the device has been implanted successfully with a 
101.4 cumulative implant years. Mean age was 69.2 years (47-85), 66% were male. 
Baseline CHAD-Score was 1.7 (0-5) and mean procedure time 59 min (35-157). Two 
patients experienced device embolization, both successfully retrieved percutaneously. 
No further embolizations have occurred, since the ﬁxation barbs were enhanced. 
Five pericardial effusions, two of them needing percutanuous puncture, one major air 
embolism, all without long term sequelae and one delivery system issue (ﬁrst generation 
design) have been reported. In 97.1% of patients warfarin was ceased at 6 months. 
Four patients, however, had a ﬂat thrombus on the device at 6 months, one of these 
patients developed a transient ischemic attack (TIA). So warfarin was restarted in these 
patients but again stopped after removal of thrombus. Another patient with a history of 
TIA experienced a TIA without LAA-thrombus visible. No ischemic stroke or systemic 
embolism have occurred. One patient died after 9 months due to an ascending aortic 
dissection. Autopsy documented a stable, well endothelialized device.
Conclusions: Preliminary data suggest the WATCHMAN LAA system to be safe and 
feasible. Further randomized study is ongoing to determine the long term effect of this 
technology on stroke reduction in comparison with warfarin.
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